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Pt(II) complexes bind preferentially at N7 of G residues of DNA, causing DNA structural 
distortions associated with anticancer activity. Some distortions induced by difunctional cisplatin 
are also found for monofunctional Pt(II) complexes with carrier ligands having bulk projecting 
toward the guanine base. This ligand bulk can be correlated with impeded rotation about the Pt–
N7(guanine) bond. The objective of this study is to understand the influences of in-plane bulk of 
Pt(Ltri)G adducts (Ltri = tridentate carrier ligand, G = guanine derivative bound to a metal, but 
not tethered to another nucleobase). 
NMR spectroscopy provided conclusive evidence that Pt(Ltri)G (Ltri = di-(2-picolyl)amine 
(N(H)dpa), N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6-Medpa), di-(6-methyl-2-
picolyl)amine (N(H)6,6!-Me2dpa), N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6,6!-
Me2dpa), N(Me)-di-(6-methyl-2-picolyl)amine (N(Me)6,6!-Me2dpa), N(propionoic acid)-di-(6-
methyl-2-picolyl)amine (N(prop)6,6!-Me2dpa), and tri-(6-methyl-2-picolyl)amine (6,6!,6!!-
Me3tpa)) adducts exist as interconverting mixtures of syn and anti rotamers from the observation 
of two sharp, comparably intense guanine H8 NMR signals. Rotational interchange is impeded 
by Ltri, and the key interactions involved steric repulsions between the pyridyl and guanine rings.  
When G is added to [Pt(N(H)6,6!-Me2dpa)Cl]Cl, the expected Pt(N(H)6,6!-Me2dpa)G mono 
adduct forms having syn and anti conformers, but also the Pt(N(H)6,6!-Me2dpa)G2 bis adducts 
consisting of ΛHT and ΔHT conformers (HT = head-to-tail). When G is added to Pt(N(R)6,6!-
Me2dpa)G adducts, the transformation of the bis adducts Pt(N(R)6,6!-Me2dpa)G2 are 
dramatically lessened, particularly when the bulk of the R group is increased. The stability of the 
Pt(N(R)6,6!-Me2dpa)G mono adducts are explained by the increased bulk of the N-substituent, 
making the bidentate coordination mode of the carrier ligand unfavorable. 
!
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CHAPTER 1. INTRODUCTION 
 
Platinum(II) compounds and their interactions with nucleotides have been studied 
extensively.1-8 The widely used anticancer drug, cisplatin (cis-Pt(NH3)2Cl2), is a compound that 
has been known of since 1845,9,10 but its antitumor activity was not discovered until 1970.11-13 
Cisplatin has been used to treat a variety of malignancies including ovarian, cervical, head and 
neck, esophageal, and nonsmall cell lung cancer.3,14,15 The discovery of cisplatin triggered a 
widespread search for related compounds with better or similar activity. Side effects, including 
nephrotoxicity, emetogenesis and neurotoxicity, have limited cisplatin treatments.16-18 After 
cisplatin is administered and enters the cells, hydrolysis occurs, and water replaces the chloride 
ligands to form a species with aqua ligands (Figure 1.1).19,20-25  The aqua complex is known to be 
the active form of the drug.19,20,21 The aqua complex can form coordinatively covalent adducts 
with various cellular components like glutathione, proteins, DNA and RNA, but DNA has been 
accepted as the critical molecular target responsible for antitumor activity of cisplatin.26,27,28 
!
 
Figure 1.1: Schematic representation of cellular uptake and activation of cisplatin (cis-
Pt(NH3)2Cl2) prior to DNA binding. 
!
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Three main types of DNA adducts that are formed with platinum compounds: intrastrand 
cross-links, interstrand cross-links, and monofunctional adducts.29-31 Cisplatin and related 
Pt(Lbi)X2 analogues (Lbi = one bidentate or two cis-unidentate N-donors, X2 = anionic leaving 
groups) attack the N7 of two adjacent G bases to form predominantly 1,2 intrastrand G*G* 
cross-link lesion. 6,32,18,33-36 G residues in DNA or oligomers with a Pt(II) bound to N7 are 
designated as G*. The distortions induced on the DNA structure upon formation of the 1,2-
intrastrand cisplatin-DNA lesion have been shown to inhibit the processes of replication and 
transcription, resulting in cell death. Much attention has been focused on the G*G* cross-link 
lesion as the active lesion responsible for anticancer activity of cisplatin.19,27 
X-ray studies of an HMG-bound 16 oligomer duplex,37 and a subsequent X-ray/NMR-
derived model of a 9 oligomer duplex,38 both containing an intrastrand cisplatin lesion, revealed 
an unusual XG* base pair (bp) step. The XG* bp step distortion involves the X•Y bp adjacent to 
the 5!-G*•C bp in the 5! direction along the duplex (referred to as the Lippard bp step, Figure 
1.2)39 and is characterized by a large positive shift and a large positive slide. Base pair steps are 
characterized by using shift, slide, and rise values to describe the nature of the DNA helix.40 The 
distortions caused by the G*G* cross-link bp step lesion and the XG* bp step lesion contain the 
largest departure from the B-DNA form. The distorted XG* bp step could possibly be more 
important towards anticancer activity than the distortion caused by the G*G* cross-link bp 
step.39,41 
X-ray studies of an oligomer adduct of a rather bulky monofunctional Pt anticancer agent, 
cis-[Pt(NH3)2(pyridine)Cl]+ (cDPCP), revealed a similar shift and slide of the XG* bp step 
(involving the X•Y bp that is adjacent to the G*•C bp in the 5! direction along the duplex), as 
seen for the cisplatin lesions.42,43 The monofuctional drug cDPCP was bound to the N7 atom of a 
!
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single guanosine residue in a DNA dodecamer duplex, and it was discovered that cDPCP blocks 
transcription from DNA template carrying adducts of the complex.42 Thus, for monofunctional 
drugs to be anticancer active, there needs to be enough bulk at one cis position to induce the 
XG* bp step distortion in DNA. 
 
Figure 1.2: Representation of the distorted XG* base pair step and G*G* cross-link base pair 
step 
 
1.1. Pt(Lbi)G2 Adducts 
Guanine bases coordinated in positions cis to a metal can have a head-to-tail (HT) or a 
head-to-head (HH) orientation (Figure 1.3). For Pt(Lbi)G2 adducts (G = guanine derivative bound 
to a metal, but not tethered to another nucleobase, Lbi = one bidentate or two cis unidentate amine 
N donors), the G bases preferentially adopt the HT orientation.44-48 In contrast, bases tethered by 
a sugar phosphate backbone, such as in Pt(Lbi)(d(G*pG*)) cross-link adducts, are most often 
found in the HH orientation, especially when a 5!-residue is present on the 5!-G* (for example, in 
Pt(Lbi)(d(TG*G*T)) adducts).27,46-48 Interconversions of HH to HT conformations via rotation 
about the Pt–N7 bonds in cis-Pt(Lbi)G2 and cross-link adducts are rapid on the NMR time scale 
!
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unless the Lbi carrier ligand is bulky. Bulky bidentate ligands lower the rotation rate, allowing 
observation of NMR signals of the conformers present in solution. Because the guanine H8 
(Figure 1.3) 1H NMR H8 signals are singlets and downfield, they are the most useful signals for 
assessing metal binding and the presence of rotamers that could arise from restricted rotation 
about the Pt–N7 bonds of cis-Pt(Lbi)G2 adducts.27,46,49-54 The study of Pt(Lbi)G2 adducts provides 
useful guidance and insight on ligand bulk and on whether such bulk can influence the properties 
of the bound nucleobase. 
 
Figure 1.3: Possible conformers for Pt(Lbi)G2 adducts (A) and possible rotamers for mono Pt(II) 
adducts (B). A generic version of G is depicted, along with the guanine base numbering scheme. 
Note that the nucleobase is represented by an arrow with the tip at the guanine H8 atom. N, N!, 
and N!! represent a nitrogen donor ligand. For bis adducts (A), when (N ≠ N!), four rotamers 
(HHu, HHd, ΛHT, ΔHT) are possible, whereas when (N = N!), only three conformers (HH, 
ΛHT, ΔHT) are possible because HHu = HHd. For mono adducts (B), both possible base 
orientations (arrow up and arrow down) lead to only one rotamer if R is not chiral, N, N!, and N!! 
are symmetric with respect to the coordination plane, and N = N!!. If N is not equal to N!!, the 
two orientations represent two rotamers. If N! is not symmetric with respect to the coordination 
plane, then there are two rotamers regardless of whether or not N = N!!. 
 
The number of observable NMR signals for Pt(Lbi)G2!adducts is determined by the local 
symmetry of the carrier ligand and asymmetry of the G ribose residue. When Lbi = a C2-
symmetrical achiral bidentate ligand, up to three [one HH and two HT (ΛHT, ΔHT)] rotamers 
may be observed in a Pt(Lbi)G2 adduct. For G = 9-ethylguanine (9-EtG), each base arrangement 
!
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(HH or HT) gives rise to only one 1H NMR signal for each proton because the two G bases, in 
either the HH or HT arrangement, are equivalent. However, in Pt(Lbi)G2 adducts, where Lbi = an 
unsymmetrical achiral bidentate ligand, four rotamers (HHu, HHd, ΛHT, ΔHT) are possible 
(Figure 2.1). The G ligands in all conformers are no longer equivalent; if G has either a chiral or 
an achiral group at N9, two H8 signals per rotamer are expected. Thus, a maximum of eight H8 
signals could possibly be observed if all four conformers exist and all are in slow exchange. If 
the Lbi is both unsymmetrical and chiral and if G lacks a chiral group, the situation is the same, 
i.e., a potential maximum of eight H8 signals could arise for such Pt(Lbi)G2 adducts.  
1.2. Pt(Ltri)G Adducts 
In Pt(Ltri)G adducts (Ltri  = a tridentate, one bidentate and one monodentate, or three 
monodentate ligands), the nucleobase orients roughly perpendicular to the coordination plane 
(defined by the Pt and the four ligating atoms of the pseudo square planar complexes, Figure 1.3, 
B). For the Pt(Ltri)G adducts, two possible base orientations are possible (arrow up and arrow 
down). Both orientations lead to only one rotamer if R is not chiral, N, N!, and N!! are symmetric 
with respect to the coordination plane, and N = N!!. If N is not equal to N!!, the two orientations 
represent two rotamers. If N! is not symmetric with respect to the coordination plane, then there 
are two rotamers regardless of whether or not N = N!!. 
To assess whether Ltri is bulky enough to interact with a guanine residue, thereby 
influencing the structure of the Pt DNA adduct, one must determine if G nucleobase rotation 
around Pt–N7 bond in Pt(Ltri)G adducts is hindered sufficiently by Ltri bulk to allow observation 
of separate sets of NMR signals for the rotamers. For non-bulky Ltri, rotation about the Pt–N7 
bond is fast on the NMR time scale, and the single H8 NMR signal observed typically for each 
unique G represents the time average of the two guanine orientations. For bulky Ltri, rotation 
!
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about the Pt-N7 bond could be hindered enough to give two separate H8 NMR signals for the 
two rotamers present in a mixture. 
For monofunctional Pt(II) agents, understanding the steric effects of bulky carrier ligands 
with guanine nucleobases can aid in understanding the effects of carrier ligand bulk on the 
mechanism of action leading to the XG* distortion of DNA. Thus, in the studies presented here, 
we assess the interactions of nucleic acid substituents with carrier ligands having in-plane bulk 
and how these interactions influence the properties of Pt(Ltri)G adducts.  
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CHAPTER 2. GUANINE NUCLEOBASE ADDUCTS FORMED BY [PT(DI-(2-
PICOLYL)AMINE)Cl]Cl: EVIDENCE THAT A TRIDENTATE LIGAND WITH ONLY 




Cisplatin (cis-Pt(NH3)2Cl2) and related difunctional PtLX2 analogues (L = one bidentate 
or two cis-unidentate N-donors, X2 = anionic leaving groups) are among the most widely studied 
anticancer agents.1-11 DNA is generally accepted as the primary target.12,13 Difunctional Pt drugs 
attack G N7 of adjacent G residues, forming a G*G* intrastrand cross-link lesion.4,6,14-17 G 
residues in DNA or oligomers with a Pt(II) center bound to N7 are designated as G*. Intense 
interest over many years focused on the distortions caused in the G*G* base pair (bp) step, 
namely the relationship of the 5!-G*•C bp to the 3!-G*•C bp.12 However, more recent 
developments have shown that another bp step could be even more distorted. X-ray studies of an 
HMG-bound 16-mer duplex in the solid state,18 and a subsequent X-ray/NMR-derived model of a 
9-mer duplex in solution,19 both containing an intrastrand cisplatin lesion, revealed an unusual 
XG* bp step. The distortion involving the X•Y bp adjacent to the 5!-G*•C bp in the 5!-direction 
along the duplex (referred to as the Lippard bp step)20 is characterized by a large positive shift 
and a large positive slide. X-ray studies of an oligomer adduct of a rather bulky monofunctional 
Pt anticancer agent have revealed a similar shift and slide of the XG* bp step involving the X•Y 
bp that is adjacent to the 5!-G*•C bp in the 5!-direction along the duplex.21,22 For a difunctional 
agent, when L is bulky, activity decreases and toxicity increases.23-27 However, for a 
monofunctional Pt(II) agent, the opposite situation may hold true: greater ligand bulk appears to 
be correlated with enhanced activity.12,21,22,28  
*Reproduced with permission from American Chemical Society: Andrepont, C.; Marzilli, P. A.; 
Marzilli, L. G., “Guanine Nucleobase Adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: 
Evidence that a Tridentate Ligand with only In-plane Bulk Can Slow Guanine Base Rotation,” 
Inorg. Chem., 2012, (51), 11961-11970. Copyright 2012 American Chemical Society 
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In simple Pt(L)(G) [tridentate L] or Pt(L)(G)2 [bidentate L] adducts (boldface G is an N9 
guanine or N9 hypoxanthine derivative not linked to another nucleobase, Figure 2.1), the 
nucleobase orients roughly perpendicular to the coordination plane (defined by the Pt and the 
four ligating atoms of the pseudo square planar complexes, Figure 2.2). In Pt(II) adducts with 
DNA, the G* nucleobase orientation is strongly influenced by a combination of the DNA 
structure and the steric interactions of the nucleobase with the carrier ligand.29,30 Considerable 
effort has been expended in studying Pt(L)(G)2 models and in comparing results to related G*G* 
intrastrand models with short oligonucleotides.12,20,29,31-33 Both model types can have as many as 
two head-to-head (HH) and two head-to-tail (HT) rotamers, depending on the bulk and symmetry 
of L (Figure 2.2).24,29,34-39 However, the monofunctional adducts have at most one syn and one 
anti rotamer (Figure 2.2). Rotamers interconvert by rotation about the Pt–N7 bond.19,24,40-43  
 
Figure 2.1: Adduct formation reactions of [Pt(N(H)dpa)Cl]+ with various purine derivatives. 
 
Because a key aspect of designing new Pt(II) drugs is to learn the effects of carrier-ligand 
bulk on the mechanism of action leading to distortion of DNA, on activity, and on toxicity,30,36 it 
is important to gain a better understanding of steric effects in monofunctional adducts. One 
method of assessing whether a carrier ligand is bulky enough to interact with a guanine residue, 
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thereby influencing the structure of the Pt drug DNA adduct, is to determine if G nucleobase 
rotation around the Pt–N7 bond in Pt(L)(G) adducts is hindered sufficiently by L to allow 
observation of separate sets of NMR signals for the rotamers.17,31,35-37,40,41,43-45 downfield G H8 1H 
NMR signals have historically been the most useful signals for assessing the presence of 
rotamers.33,46-49 With a non-bulky L, rotation about the Pt–N7 bond is fast on the NMR time 
scale, and the single H8 NMR signal observed typically for each unique G represents the time 
average of the two guanine orientations.43,45-48,50,51  
DNA adducts of the monofunctional complex, [Pt(dien)Cl]Cl (dien = 
diethylenetriamine), have been studied extensively as a “control” useful in understanding the 
nature of DNA binding of difunctional Pt(II) anticancer drugs.51-56 From the data on Pt(dien)(G) 
adducts,51 it is clear that dien is a rather small non-bulky carrier ligand. Unlike cisplatin, small 
monofunctional agents do not greatly disrupt the DNA structure on adduct formation; for 
example, minimal change in the DNA CD spectrum was caused by [Pt(dien)Cl]Cl57 and 
[Pt(NH3)3Cl]Cl58 agents. Cisplatin, in contrast, causes large CD spectral changes.57,59,60 Likewise, 
evidence exists from 31P NMR data on DNA adducts that the DNA structure is distorted by cis 
difunctional Pt agents, but not by small monofunctional Pt agents.61,62 To assess how interactions 
of nucleic acid substituents (bases, phosphate groups, etc.) with a carrier ligand having in-plane 
bulk influence the properties of Pt(L)(G) adducts, we have used NMR techniques to study 
Pt(N(H)dpa)(G) adducts containing a tridentate carrier ligand, di(2-picolyl)amine (N(H)dpa), 
with G = 5!-GMP, 5!-GDP, 5!-GTP, guanosine, 9-EtG, and 5!-IMP (Figure 2.1). Limited studies 
of Pt and Pd N(H)dpa complexes have shown evidence for cytotoxicity.63,64 However, the 

























Figure 2.2: Possible rotamers for mono and cis bis Pt(II) adducts of purine ligands illustrated 
using guanine nucleobase N9 derivatives as an example. Note that the nucleobase is represented 
by an arrow with the tip at the H8 of the purine. For the monoadducts (top two drawings), both 
possible base orientations (arrow up and arrow down) lead to only one isomer if R is not chiral, 
A, B, and C are symmetric with respect to the coordination plane, and A = C. If A is not equal to 
C, the two orientations represent two rotamers. If B is not symmetric with respect to the 
coordination plane, then there are two rotamers regardless of whether or not A = C. The middle 
two drawings show the HH orientation (left) and the HT orientation (right). For a given purine 
nucleobase derivative, as many as four rotamers are possible depending on whether or not A = B. 
 
2.2 EXPERIMENTAL SECTION 
 
2.2.1 Starting Materials 
K2[PtCl4], N(H)dpa, guanosine (Guo), 5!-guanosine monophosphate disodium salt (5!-
GMP), 5!-guanosine diphosphate sodium salt (5!-GDP), 5!-guanosine triphosphate sodium salt 
(5!-GTP), 5!-inosine monophosphate (5!-IMP), and 9-ethylguanine (9-EtG) were obtained from 
Aldrich. cis-Pt(DMSO)2Cl265 and [Pt(N(H)dpa)Cl]Cl66 were synthesized as described in the 
literature. 
2.2.2 NMR Measurements  
NMR spectra were recorded on a 400 MHz Bruker spectrometer, typically with 10 mM 
samples in a D2O/DMSO-d6 mixture (pH adjusted with 0.5 M solutions of DCl or NaOD in 
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D2O). For 1H NMR and 13C NMR spectra in D2O/DMSO-d6, peak positions are referenced 
relative to TMS by using the signals at 2.50 ppm (residual) and 39.5 ppm, respectively, of 
DMSO-d6.67 A presaturation pulse to suppress the water peak was used when necessary. ROESY 
experiments were performed at 5 °C by using a 200 ms mixing time. 1H–13C HSQC NMR spectra 
were recorded in order to assign the signals of the adducts. NMR data were processed with 
TopSpin and MestreNova software.  
2.2.3 Pt(N(H)dpa)(5!-GMP) Adduct  
A 28.6 mM solution of [Pt(N(H)dpa)Cl]Cl in DMSO-d6 (210 μL) was treated with a 38.5 
mM solution of 5!-GMP in 390 μL of D2O to give a 1:2.5 ratio (10 mM:25 mM) of Pt:5!-GMP, 
and the solution (pH ~4) was kept at 25 °C. A solution of D2O and DMSO-d6 (65:35) was 
employed to improve the solubility of the reactants. The reaction mixture was monitored by 1H 
NMR spectroscopy until there was no change in the bound vs. free H8 signal intensity, or until 
the [Pt(N(H)dpa)Cl]+ signals completely disappeared. 
2.2.4 Other Pt(N(H)dpa)(G) Adducts  
Adducts of 5!-GDP, 5!-GTP, Guo, 9-EtG, and 5!-IMP were formed in D2O/DMSO-d6 in a 
manner similar to that used for 5!-GMP. Reactions were monitored at various intervals from 10 
min to 6 d by 1H NMR spectroscopy as described above. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Background 
Two rotamers differing with respect to the G base orientation (Figure 2.2) are 
conceivable for Pt(II) complexes of the type, Pt(L)(G), when L = a tridentate carrier ligand that 
is unsymmetrical with respect to the coordination plane but symmetrical about a plane 
perpendicular to the coordination plane. The Pt(N(H)dpa)(G) adducts fall into this category 
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because the central N–H of the N(H)dpa carrier ligand projects out of the coordination plane 
(Figure 2.3). In the present study, we adopt a known stereochemical convention44 as follows: the 
rotamer with the H atom of the central N–H group and the guanine O6 on the same side of the 
coordination plane is named syn, and the rotamer with these groups on the opposite side of this 
plane is named anti (Figure 3). In a study of Pt(Me5dien)(G) adducts (Me5dien = N,N,N!,N!!,N!!-
pentamethyldiethylenetriamine), Carlone et al.44 found that the Pt(Me5dien)(5!-GMP) adduct 
gave two sharp H8 NMR signals ~0.8 ppm downfield from the free 5!-GMP H8 signal. This 
result indicates that the adduct exists as a mixture of both possible rotamers. In contrast, 
Pt(dien)(G) adducts show only one sharp H8 signal,51,52,56,68,69 indicating unimpeded rotation of 
the nucleobase, as would be expected from the low dien bulk. Thus, it is clear that the terminal 
dimethylamino groups of Me5dien have enough bulk to hinder rotation of the guanine base about 
the Pt–N7 bond. Christoforou et al.45 later showed that having either one or two unsubstituted 
terminal NH2 groups in the tridentate carrier ligand was not sufficient to hinder G rotation about 
the Pt–N7 bond.  
 
Figure 2.3: The two possible rotamers (syn and anti) for Pt(L)(G) complexes with tridentate 
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane 
perpendicular to the coordination plane are illustrated for L = N(H)dpa. Also illustrated are the 
anisotropic pyridyl rings, showing the shielding of the H8 in the syn rotamer by the pyridyl rings. 
This shielding results in an upfield shift of the syn H8 signal. The H8 in the anti rotamer points 
away from the pyridyl rings, resulting in a downfield shift of the anti H8 signal compared to the 
shift of the syn H8 signal. 
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The 1H NMR spectra of all Pt(N(H)dpa)(G) adducts formed in the present study are 
consistent with impeded rotation of the purine nucleobase around the Pt–N7 bond. For example, 
the spectrum of the Pt(N(H)dpa)(5!-GMP) adduct shows two downfield H8 signals (Figure 2.4). 
 
Figure 2.4: The aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the Pt(N(H)dpa)(5!-GMP) adduct (top) (shifts in ppm). 
 
2.3.2 NMR Assignment Strategy  
1H and 13C NMR data and assignments for the Pt(N(H)dpa)(G) adducts and the 
[Pt(N(H)dpa)Cl]+ complex are collected in Tables 2.1, 2.2, and 2.3. In Figure 2.4, the bottom 
trace for [Pt(N(H)dpa)Cl]+ shows an H6/6! signal at ~8.6 ppm, but the spectrum of the 
Pt(N(H)dpa)(5!-GMP) adduct (top) has no doublets in this region. As discussed below, the 
anisotropy of the N7-coordinated guanine nucleobase shifts the H6/6! doublets into the same 
narrow shift region as the H3/3! doublets, and as many as four signals could conceivably be 
resolved for each type of proton in the Pt(N(H)dpa)(G) adducts. Shifts of the 13C NMR signals of 
C6/6! and C3/3! are likely to be in distinctive widely dispersed regions for both the simpler 
[Pt(N(H)dpa)Cl]+ complex and the Pt(N(H)dpa)(5!-GMP) adduct; therefore, we elected to use 
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HSQC spectroscopy to assign the [Pt(N(H)dpa)Cl]+ 13C NMR signals and to use these shifts as a 
guide in assigning the Pt(N(H)dpa)(5!-GMP) 13C NMR signals.  
Table 2.1: Selected 1H NMR Shifts (ppm) for G in Pt(N(H)dpa)(G) Adducts in D2O/DMSO-d6 at 
25 °C 
G H8 free H8 anti H8 syn H1! free H1! anti H1! syn 
9-EtGa 7.67 8.73 8.40 - - - 
Guo 7.91 8.95 8.61 5.71 5.93 5.85 
5!-GMPb 7.96 9.08 8.72 5.71 5.98 5.91 
5!-GDP 7.98 9.15 8.79 5.70 5.97 5.90 
5!-GTP 7.97 9.21 8.79 5.70 5.98 5.91 
5!-IMPc 8.33 9.44 9.09 5.93 6.19 6.13 
 
a CH2: 4.16 (anti), 4.05 (syn), and 3.90 ppm (free); CH3: 1.44 (anti), 1.34 (syn), and 1.24 ppm 
(free).    b H2!: 4.69 ppm, 4.53 ppm (free). c H2: 8.26 (syn), 8.17 (anti), and 8.05 ppm (free). 
!
2.3.3 [Pt(N(H)dpa)Cl]Cl Assignments  
The pyridyl 1H NMR signals for [Pt(N(H)dpa)Cl]+ (H6/6!, H5/5!, H4/4!, and H3/3!) are 
shown in Figure 2.4. The H6/6! signal must be a doublet and also the most downfield pyridyl 
signal because of the proximity of the H6/6! protons to the endocyclic nitrogen. The difference in 
coupling constants for the H6/6! doublet (J = 5.8 Hz) and the more upfield H3/3! doublet (J = 8.0 
Hz) allows assignments of the two pyridyl triplets: the triplet at 7.98 ppm with J = 7.8, ~7.7 Hz 
is H4/4!, and the triplet at 7.34 ppm with J = 5.8, ~7.7 is H5/5!. After the proton assignments of 
[Pt(N(H)dpa)Cl]+ were confirmed with a COSY experiment, the 13C NMR signals of 
[Pt(N(H)dpa)Cl]+ were assigned through an HSQC experiment (Table 2.3, Figure A.1, Appendix 
A). An HSQC cross-peak from the H6/6! signal at 8.61-150.4 ppm assigns the C6/6! 13C NMR 
signal. Cross-peaks to the H3/3! (7.48-124.1 ppm), H4/4! (7.98-142.5 ppm), and H5/5! (7.34-
126.6 ppm) signals assign the C3/3!, C4/4!, and C5/5! signals, respectively. Cross-peaks from the 
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H7/7! signals at 4.73 and 4.49 ppm to the 13C NMR signal at 60.79 ppm assign the C7/7! signal. 
The 1D 13C NMR spectrum (shown in Figure A.1, Appendix A, and used for obtaining more 
precise shifts) reveals that the C2/2! signal (with no HSQC cross-peak) is the most downfield 13C 
NMR signal (Table 2.3), as expected from its proximity to the pyridyl nitrogen.  
Table 2.2: 1H NMR Shifts (ppm) and Coupling Constants (J, Hz) for the N(H)dpa Carrier Ligand 
in Pt(N(H)dpa)(G) and in [Pt(N(H)dpa)Cl]Cl in D2O/DMSO-d6 at 25 °C 
!
Cl or G H6/6! H5/5! H4/4! H3/3! 
Cla 8.61 (5.8) 7.34   7.98 7.48 (8.0) 





7.97 (7.8) 7.51 (8.0) 
5!-GDPc 7.58d (5.8)  
7.50e 
7.45f (5.8) 
7.23 7.98 (7.8) 7.50 (8.0) 
5!-GTPc 7.57d (5.8) 
7.49e 
7.43f (5.8) 






7.97 (7.9) 7.52 (7.7) 
Guoc 7.61d 
7.50f (5.7) 
7.25 8.02 (7.9) 7.54 (7.8) 
9-EtGc 7.56g 
7.48f (5.4) 
7.25 8.02 (7.8) 7.56 (8.0) 
a J values for H5/5! (5.8, ~7.7) and for H4/4! (8.0, ~7.7); H7/7!, endo-CH and exo-CH, 
respectively, 4.73 and 4.49 ppm. In DMSO-d6, ppm (Hz): NH, 9.03; H6/6!, 8.81 (5.8); H5/5!, 
7.63 (~6.8); H4/4!, 8.24 (~7.9); H3/3!, 7.77 (7.9); and H7/7!, endo-CH and exo-CH, respectively, 
4.92 (15.9, 8.9) and 4.60 (15.9, 5.1). b H7/7!, endo-CH and exo-CH, respectively, 4.80 and 4.57 
ppm. c J values not determined for H5/5! because of overlap of rotamer signals, and the H4/4! 
values are generally an approximate average value for coupling to H3/3! and H5/5!.  d anti. e syn, 
but overlapped with the H3/3! signal. f syn. g anti, but overlapped with the H3/3! signal. 
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For [Pt(N(H)dpa)Cl]Cl, thc C7 and C7! methylene groups are equivalent, but in each the 
protons are not equivalent and are designated as endo-CH and exo-CH protons, respectively 
(Figure 2.5). From the Karplus equation, the N–H-C–H coupling constant should be larger for 
the endo-CH signal than for the exo-CH signal, owing to the larger dihedral angle between the 
N–H and the endo-CH protons. Because N–H exchange with D2O occurs in the D2O/DMSO-d6 
mixture, a 1H NMR spectrum of [Pt(N(H)dpa)Cl]Cl in DMSO-d6 was recorded. The downfield 
H7/7! signal at 4.92 ppm has a higher N–H-C–H coupling constant (8.9 Hz) and is assigned to 
endo-CH. The upfield H7/7! signal at 4.60 ppm (5.1 Hz) is assigned to exo-CH. Thus, in the 1H 
NMR spectrum of [Pt(N(H)dpa)Cl]Cl in D2O/DMSO-d6, we assign the downfield H7/7! signal at 
4.73 ppm to endo-CH and the upfield H7/7! signal at 4.49 ppm to exo-CH. 
Table 2.3: 13C NMR Spectral Data (ppm) for [Pt(N(H)dpa)Cl]Cl and the Pt(N(H)dpa)(5!-GMP) 
adduct in D2O/DMSO-d6 at 25 °C  
!
carbons [Pt(N(H)dpa)Cl]Cl Pt(N(H)dpa)(5!-GMP)a 
C6/6! 150.4 150.4 
150.0  
149.9  
C5/5! 126.6 126.9 
126.8 
C4/4! 142.5 142.8 
C3/3! 124.1 124.3 
C2/2! 167.5 167.2 
C7/7! 60.79 60.83 
60.77 
a C8: 141.0 (anti), 141.6 (syn), and 138.8 ppm (free); C1!: 89.72 (anti), 89.76 (syn), and 88.21 






Figure 2.5: Orientation of the pyridyl rings in the [Pt(N(H)dpa)Cl]+ cation, viewed along the 
coordination plane. Also shown, the designation of the endo-CH and the exo-CH protons. 
 
2.3.4 Pt(N(H)dpa)(5!-GMP) Adduct 
The reaction of [Pt(N(H)dpa)Cl]+ with 2.5 molar equiv of 5!-GMP was monitored in 
D2O/DMSO-d6 by 1H NMR spectroscopy at 10 min, 7 h, and 49 h after mixing. Even at 10 min, 
the spectrum (Figure A.2, Appendix A) exhibited two small, sharp, downfield singlets. These 
singlets provide evidence for restricted rotation of the adduct and clearly belong to H8, the only 
type of aromatic proton in the reaction mixture (Figure 2.1) that can give a singlet signal. The 
large downfield shift change of the product H8 singlets, relative to the free 5!-GMP H8 singlet at 
7.96 ppm, can be explained only by coordination of the 5!-GMP to Pt(II) via N7. The singlets at 
9.08 and 8.72 ppm (Figure 2.4) are assigned to the anti and syn rotamers (Figure 2.3), 
respectively (see below). The H1! doublets of the rotamers are also in a quite distinctive region 
(~5.9-6.0 ppm); these signals are shifted downfield of the H1! doublet of free 5!-GMP at 5.71 
ppm (Table 2.1 and Figure A.2, Appendix A). As commonly observed, the inductive effect of the 
Pt(II) shifts the H8 and H1! signals of Pt(L)(5!-GMP) adducts downfield compared to these 
signals for free 5!-GMP.43-45,52  
Two downfield H8 singlets were found for all of the Pt(N(H)dpa)(G) adducts (see 
below). Thus, G base rotation about the Pt–N7 bond is impeded in all adducts. We attribute the 
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cause of this restricted rotation to steric impedance of nucleobase rotation by the H6/6! protons, 
which are in a fixed position projecting toward the coordinated G nucleobase. However, the shift 
difference between the two H8 signals, Δδ, is ~0.36 ppm, considerably larger than the typical 
value, such as Δδ = 0.04 found for Pt(Me5dien)(5!-GMP).44!The pyridyl rings of the Pt(N(H)dpa) 
moiety do not lie exactly in the coordination plane (Figure 2.5), and the plane of the G 
nucleobase in adducts lies more or less perpendicular to the planes of the pyridyl rings and to the 
coordination plane. In the syn rotamer, the shielding region of the pyridyl rings projects over the 
guanine H8; hence, the syn H8 signal will be shifted upfield from the anti H8 signal because of 
the anisotropic effect of the N(H)dpa pyridyl rings (Figure 2.3). Thus, the anisotropy of the 
pyridyl rings not only explains the large Δδ, but also allows us to assign the rotamers by using 
H8 shifts. These rotamer assignments are also supported by analysis of the relative shifts of the 
N(H)dpa signals as described below. 
The ~1 ppm upfield shift of the H6/6! signals (Table 2.2) is the other large shift change 
accompanying adduct formation. The upfield shift of the H6/6! pyridyl signals of N(H)dpa upon 
Pt(N(H)dpa)(5!-GMP) adduct formation is similar to that of the H6/6! signals (~1.0-1.4 ppm) 
accompanying formation of Pt(5,5!-Me2Bipy)(5!-GMP)2 from the starting complex, Pt(5,5!-
Me2Bipy)Cl2 (5,5!-Me2Bipy = 5,5!-dimethylbipyridine).35 For both types of adducts, the H6/6! 
protons have a similar relationship to the guanine nucleobase.  
In contrast to the H6/6! protons, the H3/3! protons are the pyridyl protons of the 
Pt(N(H)dpa)(5!-GMP) adduct farthest from the coordinated guanine nucleobase. Thus, the H3/3! 
doublets of the adduct should have shifts (~7.50 ppm) similar to that of the H3/3! signal of the 
starting [Pt(N(H)dpa)Cl]+ complex. As a result, the H3/3! and the H6/6! doublets of the 
Pt(N(H)dpa)(5!-GMP) adduct have similar shifts (Table 2.2). An additional complicating feature 
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in making N(H)dpa assignments is the fact that the Pt(N(H)dpa)(5!-GMP) adduct has no mirror 
plane because of the chiral sugar group; thus, the left and right sides of the N(H)dpa carrier 
ligand are magnetically inequivalent for both rotamers. Hence, each rotamer could have two 1H 
NMR signals for each type of pyridyl proton, raising the possibility that four signals could be 
resolved for each type of pyridyl proton, e.g., four H6/6! signals in a spectrum of a given adduct. 
Therefore, as mentioned, assigning which signals are H3/3! doublets and which signals 
are H6/6! doublets in a crowded spectral region with overlapping signals is difficult on the basis 
of 1H NMR shift values alone. We relied on [Pt(N(H)dpa)Cl]+ assignments to make the 1H and 
13C NMR assignments for the Pt(N(H)dpa)(5!-GMP) adduct (Figure 2.6, Tables 2.2 and 2.3). The 
1D carbon spectrum shows three resolved C6/6! peaks at 150.4, 150.0, and 149.9 ppm. In the 
HSQC spectrum of the Pt(N(H)dpa)(5!-GMP) adduct, three closely spaced 1H6/6!-13C6/6! cross-
peaks have a characteristic carbon shift of ~150.0 ppm. One cross-peak involves the quasi-triplet 
at 7.57 ppm and the two C6/6! peaks at 150.0 and 149.9 ppm; these signals are attributable to the 
anti rotamer. The other two cross-peaks involve the two doublets at 7.51 and 7.44 ppm and the 
single C6/6! peak at 150.4 ppm; these signals are attributable to the syn rotamer. The C3/3! 
pyridyl signal of the Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift (124.3 ppm) has a 
cross-peak with the broad doublet peak at 7.51 ppm; this cross-peak arises from overlapped 
H3/3! and C3/3! signals of the syn and anti rotamers.  This 7.51 ppm peak also has a cross-peak 
to the syn C6/6! peak, indicating that this peak also contains one syn H6/6! signal. In summary, 
the assignment of the four H6/6! signals involves the quasi-triplet (containing two overlapped 
anti H6/6! doublets) at 7.57 ppm, the syn H6/6! signal overlapped with the H3/3! doublets at 7.51 
ppm, and the syn H6/6! doublet at 7.44 ppm.  
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The H5/5! quasi-quartet at 7.21 ppm has a single elongated cross-peak to the C5/5! 
pyridyl signals of the Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift [126.8 and 126.9 
ppm], indicating that the signals attributable to each rotamer have slightly different chemical 
shifts, forming a quasi-quartet. Assigning the H5/5! signals specifically to the syn or anti rotamer 
is difficult to assess because these signals overlap. The C4/4! pyridyl signal of the 
Pt(N(H)dpa)(5!-GMP) adduct at a characteristic shift (142.8 ppm) has a cross-peak with the 
overlapped triplets at 7.97 ppm, thus assigning the peak to H4/4! signals from both rotamers. 
Two C7/7! peaks at 60.83 and 60.77 ppm in the 1D 13C NMR spectrum have cross-peaks to the 
cluster of H7/7! signals at 4.80 ppm and to the suppressed H7/7! signals overlapped with the 













Figure 2.6: HSQC spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GMP) adduct (shifts in 
ppm).  
 
A comparison of J values for the H6/6! and H3/3! signals of [Pt(N(H)dpa)Cl]+ (5.8 and 8.0 Hz, 
respectively, Table 2.2) with those for the Pt(N(H)dpa)(5!-GMP) adduct was used to support the 
assignments of the rotamer signal types. The two H6/6! peaks (the quasi-triplet and the upfield 
doublet) both had J ~5.4 Hz, values consistent with the expected H6/6! J value (Table 2.2). The J 
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value (~8.0 Hz) for the H3/3! signal (broad doublet) is also consistent with the value expected for 
an H3/3! signal (Table 2.2).  
A ROESY experiment allowed us to assign the H6/6! signals specifically to syn and anti 
Pt(N(H)dpa)(5!-GMP) rotamers because the N(H)dpa H6/6! protons are close to the 5!-GMP H8 
protons in both Pt(N(H)dpa)(5!-GMP) rotamers. Thus, H8-to-H6/6! NOE cross-peaks were 
expected. The ROESY spectrum (Figure 2.7) showed a very intense cross-peak from the anti H8 
signal to the quasi-triplet (a peak composed of two overlapping downfield H6/6! doublets). The 
syn H8 signal had cross-peaks to the most upfield H6/6! doublet and to the H6/6! signal that 
overlaps with the H3/3! signal. These findings confirm that the most downfield H6/6! peak is 
composed of the two H6/6! signals from the anti rotamer and that the two H6/6! signals of the 
syn rotamer are relatively upfield. The relationships of these shifts to the structure of the 
rotamers are explained next.  
 
 
Figure 2.7: 1H-1H ROESY spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GMP) adduct 
(shifts in ppm). 
 
The relative values of large upfield shift changes of the H6/6! signals on formation of the 
Pt(N(H)dpa)(5!-GMP) adduct arising from the anisotropy of the guanine nucleobase provide 
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confirmation of our assignment of the rotamers. The Pt–N7 bond restricts how closely the five-
membered ring can approach the H6/6! protons as the nucleobase wags back and forth from 
thermal motion. The H6/6! protons are not in the coordination plane (Figure 2.5), as mentioned 
above. The nucleobase H8 proton is closer to the H6/6! protons in the anti rotamer, and this 
restricts the degree of base wagging because the partial positive charge of these protons leads to 
mutual electrostatic repulsion. In addition, the H6/6! protons and the six-membered ring are on 
opposite sides of the coordination plane. Thus, as suggested in Figure 2.8, the nucleobase is 
probably not tilted on average. Overlap of the two anti H6/6! doublets (appearing as a quasi-
triplet) at 7.57 ppm results from the similar environments of the two H6/6! protons; the 
environments are similar because the anti H6/6! protons are relatively far from the six-membered 
ring (Figure 2.8), the smaller anisotropic effects lead to similar shifts for the two H6/6! signals 
and result in a relatively downfield pair of overlapping signals. For the syn rotamer, H8 is on the 
side of the coordination plane opposite to the H6/6! protons. Thus, base tilting is not hindered by 
H8-to-H6/6! electronic repulsion. Wagging leads to a closer proximity of the nucleobase 
anisotropic six-membered ring to the H6/6! protons of the syn rotamer than of the anti rotamer 
(Figure 2.8), accounting for the more upfield shift of the syn H6/6! signals than the anti H6/6! 
signals. 
The above interpretations of shift relationships are consistent in all adducts studied here 
and also with the conclusion reached by using the H8 signals. Furthermore, the H8 and H1! 
protons are both associated with the five-membered ring of the guanine base. Thus, the syn H8 
and H1! signals are affected by the anisotropy of the pyridyl rings in a similar manner: both have 














Figure 2.8: Possible orientations of the guanine base represented by an arrow. The anisotropy is 
indicated by cones emanating from the six-membered ring. Illustrated is the proximity of the six-
membered ring to the H6/6! protons in the syn rotamer, resulting in a more upfield shift of the 
H6/6! signals of the syn rotamer compared to the anti rotamer, in which the six-membered ring is 
farther away from the H6/6! protons.  
 
Anisotropy can be used to analyze the small shift changes found for the Pt(N(H)dpa)(5!-
GMP) H4/4! and H5/5! triplets, which are expected to have similar chemical shifts for both 
rotamers. Because the H4/4! pyridyl protons are positioned away from the coordinated 5!-GMP 
site, no significant shift change takes place; therefore, we can assign the most downfield broad 
triplet at 7.97 ppm to the H4/4! signals for both rotamers. The H5/5! protons are the second-
closest pyridyl protons to the 5!-GMP nucleobase. Thus, owing to the anisotropy of the six-
membered ring of the guanine base, the H5/5! triplets are shifted upfield, as compared to the 
H5/5! triplet of the starting [Pt(N(H)dpa)Cl]+ complex. The H5/5! peak of the adduct appears as a 
distorted quartet attributable to overlapping signals of the syn and anti rotamers. 
The methylene protons (H7/7!) are far from the nucleobase and were not assigned to a 
particular rotamer, mainly because of close overlap of the syn and anti rotamers. The methylene 
signals reside in the same region as the HOD solvent peak. Presaturation of the HOD signal 
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precludes using the NOE cross-peaks to assess the endo-CH and exo-CH signals. However, we 
can confidently assign the cluster of downfield signals at 4.80 ppm to the endo-CH protons and 
the suppressed signals at 4.57 ppm to the exo-CH protons because the downfield H7/7! signal of 
[Pt(N(H)dpa)Cl]Cl is the endo-CH signal, as discussed above.  
2.3.5 Pt(N(H)dpa)(5!-GTP) and Pt(N(H)dpa)(5!-GDP)  
In past work, rotamer distribution was found to be influenced by H-bonding interactions 
between phosphate and N–H groups. In addition, either the N–H group was cis to G in an amine 
ligand of Pt(L)(G) and Pt(L)(G)2 adducts or the G N1–H group was on an adjacent cis G residue 
in Pt(L)(G)2 adducts.34,38-41,70-72 Because the adducts investigated here have only one G and no N–
H protons cis to this G, the Pt(N(H)dpa)(G) adducts offer the opportunity to assess the role of a 
trans N–H group in influencing rotamer abundance. Toward this goal, adducts of 5!-GTP and 5!-
GDP were compared to the Pt(N(H)dpa)(5!-GMP) adduct, for which the ratio of the two rotamers 
was ~1:1 (Table 2.4). In Pt(N(H)dpa)(5!-GTP), the long triphosphate chain of the 5!-GTP can 
extend far enough for the γ-phosphate group to form a hydrogen bond with the trans N–H of the 
carrier ligand when the 5!-GTP nucleotide has the anti conformation (Figure 2.9). Such hydrogen 
bonding would increase the abundance of the anti rotamer. However, such hydrogen bonding 
would not occur for the 5!-GDP adduct because the diphosphate chain is too short to reach the 
trans N–H. 
The reactions of [Pt(N(H)dpa)Cl]+ with 2.5 molar equiv of 5!-GDP or 5!-GTP were 
essentially complete in one to two days at pH ~4.1. For both adducts, sharp product H8 singlets 
were observed for the anti rotamer (the downfield H8 and H1! signals) and the syn rotamer (the 
upfield H8 and H1! signals) (Figure 2.10, Tables 2.1 and 2.2, Figure A.4, Appendix A). For the 
Pt(N(H)dpa)(5!-GTP) solution at pH 4.1, the anti H8:syn H8 ratio was 1.22:1 (Table 2.4); this is 
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the only adduct having an anti H8:syn H8 ratio greater than one. The slightly larger value of Δδ 
~0.42 ppm for the 5!-GTP rotamers than for the 5!-GMP rotamers is accounted for by the 
deshielding of H8 by the overhanging phosphate groups of 5!-GTP. This chain should be close to 
H8 when a hydrogen bond is formed between the phosphate chain and the central N(H)dpa N–H 
group in the anti rotamer (Table 2.1). The H8 signal of the syn rotamer shows a similar 
downfield shift compared to that of the 5!-GMP adduct mainly because the phosphate chain has 
more conformational freedom in the absence of an H-bond interaction. The N(H)dpa aromatic 
signals in the Pt(N(H)dpa)(5!-GTP) adduct have shifts similar to those of the 5!-GMP adduct 
(Table 2.2 and Figure A.5, Appendix A). 
 
Figure 2.9: Proposed hydrogen bonding of the γ-phosphate group of 5!-GTP with the N–H in the 
anti rotamer of the Pt(N(H)dpa)(5!-GTP) adduct (lower left). The figure also illustrates that the 
distance between the N–H group and the closest phosphate group is too long to support hydrogen 
bonding in the corresponding syn 5!-GTP rotamer (bottom right) and in the anti rotamers of the 
5!-GMP and 5!-GDP adducts (top). 
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Table 2.4: Anti H8:Syn H8 Intensity Ratios for Pt(N(H)dpa)(G) Adducts 
G pH anti:syn ratio 











5!-IMPd 4.0 1:1.25 
Guo 4.1 1:1.34 
9-EtG 4.1 1:1.28 
a H8: 9.15 (anti), and 8.79 ppm (syn). b H8: 9.16 (anti), and 8.75 ppm (syn). c H8: 9.22 (anti), and 
8.79 ppm (syn). d H2: anti H2:syn H2 ratio (1.21:1).  
!
In the ROESY spectrum of the Pt(N(H)dpa)(5!-GTP) adduct (Table 2.2 and Figure A.6, 
Appendix A), the anti H8 signal has a cross-peak to the most downfield H6/6! signal, which 
contains two H6/6! signals overlapping as a broad doublet, assigning both downfield H6/6! 
signals to the anti rotamer. The syn H8 signal has cross-peaks to the H6/6! signal overlapped 
with the H3/3! signal and to the most upfield H6/6! signal, thus assigning these two H6/6! signals 
to the syn rotamer.  
To obtain further evidence that the anti rotamer of Pt(N(H)dpa)(5!-GTP) has a hydrogen 
bond from the γ-phosphate to the central N–H, the pH of the solution was raised in order to 
deprotonate more fully the γ-phosphate group, favoring hydrogen bonding and thereby 
increasing the abundance of the anti rotamer. When the pH was raised from 4.1 to 7.3, the anti 
H8:syn H8 ratio increased from 1.22:1 to 1.37:1 (Table 2.4). On the other hand, when the pH 
was lowered to 2.7, the ratio decreased to 1:1.04, and some signals shifted noticeably (Table 
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2.4). The Pt(N(H)dpa)(5!-GDP) adduct was used as a “control” because models suggest that the 
diphosphate chain of 5!-GDP is too short to form a hydrogen bond. For Pt(N(H)dpa)(5!-GDP) 
solutions at pH 4.1 and 7.5, the anti H8:syn H8 ratio was essentially unchanged at ~1:1. This 
adduct, like all other adducts except Pt(N(H)dpa)(5!-GTP), favors the syn rotamer. These 
findings and the relatively downfield H8 signal of the Pt(N(H)dpa)(5!-GTP) anti rotamer provide 
evidence for a hydrogen bond between the γ-phosphate and the N(H)dpa N–H of this adduct. 
 
 
Figure 2.10: H8 and H1! regions of the 1H NMR spectra of the Pt(N(H)dpa)(5!-GMP) adduct (A) 
and the Pt(N(H)dpa)(5!-GTP) adduct (B) (shifts in ppm). The H1! doublet of the free nucleotide 
is also shown at ~5.7 ppm. 
 
2.3.6 Pt(N(H)dpa)(5!-IMP)  
The reaction of [Pt(N(H)dpa)Cl]+ with 5!-IMP (molar ratio = 1:2.5) was complete after 50 
h (Figure A.7, Appendix A). The Pt(N(H)dpa)(5!-IMP) adduct provides another approach for 
confirming the assignment of rotamer signals because the proton of the six-membered ring of the 
hypoxanthine base has a signal that can be affected by the pyridyl ring anisotropy. For a given 
rotamer, the H2 and H8 signals are influenced in an opposite manner by this anisotropy. The H8 
singlets for the two rotamers are at 9.44 (anti) and 9.09 (syn) ppm, with an anti H8:syn H8 
intensity ratio of 1:1.25 (Figure 2.11, Table 2.4). The H2 signals were shifted downfield to 8.26 
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(syn) and 8.17 (anti) ppm from the H2 signal of free 5!-IMP at 8.05 ppm. The relationship of the 
signals agrees with the prediction based on the effects of pyridyl ring anisotropy, thus confirming 
the assignments of the anti and syn rotamer signals. The N(H)dpa aromatic signals of the 
Pt(N(H)dpa)(5!-IMP) adduct exhibit a pattern of shift changes very similar to that observed for 
other adducts (Table 2.2). However, the syn H6/6! signal does not overlap with the H3/3! signal. 
Hence both H6/6! signals for the syn rotamer are resolved (Table 2.2).  
 
 
Figure 2.11: 1H NMR spectra (25 °C, D2O/DMSO-d6) of [Pt(N(H)dpa)Cl]+ (bottom) and of the 
Pt(N(H)dpa)(5!-IMP) adduct (top) (shifts in ppm). The spectral region was selected to show the 
H8 and H2 signals, which for free 5!-IMP are respectively labeled a and b. 
 
2.3.7 [Pt(N(H)dpa)(Guo)]2+  
The large Δδ between the H8 signals of the syn and anti rotamers of the nucleotide 
adducts could be the result of different anisotropic effects of the phosphate groups in the two 
rotamers; in order to assess this possibility, we prepared the [Pt(N(H)dpa)(Guo)]2+ adduct.   
After the reaction of [Pt(N(H)dpa)Cl]+ with Guo (molar ratio = 1:2.5) was complete 
(Figure A.8, Appendix A), the two sharp H8 signals (anti H8:syn H8 ratio = 1:1.34, Table 2.4) 
had a Δδ value of ~0.34 ppm, about the same as observed for the 5!-GMP adduct. These results 
indicate that phosphate groups at the 5! position have at best a small influence on Δδ and on 
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impeding nucleobase rotation. The N(H)dpa signals were assigned by comparison to the shift 
values for the nucleotide adducts (Table 2.2).  
2.3.8 [Pt(N(H)dpa)(9-EtG)]2+  
To definitively exclude the possibility that the sugar moiety could be contributing to the large 
Δδ and to the slow nucleobase rotation of the adducts described above, we explored the 
properties of the [Pt(N(H)dpa)(9-EtG)]2+ adduct, which has a small alkyl group in place of the 
sugar. 
After the reaction was complete (Figure A.9, Appendix A), two sharp H8 1H NMR 
signals (Table 2.1) had a Δδ of 0.33 ppm, indicating slow rotation around the Pt–N7 bond. Thus, 
the sugar residue is not responsible for the slow rotation, nor for the large Δδ observed. The anti 
H8:syn H8 intensity ratio is 1:1.28 (Table 2.4). Correlating the abundance of the two sets of CH2 
and CH3 signals with that of the H8 signals establishes that the anti rotamer has the more 
downfield signals for all of the protons associated with the five-membered guanine ring (Table 
2.1).  
Because of the absence of the chiral sugar group, only one signal for each pyridyl proton 
type was observed for each rotamer. The pyridyl signals of the [Pt(N(H)dpa)(9-EtG)]2+ adduct 
have shifts very similar to those of the corresponding signals of the [Pt(N(H)dpa)(Guo)]2+ adduct 
(Table 2.2).  
2.3.9 Other Information Derived from the NMR Data  
The observation of H8-H1! cross-peaks having an equal intensity for both the syn and 
anti rotamers indicates that the nucleotide in both rotamers has conformational freedom and that 
syn and anti nucleotide conformations co-exist. Because of the high concentration of 5!-GMP 
anion in the reaction mixture, stacking interactions between the 5!-GMP base and the pyridyl 
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rings of positively charged [Pt(N(H)dpa)Cl]+ starting material cause a similar upfield shifting of 
all of the pyridyl signals immediately after the addition of 5!-GMP. For example, the H6/6! 
signal (Figure A.10, Appendix A) of the starting complex is shifted upfield by 0.08 ppm. As the 
reaction progressed, the concentration of 5!-GMP decreased, and the resulting decrease in the 
stacking interaction causes the H6/6! signal of [Pt(N(H)dpa)Cl]+ to shift downfield toward its 
original value prior to 5!-GMP addition. All of the other adducts with an anionic G (G = 5!-GDP, 
5!-GTP, 5!-IMP) showed a similar upfield shift of the pyridyl signals of the starting complex 
upon addition of G, as observed for the 5!-GMP adduct. However, when 9-EtG (an N9 guanine 
derivative) was added, no upfield shifting was observed for the [Pt(N(H)dpa)Cl]+ signals. 
2.4 CONCLUSIONS 
Two sharp 1H NMR H8 signals observed for all Pt(N(H)dpa)(G) adducts studied here (G 
= 5!-GMP, 5!-GDP, 5!-GTP, Guo, 9-EtG, and 5!-IMP) provided evidence that they all exist as 
interconverting mixtures of syn and anti rotamers. The bulk of the tridentate N(H)dpa carrier 
ligand is sufficient to impede the rotation of G about the Pt–N7 bond for these adducts. We 
conclude that the close proximity of the anisotropic pyridyl rings of N(H)dpa in Pt(N(H)dpa)(G) 
adducts to the H8 of the nucleobase accounts for the large Δδ observed for all adducts. From 
NMR data, we conclude that the pyridyl H6/6! atoms strongly impede the rotation of G in these 
adducts. The 1H NMR spectra of these Pt(N(H)dpa)(G) adducts had four potentially resolvable 
H6/6! signals because the chiral sugar group makes the left and right sides of N(H)dpa 
magnetically inequivalent for both rotamers. In the syn rotamer of Pt(N(H)dpa)(G), the relative 
proximity of the six-membered ring of G to the H6/6! pyridyl protons accounts for the upfield 
shift observed for these resonances compared to those of the anti rotamer. Tilting of G occurs in 
each of the rotamers, but a more noticeable effect is seen in the syn rotamer because of the larger 
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chemical shift difference between the two H6/6! signals for the syn rotamer, indicating that G is 
tilted, with the six-membered ring closer to one H6/6! proton than the other. Evidence was 
observed for a weak hydrogen bond between the γ-phosphate group of 5!-GTP and the central 
N–H of the carrier ligand in the Pt(N(H)dpa)(5!-GTP) adduct. From results for the 
[Pt(N(H)dpa)(9-EtG)]2+ adduct, we concluded that the guanine base alone, not the sugar or 
phosphate group, slowed the rate of nucleobase rotation about the Pt–N7 bond in nucleotide 
adducts. [Pt(N(H)dpa)Cl]Cl and its analogues should have enough bulk to be anticancer active; 
however, further studies will be necessary to evaluate their potential anticancer properties. 
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CHAPTER 3. UNUSUAL EXAMPLE OF CHELATE RING OPENING UPON 




Difunctional platinum compounds of the type, cis-Pt(Lbi)X2 [Lbi = one bidentate or two 
cis unidentate amine N-donors; X2 = one bidentate or two monodentate anionic leaving groups], 
including cisplatin (cis-Pt(NH3)2Cl2) and its analogues, are among the most effective and most 
studied anticancer agents.1-7 Pt(II) compounds interact with DNA to form a 1,2-intrastrand G*G* 
cross-link, with Pt linking the N7 of two guanines in adjacent G residues of DNA5,6,8-13 (G* 
identifies N7-platinated G residues in DNA or oligonucleotides). An X-ray/NMR-derived model 
of a duplex 9-oligomer10 and an X-ray structure of an HMG-bound 16-oligomer,11 both 
containing the intrastrand cisplatin lesion, led us to focus on the distortions involving the X•Y 
base pair (bp) adjacent to the 5!-G*•C bp in the 5! direction along the duplex.10,14-16 The X•G* bp 
has a large positive slide and a large positive shift.10,14 An oligomer adduct of a rather bulky 
monofunctional Pt anticancer agent showed a similar shift and slide of the XG* bp step adjacent 
to the 5!-G*•C bp along the 5! direction of the duplex.13,17  
Guanine bases coordinated in positions cis to a metal can have a head-to-tail (HT) or a 
head-to-head (HH) orientation (Figure 1). For Pt(Lbi)G2 adducts (bold G = guanine derivative 
bound to a metal, but not tethered to another nucleobase), the G bases preferentially adopt the 
HT orientation.18-22 In contrast, bases tethered by a sugar phosphate backbone, such as in 
Pt(Lbi)(d(G*pG*)) cross-link adducts, are most often found in the HH orientation, especially 
when a 5!-residue is present on the 5!-G* (for example, in Pt(Lbi)(d(TG*G*T)) adducts).15,20-22  
*Reproduced with permission from American Chemical Society: Andrepont, C.; Pakhomova, S.; 
Marzilli, P. A.; Marzilli, L. G., “Unusual Example of Chelate Ring Opening upon Coordination 
of the 9-Ethylguanine Nucleobase to [Pt(di(6-methyl-2-picolyl)amine)Cl]Cl,” Inorg. Chem, 
2015, 4895-4908. Copyright 2015 American Chemical Society 
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Because the guanine H8 (Figure 3.1) 1H NMR signals are singlets and downfield, they 
are the most useful signals for assessing metal binding and the presence of rotamers.15,16,23-28 
Interconversions of HH to HT conformations via rotation about the Pt–N7 bonds in cis-Pt(Lbi)G2 
and cross-link adducts are rapid on the NMR time scale unless the Lbi carrier ligand is bulky. 
Bulky bidentate ligands lower the rotation rate, allowing observation of NMR signals of the 
conformers present in solution. For a difunctional agent, activity decreases and toxicity increases 
when Lbi is bulky.5,29-32 The study of Pt(Lbi)G2 adducts provides useful guidance and insight on 




















Figure 3.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9 
derivatives (referred to with a bold G). A generic version of G is depicted in the center, along 
with the guanine base numbering scheme. Note that the nucleobase is represented by an arrow 
with the tip at the guanine H8 atom. N and N! represent a nitrogen donor ligand. When (N ≠ N!), 
four rotamers (HHu, HHd, ΛHT, ΔHT) are possible, whereas when (N = N!), only three 
conformers (HH, ΛHT, ΔHT) are possible because HHu = HHd. Regardless of whether the 
nitrogen donors are unidentate ligands or are part of a chelate (N–N or N–N!), the same number 
of conformers can exist. 
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 In contrast, monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and 
one monodentate, or three monodentate ligands; X = a monodentate monoanionic leaving group), 
have higher activity when carrier-ligand bulk is greater.13,15,17,33-36 These monofunctional agents 
also preferentially bind to G residues in DNA. It is important to gain a better understanding of 
the fundamental features of such adducts. One approach to achieve this goal is to study Pt(Ltri)G 
models to assess the effects of steric interactions between the carrier ligand and the guanine base. 
We previously studied the interactions of a tridentate carrier ligand having in-plane bulk, di-(2-
picolyl)amine (N(H)dpa, Figure 3.2), in Pt(N(H)dpa)G adducts with several G derivatives [e.g., 
9-ethylguanine (9-EtG), 5!-guanonsine monophosphate (5!-GMP), etc.].23  
 
Figure 3.2: Numbering scheme for [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+.  
 In such adducts, the guanine base has two orientations with respect to the coordination 
plane, leading to the presence of syn and anti rotamers (Figure 3.3), which can interconvert by 
rotation about the Pt–N7 bond. As shown in the figure, the rotamer with the H atom of the 
central N-H group and the guanine O6 on the same side of the coordination plane is designated 
as syn, and the rotamer with these groups on opposite sides of this plane is designated as anti.23,37 
For all Pt(N(H)dpa)G adducts studied, each rotamer showed a sharp 1H NMR G H8 signal, 




Figure 3.3: Two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with tridentate 
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane 
perpendicular to the coordination plane are illustrated for Ltri = N(H)dpa and G = 9-EtG. The H8 
proton of 9-EtG is highlighted with yellow circles. Protons in the chelate ligand N–CH2 groups 
are called exo if they project up toward the NH and endo if they project down and away from the 
NH. 
 
In the present study, we examine Pt(Ltri)G adducts formed from [Pt(Ltri)Cl]Cl (Figure 
3.2) with Ltri possessing in-plane bulk greater than that of N(H)dpa by introducing methyl groups 
at the 6/6! positions, namely Ltri = N(H)6,6!-Me2dpa (di-(6-methyl-2-picolyl)amine). The methyl 
substituents project in the direction of the guanine base in the [Pt(N(H)6,6!-Me2dpa)G]2+ 
adducts. We have employed NMR techniques to understand the influence of increased in-plane 
bulk on the properties of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct. The mono adduct was 
found to convert readily to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct (Figure 3.4). This 
process involves an unusual transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the 
tridentate to the bidentate coordination mode. Because the bidentate ligand has an asymmetric 
racemic secondary amine and because GMP nucleotides are chiral, we undertook a very brief 
study of adduct formation by 5!- and 3!-GMP with [Pt(N(H)6,6!-Me2dpa)Cl]Cl. We found 
compelling evidence that 5!- and 3!-GMP also promote the unusual tridentate-to-bidentate 
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coordination mode transformation accompanying formation of a bis adduct from the initially 
formed mono adduct. 
 
Figure 3.4: Transformation of the initially monofunctional complex, [Pt(N(H)6,6!-Me2dpa)Cl]+, 
to the bis adduct, [Pt(N(H)6,6!-Me2dpa)G2]2+, upon addition of G. Note that the atoms in the 
dangling chain are designated by a prime after the number. The methylene group protons are 
designated as exo and endo (see text) for the chelated but not for the dangling 6-methyl-2-picolyl 
chains. 
 
3.2 EXPERIMENTAL SECTION 
 
3.2.1 Starting Materials  
K2[PtCl4], 3!- and 5!-GMP, and 9-EtG were obtained from Aldrich. cis-Pt(DMSO)2Cl238 
and N(H)6,6!-Me2dpa39 were synthesized as described in the literature. The 1H NMR chemical 
shifts in CDCl3 for N(H)6,6!-Me2dpa prepared here match the reported values. 1H and 13C NMR 
shifts assigned by 2D NMR methods for N(H)6,6!-Me2dpa in a D2O/DMSO-d6 (64:36) mixture at 
pH 4.1 and 11.2 are reported in Table B.1, Appendix B.  
3.2.2 NMR Measurements  
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer, 
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted 
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO-
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d6, peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm 
(residual) and 39.5 ppm, respectively.40 A presaturation pulse to suppress the water peak was 
employed when necessary. ROESY experiments were performed at 15 °C by using a 200 ms 
mixing time. 1H–13C HSQC and HMBC NMR spectra were recorded in order to assign the 
signals of the adducts. NMR data were processed with TopSpin and MestreNova software. The 
atom-numbering system shown in Figure 3.2 is used in reporting or discussing 1H and 13C NMR 
data when the chelate ligand is tridentate. When the chelate ligand is bidentate, protons in the 
chelated 6-methyl-2-picolyl chain!are labeled as H3, H4, H5, endo-H7, exo-H7, and 6-Me, and 
protons in the dangling 6-methyl-2-picolyl chain!are labeled as H3!, H4!, H5!, H7!, and 6!-Me 
(Figure 3.4).  
3.2.3 X-ray Data Collection and Structure Determination  
Single crystals were placed in a cooled nitrogen gas stream at 90 K on a Bruker Kappa 
Apex-II DUO diffractometer equipped with Mo Κα radiation (λ = 0.71073 Å). Refinement was 
performed by full-matrix least squares methods using SHELXL,41 with H atoms in idealized 
positions. The N(2) atom of the cation in [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O is disordered over 
two positions with occupancies of 0.485:0.515 (A:B).! The cation in the [Pt(N(H)6,6!-
Me2dpa)Cl]Cl molecule is positioned on a mirror plane with the exception of the N(2) and Cl(1) 
atoms, which are out of the plane and consequently disordered over two equivalent positions. 
3.2.4 Synthesis of [Pt(N(H)6,6!-Me2dpa)Cl]Cl  
Acetonitrile solutions of cis-Pt(Me2SO)2Cl2 (10.6 mg, 0.025 mmol in 1 mL) and 
N(H)6,6!-Me2dpa (5.68 mg, 0.025 mmol in 1 mL) were mixed and allowed to stand at 25 °C. 
After 2 h, thin, yellow, X-ray quality crystals were collected on a filter and washed with 
acetonitrile; yield, 6.85 mg (56%). 1H NMR signals (ppm) in DMSO-d6:  8.45 (bs, 1H, NH), 8.03 
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(t, J = 7.8 Hz, 2H, H4/4!), 7.50 (d, J = 7.7 Hz, 2H, H5/5!), 7.47 (d, J = 7.7 Hz, 2H, H3/3!), 5.12 
(dd, J = 16.1, 9.1 Hz, 2H, endo-H7/7!), 4.65 (dd, J = 16.0, 5.2 Hz, 2H, exo-H7/7!), 2.94 (s, 6H, 
6/6!-CH3).  
 3.2.5 [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+Adduct  
A 10 mM solution of [Pt(N(H)6,6!-Me2dpa)Cl]Cl [2.96 mg in 600 µL of a 64:36 
D2O/DMSO-d6 (385 µL:215 µL) mixture] was treated with 2.5 equiv of 9-EtG (2.69 mg) to give 
a 1:2.5 ratio (10 mM:25 mM) of Pt:9-EtG, and the solution (pH ~4) was kept at 25 °C. (The 
D2O/DMSO-d6 mixture was employed to improve the solubility of the reactants.) The reaction, 
which was repeated several times, was monitored by 1H NMR spectroscopy until no change was 
observed in the bound vs free 9-EtG H8 signal intensity, or until [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ adduct formation was complete, usually ~4.5 h. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Structural Results. Overall Aspects  
Summarized in Table 3.1 are the crystal data and details of the structural refinement of 
[Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and [Pt(N(H)6,6!-Me2dpa)Cl]Cl. Selected bond lengths and 
angles are reported in Table 3.2. ORTEP plots of the cations of these two complexes and the 
numbering scheme used to describe the solid-state data are shown in Figure 3.5. All other 
references (e.g., NMR discussion) to these ligands and complexes will employ the atom-
numbering scheme shown in Figure 3.2.  
3.3.2 Coordination Parameters  
The [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ cations exhibit pseudo square planar 
geometry, with the three N atoms of the tridentate ligand bound to the Pt; a Cl atom trans to the 
N(2) atom completes the Pt coordination sphere (Figure 3.5).  
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Table 3.1: Crystal Data and Structure Refinement for [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and 
[Pt(N(H)6,6!-Me2dpa)Cl]Cl 
 
empirical formula [C12H13ClN3Pt][H2PO4]•H3PO4 •H2O [C14H17ClN3Pt]Cl 
fw 642.79 493.29 
crystal system triclinic orthorhombic 
space group Pī  Pnma 
a (Å) 6.9872(2) 15.6698(9) 
b (Å) 12.0630(4) 6.8167(4) 
c (Å) 12.8337(4) 14.2516(8) 
α 114.212(2) 90 
β (deg) 91.530(2) 90 
γ 102.012(2) 90 
V (Å3) 957.31(5) 1522.30(15) 
T (K) 100 98 
Z 2 4 
ρcalc (Mg/m3) 2.230 2.152 
abs coeff (mm-1) 7.69 9.56 
2θmax (°) 75.8 52.7 
R [I> 2σ(I)]a 0.032 0.034 
wR2b 0.068 0.075 
data/param 10174/288 1689/129 
res. dens (eÅ-3) 3.45/-1.35 1.27, -1.55 
 
aR = (∑||Fo| - |Fc||)/∑|Fo|. bwR2 = [∑[w(Fo2 - Fc2)2]/∑[w(Fο2)2]]1/2,  in which w = 1/[σ2(Fo2) + (dP)2 + 






Table 3.2: Selected Bond Distances (Å) and Angles (deg) for 
[Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O and [Pt(N(H)6,6!-Me2dpa)Cl]Cl 
!
 [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O  [Pt(N(H)6,6!-Me2dpa)Cl]Cl  
bond distances 
Pt–N(1) 2.012(2) 2.048(7) 
Pt–N(2)A 2.014(5) 1.973(8) 
Pt–N(3) 2.015(2) 2.047(7) 
Pt–Cl(1) 2.3148(6) 2.421(3) 
bond angles 
N(1)–Pt–N(3) 166.16(8) 166.3(3) 
N(1)–Pt–Cl(1) 97.17(6) 95.96(18) 
N(2)A–Pt–Cl(1) 169.5(2) 159.1(3) 
N(3)–Pt–Cl(1) 96.67(6) 95.34(18) 
N(2)A–Pt–N(1) 85.02(16) 83.2(3) 
N(2)A–Pt–N(3) 81.28(16) 83.4(3) 
   
For [Pt(N(H)dpa)Cl]+ and [Pt(N(H)6,6!-Me2dpa)Cl]+, the central N(2) atoms are 
disordered over two positions, N(2)A and N(2)B, above and below the coordination planes, 
respectively. All bond lengths and angles discussed below are for the A form. Both complexes 
have comparable N(1)–Pt–N(3) bite angles (Table 3.2); these are similar to the 167.7(2)° bite 
angle reported for [Pt(N(H)dpa)(OH2)](ClO4)2•H2O.42 The Pt–N(1) and Pt–N(3) bond distances 
(Table 3.2) for both chloro complexes compare well with reported Pt–N(sp2) bond distances 
ranging from 1.99–2.08 Å.43,44 The Pt–N(2) bond distance for [Pt(N(H)6,6!-Me2dpa)Cl]+ is 
shorter than that for [Pt(N(H)dpa)Cl]+ (Table 3.2) and for most relevant reported Pt–N(sp3) bond 
distances (2.01–2.12 Å).45-47  
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The consequences of replacing protons on C(1) and C(12) with bulkier methyl groups are 
best assessed by comparing bond distances and angles in Table 3.2 involving the Pt–Cl bond. 
The N(2)–Pt–Cl bond angle differs from 180° significantly more in [Pt(N(H)6,6!-Me2dpa)Cl]+ 
(159.1(3)°) than in [Pt(N(H)dpa)Cl]+ (169.5(2)°). This large departure from 180° in 
[Pt(N(H)6,6!-Me2dpa)Cl]+ (Figure 3.6) arises from the large steric repulsion between the 
coordinated Cl and the nearby 6/6!-Me groups.  
 
Figure 3.5: ORTEP plots showing the cations of [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O (top) and 
of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (bottom). Thermal ellipsoids are drawn with 50% probability. The 
crystals are disordered, and the cation in only one of the positions is shown. 
 
This steric interaction between the Cl and the Me groups results in a significantly longer 
Pt–Cl bond in [Pt(N(H)6,6!-Me2dpa)Cl]+ than in [Pt(N(H)dpa)Cl]+ (Table 3.2). This longer 
distance suggests that the Cl ligand is bound slightly more weakly in [Pt(N(H)6,6!-Me2dpa)Cl]+ 
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than in [Pt(N(H)dpa)Cl]+. Such weaker binding may contribute to the greater reactivity toward G 
adduct formation exhibited by [Pt(N(H)6,6!-Me2dpa)Cl]+ compared to [Pt(N(H)dpa)Cl]+. 
Furthermore, the shorter length of the Pt–N bond trans to Cl (Pt–N(2)) (Table 3.2) in 
[Pt(N(H)6,6!-Me2dpa)Cl]+ compared to [Pt(N(H)dpa)Cl]+; this shorter bond could indicate that 
the Cl trans influence is reduced as a consequence of the weaker Pt–Cl bond. The length of the 
Pt–N(2) bond in [Pt(N(H)6,6!-Me2dpa)Cl]+ (1.973(8) Å) is not significantly different from the 
Pt–N(2) bond (1.952(7) Å) reported42 for [Pt(N(H)dpa)(OH2)](ClO4)2•H2O, in which the 
secondary amine nitrogen is trans to the aqua ligand, which has a weak trans influence. 
 
Figure 3.6: Orientation of the pyridyl rings in the cation of [Pt(N(H)6,6!-Me2dpa)Cl]Cl, viewed 
along the coordination plane and showing designations of the endo-H7/7! and exo-H7/7! protons. 
The figure also illustrates the large departure of the N(2)–Pt–Cl angle from 180°. 
 
3.3.3 [Pt(N(H)6,6!-Me2dpa)Cl]Cl NMR Signal Assignments  
The 1H NMR signals for [Pt(N(H)6,6!-Me2dpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture 
are presented in Table 3.3, and the aromatic region is shown in Figure 3.7. The equivalent 
[Pt(N(H)6,6!-Me2dpa)Cl]+ methylene groups have equivalent carbon atoms (C7 and C7!), but 
each carbon bears inequivalent methylene protons (designated as endo-H7/7! and exo-H7/7!, 
Figures 3.6 and B.2).  
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Table 3.3: 1H NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl and [Pt(N(H)6,6!-Me2dpa)(9-
EtG)]2+ in D2O/DMSO-d6 (pH 4.0) at 25 °C   
 
proton a [Pt(N(H)6,6!-Me2dpa)Cl]Cl [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+  
9-EtG H8 - 8.84b, 8.54c 
H4/4! 7.80 7.81 
H3/3! 7.23 7.31 
H5/5! 7.27 7.12 
endo-H7/7! 4.87 4.88 
exo-H7/7! 4.47 4.50 
6/6!-Me 2.80 2.05b, 1.75c 
aFree 9-EtG signals (ppm): H8 7.72, CH2 3.91, and CH3 1.25; bound 9-EtG signals (ppm): CH2 
4.10 (anti), 4.01 (syn); CH3 1.26 (anti), 1.30 (syn). bSignals from the anti rotamer. cSignals from 
the syn rotamer. 
 
The signals for the corresponding protons of the parent [Pt(N(H)dpa)Cl]Cl complex were 
assigned by using the Karplus equation and the H–N–C–H coupling constants measured in 
DMSO-d6 (because the carrier-ligand N–H exchanges with D2O in the D2O/DMSO-d6 
mixture).23 The 4.92 ppm signal with the larger H–N–C–H coupling constant (8.9 Hz) for 
[Pt(N(H)dpa)Cl]+ was assigned to the endo-H7/7! signal because from the Karplus equation and 
from the H–N–C–H torsion angle, the endo-H7/7! proton would have the larger coupling 
constant. The exo-H7/7! signal at 4.60 ppm has a smaller H–N–C–H coupling constant (5.1 Hz). 
For [Pt(N(H)6,6!-Me2dpa)Cl]+, however, the H–N–C–endo-H7/7! (~149°) and H–N–C–exo-
H7/7! (~30°) torsion angles in the solid do not permit such a confident assignment as was made 
for [Pt(N(H)dpa)Cl]Cl. Nevertheless, similarities in the NH–CH coupling constants for the two 
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complexes in DMSO-d6 allow us to assign the signal of [Pt(N(H)6,6!-Me2dpa)Cl]Cl at 5.12 ppm 
(J = 9.1 Hz) to endo-H7/7! and the signal at 4.65 ppm (J = 5.2 Hz) to exo-H7/7!.  
From the assignments in DMSO-d6, we can assign the following signals for [Pt(N(H)6,6!-
Me2dpa)Cl]Cl in D2O/DMSO-d6 (64:36 mixture): the downfield H7/7! signal at 4.87 ppm to 
endo-H7/7!, and the upfield signal at 4.47 ppm to exo-H7/7!. The respective shifts in 
D2O/DMSO-d6 for [Pt(N(H)dpa)Cl]Cl are 4.73 and 4.49 ppm.23 The exo-H7/7! signals have very 
similar shifts in these two complexes, probably because the exo-H7/7! protons project away from 
the coordination sphere (Figures 3.6 and B.1, Appendix B).  
In the 1H NMR spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]+ in D2O/DMSO-d6 (64:36 mixture), 
the triplet at 7.80 ppm (Figure 3.7) is assigned to H4/4!, the only type of aromatic proton that can 
give a triplet. In a ROESY spectrum (not shown), an NOE cross-peak from the 6/6!-Me signal 
assigns the H5/5! doublet, and thus the other doublet is assigned to H3/3! (Table 3.3). 
Assignments of the 13C NMR signals for [Pt(N(H)6,6!-Me2dpa)Cl]+ were made through an 
HSQC experiment (Table 3.4 and Figure B.2, Appendix B). Cross-peaks (ppm) involving H3/3! 
(7.23-120.6), H4/4! (7.80-142.0), H5/5! (7.27-128.5), and 6/6!-Me (2.80-27.5) signals assign the 
C3/3!, C4/4!, C5/5!, and C(6/6!-Me) 13C NMR signals, respectively. Cross-peaks from the endo-
H7/7! and exo-H7/7! signals assign the 13C NMR signal at 63.3 ppm to C7/7!. Compared to the 
free ligand C7/7! shift at 52.0 ppm (Appendix B), the shift change of over 11 ppm can be 
attributed to a combination of strain induced by chelation to Pt(II) and the Pt(II) electron-




Figure 3.7: Aromatic region of the 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!-
Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6) before (bottom), 15 min after (middle), and 4.5 h after (top) 
mixing with 2.5 molar equivalents of 9-EtG (pH 4.0). Signals for the mono-adduct intermediate, 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are labeled in the middle trace, and those for the final bis-
adduct [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ product are labeled in the top trace, where the ΛHT and 
ΔHT labels designate the two H8 signals of each conformer.  
 
The two very downfield signals in the 13C NMR spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl 
(Figure B.3, Appendix B) do not have HSQC cross-peaks; these features are expected for C2/2! 
and C6/6!. The shifts for these carbons attached to the pyridyl nitrogen are expected to be 
downfield, and they are not directly attached to a proton, accounting for the absence of an HSQC 
cross-peak. The C2/2! and C6/6! signals were assigned with HMBC cross-peaks to H3/3! and 
H5/5! signals (Figure B.3, Table 3.4). At pH 4.1, the shift of the C2/2! signal at 166.7 ppm is ~16 
ppm more downfield than that of the free ligand at 151.1 ppm (Table B.1, Appendix B). The 
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results in this investigation (see below) indicate that at pH ~4 a C2/2! shift downfield of 160 ppm 
is characteristic of a bound 6-methyl-2-picolyl chain, whereas a signal upfield of 155 ppm 
indicates a dangling 6-methyl-2-picolyl chain.  
Table 3.4: 13C NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl and [Pt(N(H)6,6!-Me2dpa)(9-
EtG)]2+ in D2O/DMSO-d6 (pH 4.0) at 25 °C 
 
carbon a [Pt(N(H)6,6!-Me2dpa)Cl]Cl [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+  
9-EtG C8 - 142.6b, 142.7c 
C4/4! 142.0 142.0 
C3/3! 120.6 121.2b, 121.1c 
C5/5! 128.5 128.6 
C7/7! 63.3 62.6b, 62.2c 
6/6!-Me 27.5 26.1b, 24.8c 
C6/6! 164.8 163.9b, 163.8c 
C2/2! 166.7 167.3b, 167.7c 
a Free 9-EtG signals (ppm): C8 140.8, CH2 40.2, and CH3 16.3; bound 9-EtG signals (ppm): CH2 
41.63 (anti), 41.59 (syn); CH3 16.4 (anti), 16.0 (syn). bSignals from the anti rotamer. cSignals 
from the syn rotamer. 
 
3.3.4 [Pt(N(H)6,6!-Me2dpa)Cl]Cl Adducts with 9-EtG  
The reaction of [Pt(N(H)6,6!-Me2dpa)Cl]Cl with 2.5 molar equiv of 9-EtG in 
D2O/DMSO-d6 (64:36) was monitored by using the H8 NMR signal of 9-EtG. At 15 min, the 
spectrum (Figure 3.7) contained a total of six new H8 signals, and only 17% of the starting 
complex remained. As discussed below, two of the six new H8 signals (Figure 3.7) are assigned 
to the syn and anti rotamers (see Figure 3.3) of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct 
(accounting for ~65% of the product). The remaining four H8 signals arise from a mixture of two 
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[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers. At 2.5 h, the starting [Pt(N(H)6,6!-Me2dpa)Cl]Cl 
signals had completely disappeared. In contrast, under identical conditions, complete 
disappearance of the starting [Pt(N(H)dpa)Cl]Cl signals required ~49 h.23 The greater reactivity 
of [Pt(N(H)6,6!-Me2dpa)Cl]Cl will be discussed below. Furthermore, the reaction of 
[Pt(N(H)dpa)Cl]Cl with 9-EtG studied previously led to only the mono adduct, [Pt(N(H)dpa)(9-
EtG)]2+ (Figure 3.3).23 Finally, the H8 signals of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ had completely 
disappeared by 4.5 h (Figure 3.7), indicating that all of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ 
mono adduct had converted to bis adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, having a now 
bidentate chelate ligand (Figure 3.4).   
3.3.5 [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+Adduct  
As just mentioned, two of the six H8 signals observed at 15 min (Figure 3.7) are assigned 
to the two conformers of the mono adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+. NMR spectra were 
recorded on fresh solutions to characterize the mono adduct because it converted to the bis 
adduct with time under the reaction conditions employed. Signals in the 1H and 13C NMR spectra 
for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (Tables 3.3 and 3.4) were assigned by using 
procedures similar to those detailed above for the simpler spectrum of the [Pt(N(H)6,6!-
Me2dpa)Cl]Cl complex and those described below for the more complicated spectrum of the 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct. 
As expected from the inductive effect of Pt(II),48-50 the H8 signals at 8.84 and 8.54 ppm 
are downfield of the free 9-EtG H8 signal at 7.72 ppm (Figure 3.7 and Table 3.3). As we 
reported for the [Pt(N(H)dpa)(9-EtG)]2+ adduct,23 the tilting of the anisotropic pyridyl ring 
relative to the Pt(II) coordination plane positions this shielding region closer to the H8 proton of 
the syn conformer than to that of the anti conformer (Figure 3.3). The syn H8 signal (8.54 ppm) 
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is upfield relative to the anti H8 signal (8.84 ppm). The shift difference between the two H8 
signals (Δδ) is ~0.30 ppm, a value similar to the Δδ of ~0.33 ppm for the [Pt(N(H)dpa)(9-EtG)]2+ 
adduct.23  
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, the syn H8:anti H8 signal intensity ratio 
of 1:1.42 indicates that the syn rotamer is less favored. In this adduct, the 6/6!-Me groups create 
a sterically crowded 9-EtG coordination site. Crowding will most likely have an unfavorable 
effect on the syn rotamer because, as a consequence of the tilting of the pyridyl ring relative to 
the coordination plane, the bulky guanine six-membered ring and the 6/6!-Me groups are on the 
same side of the coordination plane (Figure B.4). This guanine ring in the syn rotamer of 
[Pt(N(H)dpa)(9-EtG)]2+ is in a less crowded environment (A, Figure B.4), and the syn:anti ratio 
is 1.28:1, indicating that the syn rotamer is more stable.  
In the syn and anti rotamers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, guanine base 
canting is likely to be minimal because of steric interactions between the guanine base and the 
6/6!-Me groups. However, for the syn and anti rotamers of the [Pt(N(H)dpa)(9-EtG)]2+ adduct, in 
the absence of the bulky methyl groups, guanine base canting is likely to occur (Figure B.4). 
Canting could lead to greater shielding of H8 by the pyridine ring. The syn (8.54 ppm) and anti 
(8.84 ppm) H8 signals for [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ are farther downfield than the syn 
(8.40 ppm) and anti (8.73 ppm) H8 signals of [Pt(N(H)dpa)(9-EtG)]2+.23 The more downfield 
shift of the H8 signals for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ rotamers may arise from a lower 
degree of guanine base canting (Figure B.4). 
In a ROESY spectrum of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ at 15 °C (Figure B.5, 
Appendix B), NOE cross-peaks to the assigned syn and anti H8 signals allow assignments of the 
6/6!-Me signals at 1.75 and 2.05 ppm to the syn and anti conformers, respectively (Table 3.3). 
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These shifts are upfield by 1.05 and 0.75 ppm, respectively, relative to the 6/6!-Me signal for 
[Pt(N(H)6,6!-Me2dpa)Cl]Cl (Table 3.3). An upfield shift is expected from the close proximity of 
these Me groups to the anisotropic 9-EtG base (Figure B.4). The more upfield shift position of 
the syn 6/6!-Me signal is consistent with these 6/6!-Me groups being on the same side of the 
coordination plane as the more shielding guanine six-membered ring. The intensity of the H8-
6/6!-Me NOE cross-peak is much lower for the syn rotamer than for the anti rotamer (Figure 
B.5), a finding consistent with the greater H8-to-6/6!-Me group distance in the syn rotamer than 
in the anti rotamer. This result also confirms our shift-based assignments of the syn and anti H8 
signals.  
The absence of H8-H8 EXSY cross-peaks in the ROESY spectrum at 15 °C of 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ (Figure B.6) indicates that interconversion between the 
rotamers is slower than for [Pt(N(H)dpa)(9-EtG)]2+, an adduct that exhibits H8-H8 EXSY cross-
peaks at 15 °C.23 Thus, as expected, the methyl groups at the 6/6!-positions of the pyridyl rings 
are more effective than 6/6! protons in impeding rotation of 9-EtG about the Pt–N7 bond.   
 3.3.6 [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+Adduct  
As mentioned, four of the six product H8 signals (Figure 3.7) arise from at least two 
conformers of a bis adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+. The two H8 signals of each 
conformer have very similar intensities, and the four bis adduct H8 signals are easily grouped 
into two pairs. The minor:major ratio of these pairs of signals remained equal to 1:1.6 throughout 
their formation, consistent with facile equilibration between the conformers. For this bis adduct 
to form, one 6-methyl-2-picolyl chain must be dangling, and the chelate ligand must convert 
from a tridentate to a bidentate coordination mode (Figure 3.4). Before discussing the signal 
assignments, we note that the finding of two pairs of H8 signals maintaining a constant ratio is 
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evidence for at least two conformers, but the situation is more complex than might appear, as 
discussed beginning in the next paragraph. 
To explain our analysis of the two pairs of H8 signals, we first review the number of 
conformers possible for such cis bis adducts, Pt(N–N)G2 and Pt(N–N!)G2 (Figure 3.1). When N–
N = a C2-symmetrical achiral bidentate ligand, up to three [one HH and two HT (ΛHT, ΔHT)] 
rotamers may be observed in a Pt(N–N)G2 adduct. Both G ligands in each conformer are 
equivalent if G lacks a chiral group (e.g., 9-EtG), and only one H8 signal per rotamer is possible. 
However, in Pt(N–N!)G2 adducts having an unsymmetrical achiral bidentate ligand, four 
rotamers (HHu, HHd, ΛHT, ΔHT) are possible (Figure 3.1). The G ligands in all conformers of 
such Pt(N–N!)G2 adducts are no longer equivalent; if G has either a chiral or an achiral group at 
N9, two H8 signals per rotamer are expected. Thus, a maximum of eight H8 signals could 
possibly be observed if all four conformers exist and all are in slow exchange. If the N–N! 
chelate ligand is both unsymmetrical and chiral and if G lacks a chiral group, the situation is the 
same, i.e., a potential maximum of eight H8 signals could arise for a Pt(N–N!)G2 adduct such as 
the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct.  
In [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers, the bidentate ligand is unsymmetrical, 
and the secondary nitrogen is an asymmetric center. In the perspective used in Figure 3.8, two 
configurations of the asymmetric center are possible. In one configuration, the NH is above the 
coordination plane and the dangling 6-methyl-2-picolyl chain is below the coordination plane 
(left sketch in Figure 3.8).  
In the other, the NH is below the coordination plane and the dangling 6-methyl-2-picolyl 
chain is above the coordination plane. Because 9-EtG has no chiral group, each conformer exists 
as an enantiomeric pair with signals that have identical shifts for each enantiomer; hence, at most 
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two H8 signals are expected for each conformer. Another consequence of the fact that 9-EtG 
lacks a chiral group is that the two configurations at the asymmetric nitrogen are formed in equal 
abundance. For the purposes of this article, we have chosen to depict only one configuration of 
the asymmetric center (the one illustrated on the right in Figure 3.8) in figures illustrating the 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ HT conformers, such as in Figure 3.9. 
 
 
Figure 3.8: The two configurations of the asymmetric secondary nitrogen center of [Pt(N(H)6,6!-
Me2dpa)G2]2+ adducts, with the methylene group of the dangling pyridyl chain below (left) and 
above (right) the coordination plane. Because 9-EtG is not chiral, these two configurations are 
formed in equal abundance in the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct. Because the HT 
conformers are chiral, the ΔHT and ΛHT conformers with the chelate configuration on the left 
have equal abundance and are the mirror images of the respective ΛHT and ΔHT conformers 
with the chelate configuration on the right. These enantiomers cannot be distinguished by typical 
NMR methods for adducts of G = 9-EtG. The configuration of the asymmetric center illustrated 
on the right is used to discuss results in this study.  
 
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, three H8 signals (at 8.15, 8.03, and 7.94 
ppm) are downfield, and one H8 signal (at 7.61 ppm) is actually slightly upfield from the free 9-
EtG H8 signal at 7.72 ppm (Table 3.5). In contrast, the H8 shifts of the mono adduct (8.54 and 
8.84 ppm) are relatively downfield. This shift pattern, which is characteristic of shifts observed 
on mono vs bis adduct formation, can be attributed to the counterbalancing effects of the Pt(II) 
inductive effect versus the anisotropic effect of the adjacent guanine. A pattern attributable to the 
same effects can be seen in shifts of signals for protons on the carbon attached to the guanine N9. 
Thus, the shifts of the 9-EtG CH2 signal in the bis adduct (averaging ~3.85 ppm) are slightly 
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upfield of that for the free 9-EtG (3.91 ppm), whereas those for the mono adduct (averaging 
~4.05 ppm) are slightly downfield (Tables 3.3 and 3.5). 
 
Figure 3.9: Possible orientations of the guanine bases in the ΔHT (top) and ΛHT (bottom) 
conformers of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adducts. As illustrated, in the ΔHT conformer 
the 9-EtG base is in close proximity to the dangling pyridyl ring; this proximity could cause the 
anisotropic 9-EtG base to induce a more upfield shift in the pyridyl ring signals (particularly H3!, 
upper right) for the ΔHT conformer, as compared to the ΛHT conformer. The illustration for the 
ΛHT conformer depicts the canting of the 9-EtG base expected when a hydrogen bond (dashed 
red line) is formed between O6 and NH. The canting positions the H8 closer to the shielding 
region of the six-membered ring of the adjacent 9-EtG base. The shift of the H8 signal of the 
canted 9-EtG base is relatively upfield.  
 
The four H8 signals of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct can be grouped into 
minor (8.15 and 7.94 ppm) and major (8.03 and 7.61 ppm) pairs. These pairs are always present 
in a 1:1.6 ratio, as mentioned above. At this point, to simplify discussion, we state that the minor 
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and major rotamers are the ΔHT and ΛHT conformers (Figure 3.9), respectively, when the 
configuration on the right in Figure 3.8 is used.  
Table 3.5: 1H NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ in D2O/DMSO-d6 
(pH 4.0) at 25 °C  
  
proton a ΛHT (major) ΔHT (minor) 
9-EtGb 
G H8 cis B 8.03  8.15 
G H8 cis D 7.61 7.94 
G CH2 cis!B 3.84 3.88 
G CH2 cis D 3.83 3.85 
G CH3 cis B 1.11 1.16 
G CH3 cis D 1.15 1.20 
6,6!-Me2dpa 
H4 7.86 7.85 
H4! 7.65 7.56 
H3 (overlapped) 7.48 7.48 
H3! 7.55 7.28 
H5 (overlapped) 7.12 7.12 
H5! 7.07 7.03 
endo-H7 5.00 5.12 
exo-H7 4.57c 4.57c 
H7! 3.72, 3.86d 3.68, 3.82d 
6-CH3 1.75 1.88 
6!-CH3 2.15 2.13 
a G = 9-EtG; cis B = signal in G bound cis to bound chain; cis D = signal in G bound cis to 
dangling chain. bfree 9-EtG 1H NMR signals: H8 7.72, CH2 3.91, and CH3 1.25 ppm. cSignals are 
masked by the HOD signal. dSignals are masked by the CH2 signals of the 9-EtG ethyl group. 
 
Because one 6-methyl-2-picolyl chain is dangling, the corresponding protons of the two 
halves of the now bidentate chelate ligand are not equivalent in all [Pt(N(H)6,6!-Me2dpa)(9-
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EtG)2]2+ conformers (Figures 3.4, 3.8, and 3.9). Four 6-Me signals of the adduct can be observed, 
and all are upfield compared to the 6/6!-Me signal of [Pt(N(H)6,6!-Me2dpa)Cl]Cl at 2.80 ppm. 
However, not all of the other types of chelate ligand signals can be resolved. [The aromatic and 
aliphatic 1H NMR spectral regions for the reaction mixture forming [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ are presented in Figures 3.7 and B.7.] Two of the four Me signals [1.88 (minor, ΔHT) 
and 1.75 (major, ΛHT) ppm] have upfield shifts similar to those of the syn (1.75 ppm) and anti 
(2.05 ppm) 6-Me signals of the mono adduct, [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+. These 6-Me 
signals of the two [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers are assigned to the 6-Me of the 
chelated 6-methyl-2-picolyl chain because such a 6-Me group is close to the anisotropic purine 
rings of the coordinated cis 9-EtG in both the ΔHT and ΛHT conformers (Figure 3.9). By 
complementary reasoning, the downfield 6!-Me signals at 2.13 (ΔHT) and 2.15 (ΛHT) ppm 
(Table 3.5), which have shifts closer to that of the 6/6!-Me signal of the free N(H)6,6!-Me2dpa 
ligand (2.40 ppm), are assigned to the 6!-Me group in the dangling chain. 
A key type of information allowing us to determine the conformations of each 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ rotamer is provided by the H8 signal shifts for the minor ΔHT 
conformer (8.15 and 7.94 ppm) and for the major ΛHT conformer (8.03 and 7.61 ppm). The very 
upfield 7.61 ppm shift is characteristic of the H8 signal of a highly canted guanine base. A high 
degree of guanine base canting is characteristic of a 9-EtG coordinated cis to the NH group of 
the carrier ligand with its O6 on the same side of the coordination plane as the NH. The resulting 
O6-to-NH hydrogen bonding leads to guanine base canting.51 Canting positions the H8 closer to 
the shielding region of the six-membered ring of the adjacent guanine base (Figure 3.9). This 
positioning of H8 results in an upfield H8 signal for the canted 9-EtG. Such NH-to-G O6 H-
bonding is possible for only one HT conformer. For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct 
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with an unresolved asymmetric bidentate ligand, the enantiomer with the asymmetric 
configuration at nitrogen shown in Figure 9 has the ΛHT conformation. The guanine base of the 
other 9-EtG (cis to the bound pyridyl ring) in the ΛHT conformer is expected to have a low 
degree of canting because of the steric interaction between the guanine six-membered ring and 
the 6-Me group. Also, this H8 is positioned far from the shielding region of the cis 9-EtG base 
(Figure 3.9). As a result, the H8 signal of this less canted 9-EtG base is relatively downfield at 
8.03 ppm. From the foregoing, it follows that the less abundant HT conformer, with H8 signals at 
8.15 and 7.94 ppm, is the ΔHT conformer. The lower abundance of this conformer may be a 
result of a steric clash of the guanine O6 with the dangling 6-methyl-2-picolyl chain or of the 
lack of any stabilizing O6-to-NH hydrogen bonding. 
For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, as mentioned above, the 6-Me protons 
of the bound pyridyl ring are close to the cis 9-EtG H8 in both [Pt(N(H)6,6!-Me2dpa)(9-EtG)2] 2+ 
conformers. H8-to-6-Me NOE cross-peaks are expected from the H8 signals of the cis 9-EtG. 
H8-to-6!-Me NOE cross-peaks could be expected for both the ΛHT and ΔHT conformers 
because rotation about the bond between the asymmetric N and CH2! positions the 6!-Me in the 
dangling chain close to the H8 of the 9-EtG cis to the secondary amine in each rotamer. 
However, the H8-to-6!-Me NOE cross-peak should be more intense for the ΛHT rotamer 
because the 9-EtG H8 and the dangling chain are on the same side of the coordination plane. 
From this reasoning, we can use NOE data to assign the H8 and Me signals to a specific 
conformer. The ROESY spectrum (Figure 3.10) has very intense NOE cross-peaks from the H8 
signal at 8.15 ppm to the 6-Me signal at 1.88 ppm and from the H8 signal at 8.03 ppm to the 6-
Me signal at 1.75 ppm. From this information, we assign the H8 signals at 8.15 and 8.03 ppm to 
the 9-EtG cis to the chelated 6-methyl-2-picolyl chain, consistent with our shift-based 
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assignment of the signals at 1.88 and 1.75 ppm to the 6-Me group of this chain in the two 
rotamers, as discussed above. 
 
Figure 3.10: The H8 and 6-Me region of the 1H-1H ROESY spectrum of the [Pt(N(H)6,6!-
Me2dpa)(9-EtG)2]2+ adduct (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). The singlet labeled X 
at left is a solvent impurity.  
 
  The H8 signals at 8.15 and 8.03 ppm are connected by an EXSY cross-peak (Figure 
3.11), confirming that the H8 signals are from the 9-EtG coordinated cis to the chelated 6-
methyl-2-picolyl chain in the two conformers. An EXSY cross-peak between H8 signals at 7.94 
and 7.61 ppm indicates that the two H8 signals are from the 9-EtG in the other coordination site, 
cis to the secondary amine. The presence of these H8-H8 EXSY cross-peaks further indicates 
that rotation about the Pt–N bonds is occurring but not at a rate fast enough to average the signals 
of all conformers.  
The H8 signal at 7.94 ppm of the minor [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ rotamer does 
not have an NOE cross-peak to a Me signal, but the H8 signal of the major rotamer at 7.61 ppm 
has a weak NOE cross-peak to the 6!-Me signal at 2.15 ppm (Figure 3.10). This information 
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allows assignment of the 6!-Me signals (Table 3.5) and also confirms that the major rotamer is 
the ΛHT conformer, with the H8 of the 9-EtG cis to the secondary amine on the same side of the 
coordination plane as the dangling 6-methyl-2-picolyl chain.  
 
 
Figure 3.11: Aromatic region of the 1H-1H ROESY spectrum of the [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ (15 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). The peak labeled H5 contains 
overlapped H5 signals of both HT rotamers. Cross-peaks shown in red are NOE cross-peaks and 
those in blue are EXSY cross-peaks. 
 
As shown in Figure 3.1, interconversion between the two HT rotamers of the 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct can pass through either one or both HH conformers. 
The 9-EtG cis to the bound chain with the 6-Me group projecting toward the guanine base would 
surely undergo slower rotation than would the 9-EtG adjacent to the dangling chain. If either of 
the two HH conformers existed in relatively high abundance, but if the HT-to-HH interchange 
were fast, separate signals for the HH/HT pair would not be observed. Thus, our observation of 
only four H8 signals does not rule out the presence of some of both HH conformers. A 
significant amount of an HH conformer could be present but not detectable in 1D NMR spectra; 
however, the HH conformer could be detectable in 2D NMR spectra. For example, a ROESY 
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spectrum would contain an H8-H8 NOE cross-peak linking H8 signals from 9-EtG cis to the 
bound pyridyl N with H8 signals from 9-EtG cis to the dangling chain because these protons are 
close in both HH conformers (Figures 3.1 and B.8). No H8-H8 NOE cross-peak was observed 
for either pair of H8 signals (minor or major) (Figure 3.11), a finding consistent with a low 
abundance of HH conformers and a dominant abundance of ΛHT and ΔHT conformers.  
Furthermore, a low abundance of HH conformers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ 
adduct is fully consistent with extensive past studies with various bidentate ligands having two 
sp2 N donors in heterocyclic aromatic rings or two sp3 N donors.20,52 Regardless of the type of N 
donor in the bidentate ligand, the HH conformer was either absent or else present in low 
abundance, except for adducts of guanine nucleotides that possess a phosphate group.26,51,53  
To further confirm our conclusions about the conformation of the HT rotamers of 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, we assessed the effect of pH on conformer abundance. At high 
pH, the N1H of guanine (Figure 3.1) becomes deprotonated, making the O6 a stronger hydrogen 
bond acceptor.51 As mentioned, only the ΛHT conformer is capable of forming a G O6–NH 
hydrogen bond (Figure 3.9). Thus, the abundance of the ΛHT conformer is expected to increase 
with pH. At low pH (4.3), the ΛHT:ΔHT ratio of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ conformers 
was 63:37, which increased to 69:31 at pH 8.3 and to 88:12 at pH 10.3 (Figure 3.12). Thus, the 
ΛHT conformer (which can form an O6–NH hydrogen bond) has an even higher abundance than 
the ΔHT conformer at high pH, in agreement with previous studies of the (rac)-BipPt(9-EtG)2 
(Bip = 2,2!-bipiperidine)20 and (rac)-Me2DABPt(9-EtG)2 (Me2DAB = N,N-dimethyl-2,3-
diaminobutane)21 adducts. For both of these adducts at high pH, the HT conformer that can form 




Figure 3.12: Aromatic region of 1H NMR spectra of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct 
(25 °C, D2O/DMSO-d6, shifts in ppm) at pH 4.3 (bottom), pH 8.3 (middle), and pH 10.3 (top).   
 
3.3.7 Further Analysis Using NMR Data  
The foregoing analysis of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct utilized H8 and 
Me signals that are well resolved. The unusual nature of the bis adduct draws further support 
from 1H NMR and 13C NMR assignments for the carrier ligand of the [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ adduct (Tables 3.5 and 3.6). The carrier-ligand assignments are explained here and in 
more detail in the Supporting Information. COSY (not shown), HSQC and HMBC (Supporting 
Information, Figures B.9-B.12) experiments were among the NMR experiments employed. As a 
reminder, protons in the chelated 6-methyl-2-picolyl chain!are labeled as H3, H4, H5, endo-H7, 
exo-H7, and 6-Me, and protons in the dangling 6-methyl-2-picolyl chain!are labeled as H3!, H4!, 
H5!, H7!, and 6!-Me (Figure 3.4). This labeling scheme is also used for the 13C NMR signals. 
! 65 
Also, designations for the endo-H7, exo-H7, and H7! protons are shown in Figure B.13 
(Appendix B). 
Table 3.6: 13C NMR Shifts (ppm) for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ in D2O/DMSO-d6 (pH 
4.0) at 25 °C  
 
carbon a ΛHT (major) ΔHT (minor) 
9-EtGb 
G C8 cis B 142.3 141.5 
G C8 cis D 141.8 141.8 
G CH2 cis B (overlapped) 41.36 41.42 
G CH2 cis D (overlapped) 41.36 41.42 
G CH2 cis B 15.5 15.6 
G CH2 cis D 15.8 16.0 
6,6!-Me2dpa 
C4 (overlapped) 142.0 142.0 
C4! (overlapped) 139.8 139.8 
C3 121.7 121.8 
C3! 124.0 123.2 
C5 (overlapped) 127.7 127.7 
C5! 125.0 124.8 
C7 (overlapped) 63.2 63.2 
C7! 59.5 59.6 
6-CH3 25.0 24.7 
6!-CH3 24.3 24.4
 
C6  162.4 162.5 
C6! 159.6 159.5 
C2 162.8 162.6 
C2! 153.4 153.3 
a G = 9-EtG; cis B = signal in G bound cis to bound chain; cis D = signal in G bound cis to 
dangling chain. b free 9-EtG 13C NMR signals: C8 140.8, CH2 40.2, and CH3 16.2 ppm. 
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For the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, the shifts of the 1H NMR (H4! and H5!) 
and 13C NMR (C3!, C4!, C5!, 6!-Me, and C7!) signals of the dangling chain are similar to those of 
the free N(H)6,6!-Me2dpa ligand (Appendix B), evidence that a bis adduct has formed. The 
pyridyl ring in the dangling chain should still experience slight inductive effects from the Pt(II) 
because the anchoring central nitrogen is bound.  
In the ΔHT conformer, the proximity of the six-membered ring of the adjacent guanine 
base to the pyridyl ring of the dangling 6-methyl-2-picolyl chain! (Figure 3.9) could result in 
slight shielding of the H3!, H4!, H5!, and 6!-Me signals. In the ΛHT conformer, the dangling 
chain and the adjacent guanine six-membered ring are on opposite sides of the coordination 
plane (Figure 3.9); thus, no shielding is expected. This reasoning explains the relatively upfield 
shifts of the H3!, H4!, H5!, and 6!-Me signals of the ΔHT conformer as compared to the 
corresponding signals of the ΛHT conformer (Table 3.5). Also, an inspection of models (Figure 
3.9) suggests that the most likely location of the dangling chain of the ΔHT conformer will 
position the H3! proton in the upfield-shifting region of the anisotropic guanine base, and indeed 
this H3! signal does have the most upfield H3! shift (Table 3.5).  
We now consider how the chemical shifts of the signals of [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ chelated 6-methyl-2-picolyl chain! differ for the two HT conformers. The shifts of 
signals (H3, H4, and H5) for the bound pyridyl group are similar for the ΛHT and ΔHT 
conformers (Table 3.5). These protons are far from the cis coordinated 9-EtG base and should 
have signals unaffected by the guanine base orientation.  As expected from the close proximity 
of the 6-Me group to the cis 9-EtG base (Figure 3.9), the 6-Me signals are upfield and have shifts 
similar to those of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+  adduct (Table 3.3). The more upfield 
shift of the 1.75 ppm 6-Me signal of the ΛHT conformer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ 
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compared to the 1.88 ppm 6-Me signal of the ΔHT conformer (Table 3.5) is consistent with the 
expectation that the anisotropic six-membered ring of the cis-bound 9-EtG is on the same side of 
the coordination plane and positioned close to the 6-Me group, resulting in a greater upfield shift 
of this 6-Me signal. This close positioning arises from the tilting of the pyridine ring resulting 
from the chelate ring pucker (Figure 3.9). The pucker is dictated by the favored equatorial 
position of the dangling chain. 
We report the 13C NMR shifts of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct in Table 
3.6 and those for the free chelate ligand in Table B.1, Appendix B. The C7 shift (overlapped at 
63.2 ppm) of the chelated 6-methyl-2-picolyl chain is similar to that in the starting [Pt(N(H)6,6!-
Me2dpa)Cl]Cl complex (Table 3.4) and thus probably reflects strain and inductive effects as we 
discussed above. The C7! shifts at 59.5 and 59.6 ppm for the dangling chain of the conformers 
have values close to that of the free ligand, as expected for a dangling chain. Compared to the 
C2/2! shift value of the free ligand (151.1 ppm, Table B.1), the C2! signals of the dangling chains 
have relatively similar shifts (~153.5 ppm), whereas the C2 shifts (~163 ppm) of the chelated 
chain are quite downfield. Likewise, the overlapped C6! shift is close to that of the free ligand 
(Table B.1). These 13C NMR data are fully consistent with the structure and properties proposed 
here for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct.   
3.3.8 Relative Reactivity of [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ with 9-EtG 
Comparison of the times required for the complete formation of [Pt(N(H)dpa)(9-EtG)]2+ 
(~49 h) vs the complete formation of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is complicated by the fact 
that the latter converts to the bis adduct on a comparable time scale. The time required for the 
formation of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is best assessed by the time needed for 
consumption of [Pt(N(H)6,6!-Me2dpa)Cl]+. The approximate times for the complete 
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disappearance of starting [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in D2O/DMSO-d6 
(64:36) on addition of 2.5 equiv of 9-EtG were 2.5 h and 49 h, respectively. This order of relative 
reactivity is opposite to that expected from steric impedance of the attack by 9-EtG on the Pt(II) 
centers because the tridentate N(H)6,6!-Me2dpa ligand has greater steric bulk than the tridentate 
N(H)dpa ligand. The order found suggests that the dissociation of the Pt–N(pyridyl ring) bond 
may be responsible for the high reactivity. Studies of PtI2(Me2phen) (Me2phen = 2,9-dimethyl-
1,10-phenanthroline) show that the steric interactions between the methyl groups of the carrier 
ligand and the coordinated iodides cause one end of the carrier ligand to dissociate and become 
monodentate, allowing a nucleophile to coordinate trans to the now-monodentate Me2phen.54 
This process is promoted by the presence of a methyl group ortho to the ring N of Me2phen.  
A detailed kinetic and mechanistic study is outside the scope of the present work. 
However, we did conduct a simple set of experiments to see if dissociation of the Pt–N(pyridyl 
ring) bond might be a process deserving further study in future. In order to assess if the 
analogous situation (a methyl group ortho to the ring N of N(H)6,6!-Me2dpa) promotes 
dissociation of the Pt–N(pyridyl ring) bond, concentrated HCl (10 µL) was added to 10 mM 
solutions of [Pt(N(H)6,6!-Me2dpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in D2O/DMSO-d6 (64:36). A 1H 
NMR spectrum recorded 10 min after addition of HCl to the [Pt(N(H)6,6!-Me2dpa)Cl]+ solution 
revealed new sets of signals (Figure B.14); these signals can be attributed to an intermediate with 
a bidentate ligand and to free protonated ligand (designated as N(H)6,6!-Me2dpaHxm+ because the 
extent and the sites of protonation were not evaluated). Over time, the set of signals of the 
protonated free ligand, N(H)6,6!-Me2dpaHxm+, became the most abundant. The ratio of signals 
for [Pt(N(H)6,6!-Me2dpa)Cl]+:N(H)6,6!-Me2dpaHxm+ was ~1:1 at 1 h. Because formation of free 
ligand involves dissociation of both pyridyl rings, dissociation of one ring must require less than 
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1 h. The 1H NMR spectra for a [Pt(N(H)dpa)Cl]+ solution under the same reaction conditions 
revealed no new set of signals after one day (Figure B.15) and even longer (3 d), indicating that 
pyridyl rings lacking a methyl group ortho to the ring N do not dissociate. 
The results above suggest that one pyridyl ring in [Pt(N(H)6,6!-Me2dpa)Cl]+ dissociates, 
forming a “bidentate intermediate” with the chelate having one 6-methyl-2-picolyl chain!bound 
as part of a five-membered chelate ring and the other 6-methyl-2-picolyl chain!dangling with an 
uncoordinated pyridyl ring N. Although overlap of one aromatic signal in the crowded region 
near 8.7 ppm (Figure B.14) precludes the observation of all six aromatic signals expected for the 
“bidentate intermediate,” the five signals clearly resolved integrate to the correct 1:1 ratio. The 
shifts of the 1H NMR signals for the bound 6-methyl-2-picolyl chain!are similar to those of the 
corresponding signals for [Pt(N(H)6,6!-Me2dpa)Cl]+, and the dangling 6-methyl-2-picolyl chain!
signals are downfield because of protonation of the pyridyl ring nitrogen, as found for the free 
N(H)6,6!-Me2dpaHxm+ ligand (shown in the top trace of Figure B.14, Appendix B). The 
“bidentate intermediate” never builds up to a high abundance, but the H4 triplet is readily 
observed downfield and undergoes informative changes in shift. The shift of the triplet is at ~7.8 
ppm for H4 in the bound chain and at ~8.3 ppm for H4 in the N(H)6,6!-Me2dpaHxm+ ligand. The 
“bidentate intermediate” has triplets at ~7.9 ppm for H4 in the bound chain and ~8.4 ppm for H4 
in the dangling chain. Thus, there is clear evidence that the intermediate contains the chelate in a 
bidentate coordination mode. 
The time required for a “bidentate intermediate” to form is comparable to or less than the 
time needed to form the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (2.5 h). Such a process forming 
this intermediate could account for the shorter time needed to form [Pt(N(H)6,6!-Me2dpa)(9-
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EtG)]2+ than to form [Pt(N(H)dpa)(9-EtG)]2+. The HCl experiment indicates that no such reactive 
“bidentate intermediate” is formed by [Pt(N(H)dpa)Cl]+.  
3.3.9 Pt(N(H)6,6!-Me2dpa)(GMP) and Pt(N(H)6,6!-Me2dpa)(GMP)2 Adducts  
The reaction of [Pt(N(H)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!- or 3!-GMP in 
D2O/DMSO-d6 (64:36) at pH 4.1 was monitored by following the H8 NMR signal. As found for 
9-EtG, these GMP nucleotides form a mono adduct that converts with time completely to a bis 
adduct (Figure 3.4). Because the charge on the GMP adducts is not known, we specify them with 
no brackets or charge. 
Each GMP mono adduct can form at most two rotamers, as is true for the achiral 9-EtG 
mono adduct. A mirror plane perpendicular to the coordination plane and passing through the Pt 
and secondary NH group bisects the Pt(N(H)6,6!-Me2dpa) moiety. Thus, the N9 chiral ribose 
group of the GMP’s does not increase the number of rotamers for a GMP mono adduct. For both 
nucleotides, the Pt(N(H)6,6!-Me2dpa)(GMP) mono adduct has the expected two very downfield 
H8 singlets, as shown for Pt(N(H)6,6!-Me2dpa)(3!-GMP) in Figure B.16, and slightly downfield 
H1! doublets, as shown for Pt(N(H)6,6!-Me2dpa)(5!-GMP) in Figure B.17. The chiral N9 ribose 
group of these nucleotides causes the corresponding protons in the two halves of the tridentate 
ligand to be magnetically inequivalent. In principle, four signals could be seen for each type of 
chelate proton, two from each of the two rotamers. However, because the ribose projects away 
from the chelate, the signals of such corresponding protons are usually not resolved. The ribose 
signals also create signal overlap problems. Nevertheless, the shifts of the H8 and H1! signals 
leave no doubt that two rotamers of each GMP mono adduct are formed as expected.23  
For both the 5!-GMP and the 3!-GMP reactions, the signals of the mono adduct diminish 
and are fully replaced by upfield-shifted H8 and H1! signals (Figures B.16 and B.17), leaving no 
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doubt that both GMP’s form a Pt(N(H)6,6!-Me2dpa)(GMP)2 bis adduct. In the cases of bis 
adducts with chiral GMP ligands or the nonchiral 9-EtG ligand, the same number of conformers 
(8) is possible. In contrast to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, which has 
enantiomers, the combination of the asymmetric secondary amine and the N9 chiral ribose group 
of GMP makes both GMP ligands in all Pt(N(H)6,6!-Me2dpa)(GMP)2 conformers magnetically 
inequivalent. Therefore, a maximum of sixteen H8 signals could be observed if all four 
conformers exist and all are in slow exchange. If the rate of conformer interchange is too fast to 
observe H8 signals for the minor HH conformers, as found for the [Pt(N(H)6,6!-Me2dpa)(9-
EtG)2]2+ adduct, then a maximum of eight H8 signals could be observed for each Pt(N(H)6,6!-
Me2dpa)(GMP)2 adduct. Assigning the H8 signals to a particular conformer and configuration of 
the secondary amine is not feasible, especially because aromatic NMR signals from the chelate 
fall in the same spectral region as the H8 signals. Indeed, only six of the probable eight H8 
signals could be found for the Pt(N(H)6,6!-Me2dpa)(5!-GMP)2 adduct in 1H NMR spectra (not 
shown). However, we can identify eight H8 signals (Figure B.16) from the Pt(N(H)6,6!-
Me2dpa)(3!-GMP)2 adduct, consistent with the anticipated presence of four dominant HT 
conformers.  
Although the 1H NMR evidence for the Pt(N(H)6,6!-Me2dpa)(GMP)2 bis adducts is 
compelling, we also obtained 13C NMR data supporting the existence of such adducts. For 
example, HSQC cross-peaks at ~3.8–59.5 ppm identify C7! in dangling 6-methyl-2-picolyl 
chains, and HSQC cross-peaks at ~4.6–62.5 ppm and at ~5.0–62.5 ppm identify C7 in bound 
chains. Thus, the overlapped 1H NMR signals at ~3.80 ppm in a crowded, overlapped 1H NMR 
spectral region for adducts of both nucleotides give HSQC cross-peaks to a 13C NMR signal at 
59.4 ppm (5!-GMP) and at 59.6 ppm (3!-GMP), assigning the dangling chain C7! signals. Both 
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GMP adducts thus have C7! signals with shifts that are very similar in value to the 59.6 ppm of 
the dangling chain C7! signal in the 9-EtG bis adduct. This similarity is further confirmation that 
the GMP’s form a bis adduct similar to the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct 
characterized in depth above. As found with 9-EtG, the GMP nucleotides clearly transform the 
N(H)6,6!-Me2dpa chelate ligand coordination mode from tridentate to bidentate.  
3.4 CONCLUSIONS  
The bulk of the 6/6!-Me groups of [Pt(N(H)6,6!-Me2dpa)Cl]Cl causes the chelate ligand 
to convert from a tridentate to a bidentate coordination mode, having one pyridyl chain dangling, 
facilitating coordination of 9-EtG, first to a mono adduct and then to a bis adduct. Much less 
time is required to form the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ mono adduct than to form the 
[Pt(N(H)dpa)(9-EtG)]2+ mono adduct. The bulk of the methyl groups on the carrier ligand causes 
one of the pyridyl rings to dissociate, thus promoting faster formation of the mono adduct. 
Conversion to a bis adduct produces an asymmetric center at the secondary nitrogen, which for 
each conformer present gives rise to an enantiomeric pair having signals that cannot be resolved 
by ordinary NMR methods. The bulk of the 6-Me groups is sufficient to impede rotation of the 
guanine base about the Pt–N7 bond of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct; thus, H8 
signals for conformers could be resolved and assigned. The nature of both the guanine base and 
the carrier ligand in the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct influences the distribution of 
conformers and their characteristics. The ΛHT conformer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ is 
more abundant than the ΔHT conformer, most probably because of the formation of a weak 
hydrogen bond between the NH of the bidentate carrier ligand and the 9-EtG O6. The 5!- and 3!-
GMP nucleotides form Pt(N(H)6,6!-Me2dpa)(GMP)2 adducts, in which the chelate ligand 
coordination mode was transformed from tridentate to bidentate. 
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The abundance of the syn rotamer relative to the anti rotamer is less for the [Pt(N(H)6,6!-
Me2dpa)(9-EtG)]2+ adduct than that reported for the [Pt(N(H)dpa)(9-EtG)]2+ adduct.23 The syn 
rotamer of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ is probably destabilized by steric interaction of the 
bulky guanine six-membered ring and the 6/6!-Me groups; these groups are on the same side of 
the coordination plane in the syn rotamer. We also conclude from the absence of H8-H8 EXSY 
cross-peaks for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct that the bulk of the methyl groups is 
sufficient to significantly decrease the ease of interconversion between rotamers as compared to 
the [Pt(N(H)dpa)(9-EtG)]2+ adduct, for which H8-H8 EXSY cross-peaks were observed in the 
previous study.23  
Our study was motivated by the desire to understand the effect of steric bulk of the carrier 
ligand on the bound guanine derivative. Clearly the Pt(N(H)6,6!-Me2dpa) moiety does interact 
sterically with the guanine base more than the Pt(N(H)dpa) moiety does. However, it is also clear 
that the 6/6!-Me groups weaken the Pt–N bond to such an extent that the tridentate ligand 
converts to a bidentate ligand. This chemistry showing the facile opening of chelate rings by 
nucelobase addition to Pt(II) compounds is interesting and unusual. Furthermore, our work 
provides a caveat: a monofunctional Pt(II) complex with bulky carrier ligands that are chelates 
forming Pt–N bonds of normal length may not necessarily contain Pt–N bonds strong enough to 
prevent bifunctional binding to DNA. 
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 Clinically used anticancer agents, such as cisplatin and its Pt(Lbi)X2 analogues (Lbi = one 
bidentate or two cis-unidentate N-donor carrier ligands, X2 = anionic leaving groups), function 
by forming a 1,2-intrastrand G*G* cross-link between two adjacent guanines of d(GpG) 
sequences in DNA (G* identifies N7-platinated G residues in DNA or oligonucleotides).1-8 NMR 
and X-ray studies of duplex oligomers containing such an intrastrand cross-link lesion9,10 and an 
oligomer adduct of a rather bulky monofunctional Pt anticancer agent11,12 have all revealed a 
similar and unusual location of the X•Y base pair (bp) adjacent to the 5!-G* bp. (This location 
creates an unusual slide and shift in the XpG* bp step.) Solution studies established that this 
unusual XpG* bp step exists in solution for most duplexes with a G*pG* intrastrand cross-link.9 
The XpG* bp step structural distortion may be even more important in anticancer activity than 
the G*pG* bp step distortion.13,14 
 Monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and one 
monodentate, or three monodentate ligands; X = a monodentate, monoanionic leaving group), 
have higher activity when carrier-ligand bulk is greater.11,12,15-19 These monofunctional agents also 
preferentially bind to G residues in DNA. Recent work suggests that monofunctional and 
bifunctional agents can have similar biological effects.20 Unlike monofunctional Pt(II) agents, 
however, bifunctional Pt(II) agents, Pt(Lbi)X2, have lower activity and higher toxicity when the 
carrier-ligand bulk is greater.5,21-24 Thus, it is important to gain a better understanding of the 
fundamental features of such adducts. One approach toward achieving this goal is to assess the 
effects of steric interactions between the carrier ligand and the guanine base in Pt(Ltri)G models 
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(G = guanine derivative bound to platinum, but not tethered to another nucleobase, Figure 
4.1).6,25-30  
!
Figure 4.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9 
derivatives (referred to with bold G). A generic version of G is depicted in the center, along with 
the guanine base numbering scheme. R can be an alkyl group, ribose, or a ribose phosphate. Note 
that the nucleobase is represented by an arrow with the tip at the guanine H8 atom. N and N! 
represent a nitrogen donor ligand. When (N ≠ N!), four rotamers (ΛHT, ΔHT, HHu, HHd) are 
possible, whereas when (N = N!), only three conformers (ΛHT, ΔHT, HH) are possible because 
HHu = HHd. The same number of conformers can exist regardless of whether the nitrogen 
donors are unidentate ligands or are part of a chelate (N–N or N–N!). 
 
 We previously studied the interactions of several G derivatives [e.g., 9-ethylguanine (9-
EtG), 5!-guanosine monophosphate (5!-GMP), etc.] in Pt(Ltri)G mono adducts with a carrier 
ligand having low in-plane bulk, di-(2-picolyl)amine (N(H)dpa)31 and a related ligand, N(H)6,6!-
Me2dpa (di-(6-methyl-2-picolyl)amine), having high in-plane bulk, Figure 4.2.32  
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Figure 4.2: Line drawing and numbering scheme for the [Pt(N(H)dpa)Cl]+, [Pt(N(H)6-
Medpa)Cl]+, and [Pt(N(H)6,6!-Me2dpa)Cl]+ cations. 
 
 In such Pt(Ltri)G mono adducts, the guanine base has two orientations with respect to the 
coordination plane, leading to the presence of syn and anti rotamers (Figure 4.3), which can 
interconvert by rotation about the Pt–N7 bond. As shown in Figure 4.3, the rotamer with the H 
atom of the central N-H group and the guanine O6 on the same side of the coordination plane is 
designated as syn, and the rotamer with these groups on opposite sides of this plane is designated 
as anti.26,31 The observation of two sharp 1H NMR G H8 signals for all Pt(N(H)dpa)G and 
Pt(N(H)6,6!-Me2dpa)G mono adducts indicates that these rotamers do indeed exist and that 
guanine base rotation about the Pt–N7 bond is impeded by the bulk of the tridentate carrier 
ligands, even by the small pyridyl H6/6! atoms of N(H)dpa, which are bulky enough to prevent 
time-averaging of the two H8 signals.31 We noted in this study of the Pt(N(H)dpa)G adducts that 
the tilting of the pyridyl rings relative to the Pt(II) coordination plane positions the anisotropic 
pyridyl ring shielding region closer to the H8 proton of the syn conformer than to that of the anti 
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conformer (Figure 4.3). The syn H8 signal is upfield relative to the anti H8 signal. As a 
consequence of this pyridyl ring tilting, the bulky guanine 6-membered ring is on the same side 
of the coordination plane as the pyridyl H6/6! atoms in Pt(N(H)dpa)G and as the pyridyl 6/6!-Me 
groups in Pt(N(H)6,6!-Me2dpa)G mono adducts in the syn rotamer.31,32  
!
Figure 4.3: Two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with tridentate 
ligands unsymmetrical with respect to the coordination plane but symmetrical about a plane 
perpendicular to the coordination plane are illustrated for Ltri = N(H)dpa and G = 9-EtG. The 
anisotropic pyridyl rings shields the H8 in the syn rotamer.31 This shielding results in an upfield 
shift of the syn H8 signal. The H8 in the anti rotamer points away from the pyridyl rings, 
resulting in a downfield shift of the anti H8 signal compared to the shift of the syn H8 signal. 
Protons in the chelate ligand N–CH2 groups are called endo if they project down and away from 
the NH and exo if they project up toward the NH. The H8 proton of 9-EtG and the NH proton are 
highlighted with a magenta circle. 
 
Despite some similarity in properties of the Pt(N(H)dpa)G and Pt(N(H)6,6!-Me2dpa)G mono 
adducts, an excess of G has no effect on the Pt(N(H)dpa)G mono adduct,31 but an excess of G 
readily converts the Pt(N(H)6,6!-Me2dpa)G mono adduct unexpectedly and completely to the 
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Pt(N(H)6,6!-Me2dpa)G2 bis adduct (Figure 4.4).32 Unlike Pt(Ltri)G mono adducts, which have 
just two rotamers, Pt(Lbi)G2 adducts can have as many as two head-to-head (HHu and HHd) and 
two head-to-tail (ΛHT and ΔHT) conformers, depending on the bulk and symmetry of the carrier 
ligands (Figure 5.1).5,13,33-38 Formation of the bis adduct (Figure 4.4) involved an unusual 
transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the tridentate to the bidentate 
coordination mode. The design of a monofunctional Pt(II) drug with bulky carrier ligands should 
ensure that the Pt–N bonds are strong enough to allow the agent to remain monofunctional when 
bound to DNA. For this reason, we examined Pt(N(H)6-Medpa)G mono adducts formed from 
[Pt(N(H)6-Medpa)Cl]Cl (N(H)6-Medpa = N-(6-methyl-2-picolyl)-N-(2-picolyl)amine), Figure 2. 
Our overall goal was to obtain a rough scale of the effect of the systematic increase in carrier-
ligand bulk from N(H)dpa to N(H)6-Medpa to N(H)6,6!-Me2dpa. 
 
Figure 4.4: Transformation of the initially monofunctional complex, [Pt(N(H)6,6!-Me2dpa)Cl]+, 
to the bis adduct, [Pt(N(H)6,6!-Me2dpa)G2]2+, upon addition of G. The methylene group protons 
are designated as exo and endo (see text). 
 
 In this study, we have employed NMR techniques to assess the influence of intermediate 
in-plane bulk on the properties of Pt(N(H)6-Medpa)G mono adducts. Because of the 
unsymmetrical nature of the carrier ligand, the [Pt(N(H)6-Medpa)Cl]Cl complex is chiral, the 
chiral center being the central NH of the tridentate ligand. The coordinated ligand is 
unsymmetrical both with respect to the coordination plane and across a plane perpendicular to 
the coordination plane. When G contains a chiral group (e.g., 5!-GMP), each of the syn and anti 
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rotamers could have two 1H NMR signals for each type of proton. This situation raises the 
possibility that four signals could be resolved for each type of proton [e.g., four H8 or four H6! 
signals in the 1H NMR spectrum of a given Pt(N(H)6-Medpa)G adduct]. If G lacks a chiral 
group (e.g., 9-EtG), only one syn and one anti rotamer are possible. Thus, only two 1H NMR 
signals (one for each rotamer) can be resolved for each type of proton in the spectrum of the 
Pt(N(H)6-Medpa)(9-EtG) mono adduct. In the presence of an excess of G, Pt(N(H)6-Medpa)G 
formed only small amounts of the Pt(N(H)6-Medpa)G2 bis adduct in comparison to Pt(N(H)6,6!-
Me2dpa)G mono adducts, which convert readily and completely to the Pt(N(H)6,6!-Me2dpa)G2 
bis adduct. Thus, bis adducts are less favored and form in lower abundance when the carrier 
ligand has lower bulk. Also, the ease of interconversion of Pt(N(H)6-Medpa)G rotamers is less 
facile than for rotamers of Pt(N(H)dpa)G adducts, which have a smaller carrier ligand.31 
Intermediate properties of adducts are expected when the carrier ligand has intermediate bulk. 
However, it is surprising that the syn rotamer is much more favored in Pt(N(H)6-Medpa)G than 
in either Pt(N(H)dpa)G or Pt(N(H)6,6!-Me2dpa)G adducts. An important goal of the current 
study is to elucidate the reasons for the high abundance of the syn rotamer for all Pt(N(H)6-
Medpa)G adducts studied.  
4.2 EXPERIMENTAL SECTION 
4.2.1 Starting materials  
K2[PtCl4], 5!-guanosine monophosphate disodium salt (5!-GMP), 3!-guanosine 
monophosphate disodium salt (3!-GMP), 5!-guanosine triphosphate disodium salt (5!-GTP), and 
9-EtG were obtained from Aldrich. cis-Pt(DMSO)2Cl239 and N(H)6-Medpa40 were synthesized as 
described in the literature, and the 1H NMR chemical shifts observed matched the reported 
values. 
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4.2.2 NMR Measurements 
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer, 
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted 
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO-d6, 
peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm 
(residual) and 39.5 ppm, respectively.41 A presaturation pulse to suppress the water peak was 
used when necessary. ROESY experiments were performed at 15 °C by using a 200 ms mixing 
time. 1H–13C HSQC NMR spectra were recorded in order to assign the signals of the Pt(N(H)6-
Medpa)G adducts. NMR data were processed with TopSpin and MestreNova software.  
4.2.3 X-ray Data Collection and Structure Determination  
Single crystals were placed in a cooled nitrogen gas stream at 100 K on a Bruker Kappa 
Apex-II DUO diffractometer equipped with Mo Ka radiation (λ = 0.71073 Å). Refinement was 
performed by full-matrix least squares methods using SHELXL,42 with H atoms in idealized 
positions. The entire cation of [Pt(N(H)6-Medpa)Cl]PF6•H2O is disordered over a mirror plane. 
4.2.4 Synthesis of [Pt(N(H)6-Medpa)Cl]Cl  
Acetonitrile solutions of cis-Pt(Me2SO)2Cl2 (10.6 mg, 0.025 mmol in 1 mL) and N(H)6-
Medpa (5.33 mg, 0.025 mmol in 1 mL) were mixed and kept at 25 °C. After 2 h, the white 
precipitate that had formed was collected on a filter and washed with acetonitrile; yield, 9.16 mg 
(76%). 1H NMR signals (ppm) upon dissolution of the precipitate in DMSO-d6: 8.93 (d, J = 6.0 
Hz, 1H, H6!), 8.90 (bs, 1H, NH), 8.23 (t, J = 7.8 Hz, 1H, H4!), 8.06 (t, J = 7.8 Hz, 1H, H4), 7.71 
(d, J = 7.9 Hz, 1H, H3!), 7.64 (t, J = 7.1 Hz, 1H, H5!), 7.57 (d, J = 7.6 Hz, 1H, H3), 7.49 (d, J = 
7.9 Hz, 1H, H5), 5.05 (dd, J = 15.5, 9.8 Hz, 1H, endo-H7), 4.61 (dd, J = 15.5, 4.6 Hz, 1H, exo-
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H7), 4.91 (dd, J = 16.5, 8.1 Hz, 1H, endo-H7!), 4.53 (dd, J = 16.5, 5.8 Hz, 1H, exo-H7!), 2.88 (s, 
3H, 6-CH3). ESI-MS m/z : [M+] calcd. for C13H15ClN3Pt, 443.060; found, 443.051. 
4.2.5 Crystallization of [Pt(N(H)6-Medpa)Cl]PF6•H2O 
Aqueous solutions (2.5 mM) of [Pt(N(H)6-Medpa)Cl]Cl (2.39 mg in 2 mL) and NaPF6 
(0.85 mg in 2 mL) were mixed, and the resulting solution became slightly cloudy. The thin, 
white, X-ray quality crystals that formed after one day at room temperature were collected by 
filtration and washed with water. Upon dissolution of the crystals in DMSO-d6, the sample gave 
1H NMR signals identical to those of the chloride salt except for the NH signal (bs, 1H, 8.56 
ppm). The signal is more downfield for the chloride salt because the chloride ion interacts with 
the NH, a feature we have discussed previously.28,43  
4.2.6 Adduct Formation of [Pt(N(H)6-Medpa)Cl]Cl with G = 9-EtG, 3!-GMP, and 5!-GMP 
A 10 mM solution of [Pt(N(H)6-Medpa)Cl]Cl in 600 mL of a 65/35 D2O/DMSO-d6 (390 
mL/210 mL) mixture] was treated with 2.5 equiv of G to give a 1:2.5 ratio (10 mM:25 mM) of 
Pt:G, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was employed to 
improve the solubility of the reactants.) An excess of G was used to ensure that the reaction went 
to completion. The reaction, which was repeated several times, was monitored by 1H NMR 
spectroscopy until there was no change in the bound vs free G H8 signal intensity, or until the 
[Pt(N(H)6-Medpa)Cl]Cl signals completely disappeared. The reaction was usually complete at 
1.5 h. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Structural results for [Pt(N(H)6-Medpa)Cl]+. Overall aspects  
Summarized in Table 4.1 are the crystal data and details of the structural refinement of 
[Pt(N(H)6-Medpa)Cl]PF6•H2O. Selected bond lengths and angles are reported in Table 4.2. The 
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ORTEP plot of the cation and the numbering scheme used to describe the solid-state data are 
shown in Figure 4.5. All other references (e.g., NMR discussion) to this ligand and complex will 
employ the atom-numbering scheme shown in Figure 4.2, which will also be used to discuss 
related complexes.   
Table 4.1: Crystal data and structural refinement for [Pt(N(H)6-Medpa)Cl]PF6•H2O. 
empirical formula [C13H15ClN3Pt]PF6•H2O"
fw 606.80 
crystal system monoclinic 
space group C2/m 
a (Å) 10.7680(7) 
b (Å) 23.591(2) 
c (Å) 6.9710(4) 
α 90 
β (deg) 106.283(3) 
γ 90 
V (Å3) 1699.8(2) 
T (K) 100 
Z 4 
ρcalc (Mg/m3) 2.371 
abs coeff (mm-1) 8.58 
2θmax (°) 52.8 
R indicesa 0.036 
wR2 =[I > 2σ(I)]b 0.079 
data/parameters 1804/203 
res. dens. (eÅ-3) 0.96, -1.17 
a R = (∑||Fo| - |Fc||)/∑|Fo|. b wR2 = [∑[w(Fo2 - Fc2)2]/∑[w(Fο2)2]]1/2,  in which w = 1/[σ2(Fo2) + (dP)2 + (eP)] 
and P = (Fo2 + 2Fc2)/3. 
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4.3.2 Coordination Parameters  
 
The [Pt(N(H)6-Medpa)Cl]+ cation exhibits pseudo square planar geometry, with a 
tridentate ligand bound to the Pt with its three N atoms; a Cl atom trans to the N(2) atom 
completes the coordination around Pt (Figure 4.5). The entire [Pt(N(H)6-Medpa)Cl]+ cation is 
disordered over a mirror plane, and all bond lengths and angles discussed below for the cation are 
from the A form. The N(1)–Pt–N(3) bite angle of [Pt(N(H)6-Medpa)Cl]+ is similar to the ~166° 
bite angle reported for [Pt(N(H)dpa)Cl]Cl•H2O,44 [Pt(N(H)dpa)(OH2)]ClO4,44 and [Pt(N(H)6,6!-
Me2dpa)Cl]Cl32 (Tables 4.2 and C.1). The Pt–N(1) and Pt–N(3) bond distances (Table 4.2) for 
[Pt(N(H)6-Medpa)Cl]+ compare well with other Pt–N(sp2) bond distances ranging from 1.99–
2.08 Å.45,46  
Table 4.2: Selected bond distances (Å) and angles (deg) for [Pt(N(H)6-Medpa)Cl]PF6•H2O.  
bond distance bond angles 
Pt–N(1) 2.069(16) N(1)–Pt–N(3) 164.3(6) 
Pt–N(2) 1.96(2) N(1)–Pt–Cl(1) 103.7(7) 
Pt–N(3) 2.019(16) N(2)A–Pt–Cl(1) 169.4(5) 
Pt–Cl(1)  2.316(3) N(3)–Pt–Cl(1) 92.0(6) 
  N(2)A–Pt–N(1) 83.4(6) 
   N(2)A–Pt–N(3) 81.4(4) 
 
The trans N(2)–Pt–Cl bond angles of [Pt(N(H)6-Medpa)Cl]PF6•H2O (169.4(5)°) and of 
[Pt(N(H)dpa)Cl]Cl•H2O (169.5(2)°)44 differ from 180° significantly more than does the 
corresponding trans N(2)–Pt–O bond angle in [Pt(N(H)dpa)(OH2)](ClO4)2 (176.4(3)°, Table 
C.1).44 The departure from 180° of the trans N–Pt–Cl bond angle in [Pt(N(H)6-
Medpa)Cl]PF6•H2O and in [Pt(N(H)dpa)Cl]Cl can be attributed to the larger steric interactions 
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between the coordinated Cl and the H6/6! protons and 6-Me groups than the steric interactions 
with the aqua ligand of [Pt(N(H)dpa)(OH2)](ClO4)2. The H6/6! signals have relatively downfield 
shifts because of the inductive effect of the nearby Pt(II)-coordinated ring nitrogen. Thus, these 
protons bear a partial positive charge (δ+), which would create an attractive electrostatic 
interaction with both the Cl and the aqua ligands. For [Pt(N(H)6-Medpa)Cl]PF6•H2O, the steric 
interaction between the Cl and the 6-Me group is not reflected in a statistically longer Pt–Cl bond 
in [Pt(N(H)6-Medpa)Cl]PF6•H2O (2.316(3) Å) than in [Pt(N(H)dpa)Cl]Cl•H2O (2.301(2) Å) 
(Table C.1). However, the steric effect displaces the Cl toward the unsubstituted pyridyl ring, 
making the cis N(1)–Pt–Cl bond angle (103.7(7)°) much larger than the cis N(3)–Pt–Cl angle 
(92.0(6)°)  (Table 4.2). For [Pt(N(H)dpa)Cl]Cl•H2O 44, in contrast, the cis N(1)–Pt–Cl bond angle 
was not significantly different from the cis N(3)–Pt–Cl angle.  
 
Figure 4.5: Ortep plot of the [Pt(N(H)6-Medpa)Cl]+ cation. Thermal ellipsoids are drawn with 
50% probability. The crystal is disordered, and the cation in only one of the positions is shown. 
 
The Pt–N(2) bond distance for [Pt(N(H)6-Medpa)Cl]PF6•H2O (1.96(2) Å) is at the short 
end of the range (2.01 to 2.12 Å) of most Pt–N(sp3) bond distances.30,47,48 This situation is 
probably caused by the nature of the di(2-picolyl)amine chelate ring system. Similar Pt–N(2) 
bond distances (Table C.1) were reported for [Pt(N(H)dpa)Cl]Cl•H2O (2.009(12) Å) and 
[Pt(N(H)dpa)(OH2)](ClO4)2 (1.952(7) Å),44 a finding that is not statistically significant but is 
suggestive of a weak trans influence of the Cl ligand. Taken together, all response to steric strain 
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in [Pt(N(H)6-Medpa)Cl]PF6•H2O appears to be reflected in the bond angles, notably the cis N–
Pt–Cl angles, rather than in the bond distances (Table 4.2). 
4.3.3 [Pt(N(H)6-Medpa)Cl]Cl NMR Signal Assignments 
The protons of the bound chelate ligand are labeled H3, H4, H5, and 6-Me for the 
methyl-substituted pyridyl group and H3!, H4!, H5!, H6! for the unsubstituted pyridyl group. This 
labeling scheme of using primes to designate the half of the ligand with the unsubstituted pyridyl 
group is also used for the 13C NMR signals and for signals of the endo and exo protons as shown 
in Figure 4.3. The 1H NMR signals for [Pt(N(H)6-Medpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture 
are reported in Table 4.3, and the aromatic region is shown in Figure 4.6.  

















Figure 4.6: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (top) recorded at 1.5 h 
after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). No bis adduct was 
detectable at this time. 
 
The H6! signal must be a doublet, and also it must be the most downfield pyridyl signal 
because of the proximity of the H6! proton to the Pt(II)-bound endocyclic nitrogen, as noted 
above. By using this H6! doublet at 8.75 ppm, a COSY experiment permitted assignment of the 
other signals of the unsubstituted ring (Table 4.3). The remaining aromatic signals belong to the 
substituted pyridyl ring. The triplet at 7.82 ppm is assigned to the H4 signal, the only aromatic 
proton that can give a triplet. A peak at 7.29 ppm contains overlapped H3 and H5 signals. In a 
ROESY spectrum (not shown), an NOE cross-peak from the 6-Me signal (2.74 ppm) to the 
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signal at 7.28 ppm assigns the H5 signal, and the peak at 7.30 ppm is assigned to H3. The 1H 
NMR shift of the H6! signal (8.75 ppm) for [Pt(N(H)6-Medpa)Cl]+ is farther downfield than the 
shift of the H6/6! signal (8.61 ppm) for [Pt(N(H)dpa)Cl]+ (Table C.2), a consequence of the 
deshielding Cl ligand being pushed closer toward the H6! proton (2.58 Å non-bonded distance) 
in [Pt(N(H)6-Medpa)Cl]+ than in [Pt(N(H)dpa)Cl]+ (2.76 Å  non-bonded distance). 
 
Table 4.3: 1H NMR shifts (ppm) for [Pt(N(H)6-Medpa)Cl]Cl and Pt(N(H)6-Medpa)G adducts (G 
= 9-EtG, 3!-GMP, 5!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).   
 
protons Cl 9-EtG 3!-GMP 5!-GMP 5!-GTP 
H4 7.82 7.86a 7.86a 7.83a 7.81a 
H4! 8.02 8.01b, 7.99c 7.99a 7.98a 7.94a 
H3 7.30 7.38b, 7.36c 7.37b, 7.36c 7.35a 7.32a 
H3! 7.43 7.51b, 7.49c 7.49a 7.47a 7.45a 
H5 7.28 7.18b, 7.22c 7.18b, 7.23c 7.14b, 7.19c 7.13b, 7.17c 
H5! 7.42 7.28b, 7.21c 7.28b, 7.20c 7.28b, 7.18c 7.27b, 7.18c 
endo-H7 4.86 4.93b, 4.88c 4.94b, 4.90c 4.94a 5.02a 
endo-H7! 4.69 4.78b, 4.74c 4.76a 4.78b, 4.77c 4.84a  
exo-H7 4.50 4.56d 4.57d 4.56d 4.57d 
exo-H7! 4.46 4.58d 4.58d 4.59d 4.58d 










aanti and syn signals are overlapped. bSignals from the anti rotamer. cSignals from the syn 
rotamer. dSignals are overlapped with the HOD signal. 
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The methylene protons of the unsymmetrical carrier ligand of [Pt(N(H)6-Medpa)Cl]+ are 
designated as endo-H7, exo-H7, endo-H7!, and exo-H7! (Figure 4.3). The related signals of the 
parent [Pt(N(H)dpa)Cl]Cl31 complex were assigned by applying the Karplus equation to the H–
N–C–H coupling constants measured in DMSO-d6, a solvent used because the carrier-ligand N–
H proton exchanges with deuterium from D2O in D2O/DMSO-d6 mixtures.31 Similarities in the 
NH–CH coupling constants for [Pt(N(H)6-Medpa)Cl]+ and [Pt(N(H)dpa)Cl]+ in DMSO-d6 allow 
us to assign the signals of [Pt(N(H)6-Medpa)Cl]+ in DMSO-d6 at 5.05 (9.8 Hz), 4.91 (8.1 Hz), 
4.61 (4.6 Hz), and 4.53 ppm (5.8 Hz) to the endo-H7, endo-H7!, exo-H7, and exo-H7! protons, 
respectively. Because the exo-H7 and exo-H7! protons are closer to the H3 and H3! protons than 
are the endo-H7 and endo-H7! protons, a ROESY experiment (Figure C.1) was used to confirm 
the assignments in DMSO-d6 (Experimental Section). Strong NOE cross-peaks from the H3 
doublet (at 7.57 ppm) and the H3! doublet (at 7.71 ppm) assign the signals at 4.61 ppm and at 
4.53 ppm to the exo-H7 and exo-H7! protons, respectively. Weak H3-endo-H7 (7.57–5.05 ppm) 
and H3!-endo-H7! (7.71–4.91 ppm) NOE cross-peaks complete the methylene proton 
assignments. From these chemical shifts in DMSO-d6, we can assign the endo-H7, endo-H7!, 
exo-H7, and exo-H7! signals for [Pt(N(H)6-Medpa)Cl]+ in D2O/DMSO-d6 (Table 4.3). These 
assignments in D2O/DMSO-d6 were also confirmed with ROESY data (not shown). 
Assignments of the 13C NMR signals for [Pt(N(H)6-Medpa)Cl]+ in D2O/DMSO-d6 were 
made through an HSQC experiment (Figure 4.7 and Table C.3). Cross-peaks (ppm) involving H3 
(7.30-121.1), H3! (7.43-123.7), H4 (7.82-142.2), H4! (8.02-142.6), H5 (7.28-128.4), H5! (7.42-
126.3), H6! (8.75-149.7), 6-Me (2.74-27.9) signals assign the C3, C3!, C4, C4!, C5, C5!, C6!, and 
C(6-Me) 13C NMR signals, respectively. Cross-peaks from the endo-H7 and exo-H7 signals 
assign the 13C NMR signal at 62.8 ppm to C7. Cross-peaks from the endo-H7! and exo-H7! 
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signals assign the 13C NMR signal at 60.7 ppm to C7!. The 1D 13C NMR spectrum (Figure 4.7) 
contains three very downfield 13C NMR signals that do not have HSQC cross-peaks, features 
expected for C2, C2!, and C6, the carbons attached to the pyridyl nitrogen. HMBC cross-peaks 
from these 13C NMR signals at 166.5, 168.3, and 165.3 ppm to the H3, H3!, and H5 signals 
(Figure C.2) allow assignment to C2, C2!, and C6 (Table C.3). Except for the H6/6! and (to a 
lesser extent) the methyl 1H NMR shifts, the 1H and 13C NMR signals of the unsubstituted (u) and 
methyl-substituted (s) pyridyl rings of [Pt(N(H)6-Medpa)Cl]Cl have shifts that compare very 
well to shifts of the corresponding u and s signals of [Pt(N(H)dpa)Cl]Cl31 and [Pt(N(H)6,6!-
Me2dpa)Cl]Cl32 (Tables C.2 and C.3). 


































Figure 4.7: HSQC spectrum of [Pt(N(H)6-Medpa)Cl]Cl (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, 
shifts in ppm). Peaks labeled X are a mixture of solvated species and impurities.  
 
4.3.4 [Pt(N(H)6-Medpa)(9-EtG)]2+ Adduct 
 
The reaction of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 9-EtG in D2O/DMSO-d6 
64:36) monitored by 1H NMR spectroscopy at 10 min, 1.5 h, and 1 d reached completion after 
~1.5 h, as evidenced by the complete disappearance of the [Pt(N(H)6-Medpa)Cl]+ signals (Figure 
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4.6). In contrast, under identical conditions, complete disappearance of the starting 
[Pt(N(H)dpa)Cl]Cl signals required ~49 h.31 The spectrum exhibited two new, sharp singlets at 
8.80 and 8.43 ppm (Table 4.4). These are clearly Pt(II)-bound 9-EtG H8 singlets. H8 is the only 
type of aromatic proton in the reaction mixture that can give a singlet, and the downfield shift 
change relative to the free 9-EtG H8 singlet (7.72 ppm) is consistent with coordination of 9-EtG 
to Pt(II) via N7.25,28,31 The singlets maintained a constant ratio, indicating the formation of syn 
and anti rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct in dynamic equilibrium.  
Table 4.4: Selected 1H NMR shifts (ppm) for G in Pt(N(H)6-Medpa)G adducts in D2O/DMSO-d6 
(64:36, pH 4.0, 25 °C). 
 
G free H8 anti H8  syn H8  free H1!  anti H1!  syn H1!  
9-EtGa 7.72 8.80 8.43 - - - 
3!-GMP 7.87 9.05, 9.04 8.67 5.72 5.96, 5.95 5.87, 5.85 
5!-GMP 7.99 9.13 8.77, 8.76 5.72 5.95, 5.94 5.87, 5.86 
5!-GTP 8.06 9.22, 9.21 8.84, 8.81 5.73 5.95 5.87 
a CH2: 4.15 (anti), 4.03 (syn), and 3.91 ppm (free); CH3: 1.39 (anti), 1.30 (syn), and 1.24 ppm 
(free). 
 
The presence of two sharp, well-resolved H8 signals from [Pt(N(H)6-Medpa)(9-EtG)]2+ 
(Figure 4.6) provides evidence for restricted guanine base rotation in this adduct. We attribute 
the cause of this restricted rotation in this and related adducts to the steric impedance of 
nucleobase rotation by the carrier-ligand Me groups or protons at the 6/6! pyridyl ring positions; 
these project toward the coordinated guanine nucleobase and would clash with the guanine O6 
during guanine rotation about the Pt–N7 bond. In the ROESY spectrum of [Pt(N(H)6-Medpa)(9-
EtG)]2+ at 15 °C, H8-H8 EXSY cross-peaks are absent (Figure 4.8), whereas H8-H8 EXSY 
cross-peaks are present in the ROESY spectrum for the [Pt(N(H)dpa)(9-EtG)]2+ analogue under 
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similar conditions.31 As might be expected, the 6-methyl-substitutent on one carrier-ligand 




Figure 4.8: 1H-1H ROESY spectrum showing H8-H6! and H8-6-Me NOE cross-peaks and the 
absence of H8-H8 EXSY cross-peaks of [Pt(N(H)6-Medpa)(9-EtG)]2+ (D2O/DMSO-d6 (64:36), 
pH 4.0, 15 °C, shifts in ppm). The spectrum was recorded 2 h after initiation of the adduct 
formation reaction. Peak labeled X is from solvent impurity.  
 
Using reasoning discussed above and in previous work,31 we assign the H8 singlets of 
[Pt(N(H)6-Medpa)(9-EtG)]2+ to the syn and anti rotamers (Table 4.4). The shift of the syn H8 
signal (8.43 ppm) is similar to the syn H8 shift (8.40 ppm) of [Pt(N(H)dpa)(9-EtG)]2+, but the 
anti H8 shift of [Pt(N(H)6-Medpa)(9-EtG)]2+  is more downfield (8.80 ppm) than the anti H8 shift 
of [Pt(N(H)dpa)(9-EtG)]2+ (8.73 ppm)31 (Table C.4). The Δδ (the chemical shift difference 
between the syn and anti H8 signals) is 0.37 ppm for [Pt(N(H)6-Medpa)(9-EtG)]2+, a value 
comparable to the Δδ ~ 0.33 ppm found for [Pt(N(H)dpa)(9-EtG)]2+ 31 (Table 4.5). For the 
[Pt(N(H)dpa)(9-EtG)]2+ adduct,31 the syn rotamer was favored, with a syn H8:anti H8 ratio of 
1.28:1 (Table 4.5), but the syn rotamer was more favored for [Pt(N(H)6-Medpa)(9-EtG)]2+, with 
a syn H8:anti H8 intensity ratio of 2.10:1 (Figure 4.6 and Table 4.5). In contrast, the anti rotamer 
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of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct was highly favored (Figure 4.9). The unusual 
dependence of the syn H8:anti H8 ratio on the carrier-ligand bulk (Figure 4.9) is discussed later.  
Table 4.5: Selected 1H NMR shifts (ppm), syn H8:anti H8 intensity ratios, and Δδ for the 
Pt(N(H)dpa)G and Pt(N(H)6-Medpa)G adducts (G = 9-EtG, 5!-GMP, 3!-GMP, and 5!-GTP) in 
D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
adducts free H8 syn H8 anti H8 syn H8:anti H8 Δδ 
[Pt(N(H)dpa)(9-EtG)]2+a 7.72 8.40 8.73 1.28:1 0.33 
Pt(N(H)dpa)(3!-GMP)b 7.87 8.64 8.98 1.35:1 0.34 
Pt(N(H)dpa)(5!-GMP)a 7.96 8.72 9.08 1.14:1 0.36 
Pt(N(H)dpa)(5!-GTP)a 7.97 8.79 9.21 1:1.22 0.42 
      
[Pt(N(H)6-Medpa)(9-EtG)]2+ 7.73 8.43 8.80 2.10:1 0.37 
Pt(N(H)6-Medpa)(3!-GMP) 7.87 8.67 9.05, 9.04 2.27:1 0.38 
Pt(N(H)6-Medpa)(5!-GMP) 7.97 8.77, 8.76 9.13 2.19:1 0.36 
Pt(N(H)6-Medpa)(5!-GTP) 7.98 8.84, 8.81 9.22, 9.21 1.96:1 0.41 
a Ref 31. b This work, adduct was prepared in a similar manner as in Ref 31. 
 
 
Figure 4.9: Plot of the syn H8:anti H8 ratios of Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G, and 
Pt(N(H)6,6-Me2dpa)G adducts [G = 9-EtG (blue), 5!-GMP (red), and 3!-GMP (green)]. Dotted 
line represents the point at which the syn H8:anti H8 ratio is 1:1.   
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1H and 13C NMR data for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (Figures 4.10 and C.3) 
and the [Pt(N(H)6-Medpa)Cl]Cl complex (Figure 4.7) are collected in Tables 4.3, C.2, C.3, C.4, 
and C.5. The carrier-ligand signal assignments for [Pt(N(H)6-Medpa)(9-EtG)]2+ are explained in 
Appendix C. From the assignments, the 1H and 13C NMR shifts of the signals of the methyl-
substituted pyridyl group of [Pt(N(H)6-Medpa)(9-EtG)]2+ compare well with the methyl-
substituted pyridyl group signals of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, and the 1H and 13C NMR 
shifts of the signals of the unsubstituted pyridyl ring of [Pt(N(H)6-Medpa)(9-EtG)]2+ compare 
well with the shifts of the unsubstituted pyridyl group signals of [Pt(N(H)dpa)(9-EtG)]2+31 (Tables 
































Figure 4.10: Aromatic region of the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct 
(D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peak labeled free H8 is from an excess of 
free 9-EtG. The spectrum was recorded 5 h after initiation of the adduct formation reaction. 
 
A ROESY experiment was performed to confirm the assignments of the syn and anti H6! 
and 6-Me signals of [Pt(N(H)6-Medpa)(9-EtG)]2+ (Figure 4.8). The NOE cross-peak between the 
syn H8 signal at 8.43 ppm and the signal at 7.23 ppm (overlapped with the H5 and H5! signals) 
confirms the assignment of this signal to the syn H6! (Figure 4.8). An NOE cross-peak between 
the anti H8 signal at 8.80 ppm and the signal at 7.48 ppm (overlapped with the H3! signals) 
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confirms the anti H6! assignment. The anti H8 signal had an NOE cross-peak to the 6-Me signal 
at 1.80 ppm, and the syn H8 signal had an NOE cross-peak to the 6-Me signal at 1.73 ppm 
(Figure 4.8). The results that the more downfield H6! and 6-Me signals from the anti rotamer are 
downfield from those of the syn rotamer are similar to the findings for the H6/6! signals of the 
syn and anti rotamers of [Pt(N(H)dpa)(9-EtG)]2+.31 Compared to the shifts of the respective 
chloro complex at 8.75 and 8.61 ppm, the upfield shift changes of the syn (7.23 ppm) and anti 
(7.48 ppm) H6! signals for [Pt(N(H)6-Medpa)(9-EtG)]2+  are larger than those for the syn (7.48 
ppm) and anti (7.56 ppm) H6/6! signals for [Pt(N(H)dpa)(9-EtG)]2+ (Tables 4.3, C.2 and C.4). 
The relationships of these shift changes to the structure of the rotamers are explained next.   
As mentioned, the greater bulk of the 6-Me group than the H6! proton causes the Cl 
ligand to move closer to the unsubstituted pyridyl ring H6! proton (2.58 Å) of [Pt(N(H)6-
Medpa)Cl]+ (Figure 4.5) than the corresponding distance (2.76 Å) in [Pt(N(H)dpa)Cl]+.44 The 6-
Me group is expected to force the nucleobase toward the H6! protons in both the syn and anti 
rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct. The resulting closer position of the 
anisotropic guanine to the H6! proton causes a more upfield shift of the H6! signals of the syn 
and anti rotamers of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct, as compared to the syn and anti 
H6/6! signals of the [Pt(N(H)dpa)(9-EtG)]2+ adduct (Tables 4.3 and C.4).  
In order to assess the degree of base canting for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct, 
NOE cross-peak intensities were compared. Relative to its abundance, the syn rotamer of 
[Pt(N(H)6-Medpa)(9-EtG)]2+ should have weaker H8-6-Me and H8-H6! NOE cross-peaks 
because of the longer distances of H8 to the 6-Me group and the H6! proton (Figure 4.11 C) as 




















H8-6-Me NOE cross-peak intensities are very similar for the syn and anti rotamers of [Pt(N(H)6-



























Figure 4.11: Models of the syn (A) and anti (B) rotamers of the Pt(N(H)dpa)G adducts, syn (C) 
and anti (D) rotamers of the Pt(N(H)6-Medpa)G adducts, and of the syn (E) and anti (F) rotamers 
of the Pt(N(H)6,6!-Me2dpa)G adducts. The R group of G is omitted for clarity. The van der 
Waals radii of all atoms were taken into account in constructing these models. Note that the 6-
membered guanine ring in the syn conformers is pointing up, allowing favorable electrostatic 
attraction between the G 6-membered ring δ- O6 and the δ+ H6/6! and H6! protons in A and C, 
but causing steric repulsion of the G 6-membered ring with the 6-Me and 6!-Me groups in E and 
with the 6-Me group in C. The latter interaction is alleviated by canting. Note that the 6-
membered guanine ring in the anti conformers is pointing down, alleviating the crowding but 
increasing electrostatic repulsion between the G 5-membered ring δ+ H8 and the δ+ H6/6! and 
H6! protons in B and D. This repulsion is not an issue for the anti rotamer (F) in the Pt(N(H)6,6!-
Me2dpa)G adducts, possibly accounting for the high abundance of the anti rotamer of these 
adducts.32  
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A syn H8-6-Me NOE cross-peak comparable in intensity to the anti H8-6-Me NOE cross-
peak despite the longer syn H8-6-Me distance is consistent with the syn H8:anti H8 ratio of 
2.10:1 for the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct. Although the syn rotamer is highly abundant, 
the syn H8-H6! NOE cross-peak has a much smaller intensity than the anti H8-H6! NOE cross-
peak (Figure 4.8). From a comparison of the relative sizes of the H8-H6! and the H8-6-Me cross-
peaks, it seems possible that the base is canted. (As discussed below, we believe such canting 
could occur so as to minimize the H8-H6! electrostatic repulsion in the syn rotamer.)  
4.3.5 Pt(N(H)6-Medpa)(5!-GMP) and Pt(N(H)6-Medpa)(5!-GTP) Adducts   
The reactions of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 5!-GMP or 5!-GTP in 
D2O/DMSO-d6 (64:36) were monitored by 1H NMR spectroscopy at 10 min, 1.5 h, and 1 d. The 
reactions reached completion after ~1.5 h, as evidenced by the complete disappearance of the 
[Pt(N(H)6-Medpa)Cl]+ signals by 1.5 h (Figures 4.12, 4.13, C.4 and C.5). Except as noted below, 
the results for these two 5!-nucleotides were similar. 
!
!
Figure 4.12: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GMP) adduct (top) recorded at 1.5 h after 
mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).  
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For Pt(N(H)6-Medpa)(5!-GMP), we assigned the H8 singlets to the syn (8.77 and 8.76 
ppm) and anti (9.13 ppm) rotamers, respectively (Table 4.4). Only the syn rotamer exhibited 
resolved H8 signals for the two NH chiralities of the carrier ligand and had a 1:1 ratio. The syn 
H8:anti H8 intensity ratio is 2.19:1 (Figure 4.12 and Table 4.5). The Δδ between the two H8 
signals (0.36 ppm) is comparable to the Δδ ~ 0.36 ppm found for Pt(N(H)dpa)(5!-GMP).31 The 
absence of H8-H8 EXSY cross-peaks in the ROESY spectrum (Figure C.6) of Pt(N(H)6-
Medpa)(5!-GMP) at 15 °C indicates that interconversion between rotamers is slow compared to 
the Pt(N(H)dpa)(5!-GMP)31 adduct, for which EXSY cross-peaks were observed. The carrier-
ligand signals in the Pt(N(H)6-Medpa)(5!-GMP) adduct have shifts similar to those of the 9-EtG 
adduct (Tables 4.3 and C.6, Figures 4.12 and C.4).  
"
"
Figure 4.13: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GTP) adduct, recorded at 10 min (middle) 
and at 1.5 h (top) after mixing (25 °C, D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm)."
"
The Pt(N(H)6-Medpa)(5!-GTP) adduct has properties (Tables 4.3, 4.4, 4.5, and C.7 and 
Figures 4.13 and C.5) that are very similar to those of the Pt(N(H)6-Medpa)(5!-GMP) adduct. 
Both H8 singlets for both the syn (8.84 and 8.81 ppm) and the anti (9.22 and 9.21 ppm) rotamers 
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were resolved for the Pt(N(H)6-Medpa)(5!-GTP) adduct. For each rotamer type, the H8 signals 
had a 1:1 intensity ratio (Figures 4.13 and C.5), indicating that the two chiral configurations at 
the secondary amine have no influence on the relative stability of either the syn or the anti 
rotamers. 
4.3.6 Pt(N(H)6-Medpa)(3!-GMP) Adduct  
 
The reaction of [Pt(N(H)6-Medpa)Cl]Cl with 2.5 molar equiv of 3!-GMP in D2O/DMSO-
d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 3 h, and 1 d. The reaction reached 
completion after ~3 h, as evidenced by the complete disappearance of the [Pt(N(H)6-Medpa)Cl]+ 
signals by 3 h (Figures 4.14 and C.7). We assigned the H8 singlets to the syn (8.67) and anti 
(9.05 and 9.04 ppm) rotamers. In this case, the H8 signals of the syn rotamer were not resolved, 
but the anti rotamers exhibited two H8 signals in a 1:1 ratio. The syn H8:anti H8 intensity ratio is 
2.27:1 (Figure 4.14 and Table 4.5).  
!
 
Figure 4.14: Aromatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(3!-GMP) adduct, recorded at 10 min (middle) 
and at 3 h (top) after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm).  
 
The Δδ between the two H8 signals (0.38 ppm) is comparable to the Δδ = 0.34 ppm 
found for Pt(N(H)dpa)(3!-GMP) (Table 4.5 and C.8). The carrier-ligand signals in the Pt(N(H)6-
Medpa)(3!-GMP) adduct have shifts similar to those observed for the other adducts (Tables 4.3 
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and C.8, Figures 4.14 and C.7). Thus, the location of the phosphate groups at the 3! or 5! position 
of the ribose groups does not appear to have a major effect on the properties of the adducts.   
4.3.7 Factors Influencing the Syn:Anti Ratio of the Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G, and 
Pt(N(H)6,6!-Me2dpa)G Adducts 
 
In this section, we assess how changes in the features of the carrier ligand could explain 
the unusual trend of the syn:anti ratio of rotamers for the following Pt(Ltri)G mono adducts: 
Pt(N(H)6-Medpa)G >> Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G (Figure 4.9). We focus on three 
factors in order of perceived importance that appear to influence this unusual trend. First, we 
discuss the electrostatic repulsion between protons bearing relatively high partial positive 
charges, the G H8 proton in the smaller 5-membered nucleobase ring and carrier-ligand H6/6! or 
H6! protons. Second, we consider the steric interactions between the carrier-ligand 6/6!-Me or 6-
Me groups and the larger G six-membered ring. Third, we mention the favorable electrostatic 
attraction between G O6 and carrier-ligand H6/6! or H6! protons. The Pt(Ltri)G adducts, 
[Pt(N(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are 
discussed first because these adducts have the simplest G derivative used in this study. 
 The pyridyl ring tilting, as discussed in the Introduction and in previous reports,31,32 is a 
consequence of the sp3 geometry of the central NH group of the tridentate ligand. The methylene 
carbons are positioned on the opposite side of the coordination plane as the NH group. The two 
bonds from the pyridyl ring, one to the methylene groups and one to the Pt(II), require that the 
pyridyl ring tilts in such a manner as to project the pyridyl H6/6! atoms and the pyridyl 6/6!-Me 
groups upward toward the same side of the coordination plane as the NH group. In the 
Pt(N(H)dpa)G, Pt(N(H)6,6!-Me2dpa)G, and Pt(N(H)6-Medpa)G mono adducts, the bulky 
guanine 6-membered ring in the syn rotamer is on the same side of the coordination plane as the 
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pyridyl H6/6! atoms, the pyridyl 6/6!-Me groups, and the pyridyl H6! atom and the pyridyl 6-Me 
group, respectively (Figure 4.11). 
In the anti rotamer of [Pt(N(H)dpa)(9-EtG)]2+ as well as all other related Pt(Ltri)G mono 
adducts, the nucleobase δ+ H8 proton is on the same side of the coordination plane as the 
δ+ H6/6! protons (Figures 4.3 and 4.11). The resulting proximity of H8 to the H6/6! protons 
(Figure 4.11) causes unfavorable electrostatic repulsion between the partial positive charges of 
these protons, and this repulsion leads to a lower abundance of the anti rotamer (Table 4.5). In 
contrast, the H8 of the syn rotamer is on the opposite side of the coordination plane to the H6/6! 
protons (Figures 4.3 and 4.11). Thus, the greater separation between these protons in the syn 
rotamer decreases H8-H6/6! electronic repulsions. Also, the partially negative O6 of guanine is 
on the same side of the coordination plane as the partially positive H6/6! protons of the carrier 
ligand, a juxtaposition possibly leading to favorable electrostatic interactions in the syn rotamer. 
These factors help to account for the syn H8:anti H8 ratio of 1.28:1 for [Pt(N(H)dpa)(9-EtG)]2+ 
(Table 4.5). For the syn rotamer of [Pt(N(H)6-Medpa)(9-EtG)]2+, the guanine base can cant in the 
direction that positions the 6-membered ring away from the bulky 6-Me group. Such canting also 
positions the guanine δ+ H8 proton away from the δ+ H6! proton and the guanine δ- O6 closer to 
the δ+ H6! proton. Therefore, electrostatic interactions become more favorable and increase the 
abundance of the syn rotamer (syn H8:anti H8 ratio = 2.10:1) compared to this ratio for 
[Pt(N(H)dpa)(9-EtG)]2+. [This reasoning also applies to other Pt(N(H)6-Medpa)(G) adducts and 
could account for the high syn H8:anti H8 ratio for these adducts in all cases, see below]. For the 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct, which has no δ
+ H6! protons, the rotamer abundance is 
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influenced by repulsive steric interactions between the 9-EtG 6-membered ring and the chelate 
ligand 6/6!-Me groups. Favorable electrostatic interactions are less likely to play a role because 
the methyl protons bear a relatively low partial positive charge. Thus, the syn rotamer is now less 
favored than the anti rotamer for the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct (Figure 4.11) with a 
"reversed" syn H8:anti H8 ratio of 1:1.42.  
According to the combined results for adducts of all G studied in this work or recent 
previous reports,31,32 the trend in the syn H8:anti H8 ratio, namely Pt(N(H)6-Medpa)G >> 
Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G (Figure 4.9), reflects primarily the nature of the carrier 
ligand. These newer studies are consistent with findings in very early studies of other Pt(Ltri)(5!-
GMP) adducts with polyamine ligands; in these older investigations, a phosphate group on the 
N-9 substituent was shown to influence significantly the syn:anti ratio only when the terminal 
donor groups of Ltri had NH groups that could form H-bonds with a 5!-phosphate group.25,26  
4.3.8 Pt(N(H)6-Medpa)G2 Adducts  
In addition to the signals of the [Pt(N(H)6-Medpa)(9-EtG)]2+ mono adduct, the spectrum 
of the 9-EtG reaction mixture at 24 h contained new signals including two methyl signals (Figure 
4.15). The shifts at 2.11 (major) and 2.12 (minor) ppm and the ratio (1.6:1) of these signals 
resemble the dangling pyridyl methyl signal shifts (~2.14 ppm) and the ratio (1.6:1) for the 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct.32 However, unlike the latter bis adduct, which forms 
at 100%, only ~20% of the total product was the [Pt(N(H)6-Medpa)(9-EtG)2]2+ bis adduct, and 
the mono adduct dominated at ~80%. The 1H NMR spectrum recorded after 3 months (not 
shown) showed no further formation of the bis adduct. The formation of the bis adduct is 
probably a result of the repulsive steric interaction between the 6-Me and the guanine base in the 
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct; however, the presence of just one methyl substituent creates 
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only moderate steric crowding and thus leads to only ~20% of the [Pt(N(H)6-Medpa)(9-EtG)2]2+ 


















Figure 4.15: 1H NMR spectra of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (D2O/DMSO-d6 (64:36), 
pH 4.0, 25 °C, shifts in ppm) at 1 day after mixing. Labeled peaks show the formation of the bis 
adduct [Pt(N(H)6-Medpa)(9-EtG)2]2+. X = solvent impurity.   
 
1H NMR spectra of the other Pt(N(H)6-Medpa)G solutions in D2O/DMSO-d6, pH ~ 4 (G 
= 5!-GMP, 5!-GTP, and 3!-GMP) taken after 24 h and after 1 month all had small signals 
attributable to bis adducts with ~5–15% abundance. The new signals attributable to a small 
amount of the Pt(N(H)6-Medpa)(5!-GMP)2 and Pt(N(H)6-Medpa)(3!-GMP)2 adducts are shown 
in Figures C.8 and C.9. 1H NMR spectra (not shown) of these Pt(N(H)6-Medpa)G solutions in 
D2O/DMSO-d6 pH ~8 (taken 24 h after the pH was raised) contained slightly stronger signals 
consistent with ~20% of the bis adduct, especially for G = 5!-GMP and 5!-GTP. This increased 
abundance of these bis adducts could result from interactions between the deprotonated 




The bulk of the 6-Me group and the H6! proton are sufficient to impede rotation of the 
guanine base about the Pt–N7 bond of the Pt(N(H)6-Medpa)G adducts; thus, H8 signals for the 
syn and anti rotamers could be resolved and assigned. We also conclude from the absence of H8-
H8 EXSY cross-peaks for the Pt(N(H)6-Medpa)G adducts that the bulk of only one methyl group 
is sufficient to significantly decrease the ease of interconversion between rotamers as compared 
to the Pt(N(H)dpa)G adducts, for which H8-H8 EXSY cross-peaks were observed in a previous 
study.31  
All G adducts formed with [Pt(N(H)6-Medpa)Cl]+ in this study favored highly the mono 
adducts, Pt(N(H)6-Medpa)G. The trend in increasing carrier-ligand bulk is reflected, as 
expected, in the following order from lowest to highest abundance of bis adducts: Pt(N(H)dpa)G2 
<< Pt(N(H)6-Medpa)G2 < Pt(N(H)6,6!-Me2dpa)G2. 
The syn:anti ratio of rotamers for the Pt(Ltri)G mono adducts compared here follows an 
unusual trend: Pt(N(H)6-Medpa)G >> Pt(N(H)dpa)G > Pt(N(H)6,6!-Me2dpa)G. In the anti 
rotamer of Pt(N(H)6-Medpa)G adducts, the H8 appears to be already close to the 6-Me group, as 
shown by the strong H8-6-Me NOE cross-peak (Figure 4.8). Thus, the base may not be able to 
cant in order to minimize the δ+ H8-to-δ + H6! electrostatic repulsion, consistent with a close H8-
H6! distance and thus accounting for the strong H8-H6! NOE cross-peak (Figure 4.8). We 
believe this unfavorable δ+ H8-to- δ+ H6! repulsion in the anti rotamer (uncompensated by any 
δ- O6-to- δ+ H6! attraction) explains why the anti rotamer is less favored. For the syn rotamer of 
Pt(N(H)6-Medpa)G adducts, the guanine base cants in the direction such that the 6-membered 
ring is positioned away from the bulky 6-Me group. Such canting relieves the H8-H6! 
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electrostatic repulsion and places the guanine δ- O6 closer to the δ+ H6! proton, creating a 
favorable electrostatic attraction. Therefore, electrostatic interactions become more favorable and 
increase the abundance of the syn rotamer when the carrier ligand has a combination of one 
sterically hindering methyl group and one δ+ proton at the 6/6! positions.  
Because, unlike Pt(N(H)6-Medpa)G adducts,  there are no bulky methyl groups in the 
Pt(N(H)dpa)G adducts, δ+ H6/6! proton electrostatic interactions play the larger role in 
influencing rotamer abundance. For Pt(N(H)dpa)G adducts, electrostatic repulsions are stronger 
in the anti rotamer and weaker in the syn rotamer. As a result, the syn rotamer is more abundant 
for Pt(N(H)dpa)G adducts.31 In contrast, because there are no δ+ H6/6! protons and instead there 
are bulky methyl groups in the Pt(N(H)6,6!-Me2dpa)G adducts, steric interactions play a larger 
role in influencing rotamer abundance. For Pt(N(H)6,6!-Me2dpa)G adducts, steric repulsions are 
weaker in the anti rotamer and stronger in the syn rotamer. As a result, the anti rotamer is more 
abundant also for Pt(N(H)6,6!-Me2dpa)G adducts.32  
This research program was motivated by the desire to understand the effect of steric bulk 
of the carrier ligand on the interligand interaction of the carrier ligand with Pt(II)-bound guanine 
derivatives. The present work, invoking electrostatic contributions to interligand interactions to 
explain the trend in syn:anti ratios, points to the possible consideration of such electrostatic 
contributions in the design of potential monofunctional Pt(II) anticancer agents. 
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CHAPTER 5. PT(DI-(2-PICOLYL)AMINE)Cl]+ COMPLEXES DERIVATIZED WITH 
ALKYL SUBSTITUENTS ON THE CENTRAL NITROGEN ATOM OR PICOLYL 
RING ATOMS. DRAMATICALLY DIFFERENT REACTIVITY TOWARD N-9 




Compounds of the type cis-Pt(Lbi)X2 (Lbi = one bidentate or two cis-unidentate N-donor 
ligands, X2 = anionic leaving ligands), including cisplatin (cis-Pt(NH3)2Cl2) are among the most 
widely used clinical anticancer agents.1-7 Pt(II) anticancer compounds target DNA and bind 
preferentially at the N7 atom of two adjacent guanine bases forming an G*pG* intrastrand cross-
link (G* = N7-platinated G residue).5,6,8-11 An molecular structure of an HMG bound 16-oligomer 
G*pG* adduct9,10 was used to derive a starting structure of a duplex 9-oligomer G*pG* adduct.9 
The oligomer exhibited an unusual XpG* base pair step. When G* is an adduct of a rather bulky 
monofunctional Pt anticancer drug, a closely related base pair step with a large positive shift and 
slide exists in the solid state.11,12 Unlike for monofunctional Pt(II) agents, where high carrier-
ligand bulk increases anticancer activity,10,11,13-17 bifunctional Pt(II) agents, Pt(Lbi)X2, have higher 
toxicity and lower activity when the carrier-ligand bulk is greater.5,18-21 
Monofunctional Pt(II) agents, Pt(Ltri)X (Ltri = a tridentate, one bidentate and one 
monodentate, or three monodentate ligands; X = a monodentate, monoanionic leaving group), 
also bind to G residues in DNA and have been shown to have similar biological effects as 
bifunctional agents.22 Thus, for Pt(Ltri)G models (G = guanine derivative bound to platinum, but 
not tethered to another nucleobase, Figure 5.1),6,23-28 assessment of the effects of steric 
interactions between the carrier ligand and the guanine base is important to the understanding of 
the fundamental factors influencing these types of adducts. We previously studied the 
interactions of several G derivatives (e.g. 5!-GMP, 3!-GMP, and 5!-GTP) in Pt(Ltri)G mono 
adducts with the carrier ligand having low in-plane bulk, di-(2-picolyl)amine (N(H)dpa),29 a 
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carrier ligand with moderate in-plane bulk, N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6-
Medpa),30 and a carrier ligand with high in-plane bulk, di-(6-methyl-2-picolyl)amine (N(H)6,6!-
Me2dpa),31 Figure 5.2.  
 
Figure 5.1: Possible conformers for Pt(Lbi)G2 adducts with two bound monodentate guanine N9 
derivatives (referred to with bold G). A generic version of G is depicted in the center, along with 
the guanine base numbering scheme. R can be ribose or a ribose phosphate. Note that the 
nucleobase is represented by an arrow with the tip at the guanine H8 atom. N and N! represent a 
nitrogen donor ligand. When (N ≠ N!), four conformers (HHu, HHd, ΛHT, ΔHT) are possible, 
whereas when (N = N!), only three conformers (HH, ΛHT, ΔHT) are possible because HHu = 
HHd. The same number of conformers can exist regardless of whether the nitrogen donors are 
unidentate ligands or are part of a chelate (N–N or N–N!). 
 
 In Pt(Ltri)G mono adducts (Figure 5.3), the two orientations of the guanine base with 
respect to the coordination plane lead to syn and anti rotamers, which can interconvert by 
rotation about the Pt–N7 bond. As shown in Figure 5.3, the rotamer with the H atom of the 
central N-H group and the guanine O6 on the same side of the coordination plane is designated 
as syn, and the rotamer with these groups on opposite sides of this plane is designated as anti.24,29 
The observation of two sharp 1H NMR G H8 signals for all Pt(N(H)dpa)G, Pt(N(H)6-Medpa)G, 
and Pt(N(H)6,6!-Me2dpa)G mono adducts indicated that these rotamers do indeed exist and that 
! 112 
guanine base rotation about the Pt–N7 bond was impeded by the bulk of the tridentate carrier 
ligands.  
 
Figure 5.2: Line drawing and numbering scheme for [Pt(Ltri)Cl]+ cations. 
 We noted in the study of the Pt(N(H)dpa)G adducts29 that the tilting of the pyridyl rings 
relative to the Pt(II) coordination plane positions the anisotropic pyridyl ring shielding region 
closer to the H8 of the syn conformer than to the H8 of the anti conformer (Figure 5.3). The syn 
H8 signal is upfield relative to the anti H8 signal. Correlating the abundance of the set of H1! 
signals with that of the H8 signals established that the anti rotamer has the more downfield 
signals for all of the protons associated with the five-membered guanine ring.29 
 In the presence of an excess of G, the Pt(N(H)dpa)G29 mono adduct was the final 
product. In contrast, Pt(N(H)6,6!-Me2dpa)G mono adducts were unexpectedly found to convert 
readily and completely to the Pt(N(H)6,6!-Me2dpa)G2 bis adduct (Figure 5.4).31 The Pt(N(H)6-
Medpa)G mono adducts were highly stabile, but small amounts of the  Pt(N(H)6-Medpa)G2 bis 
adduct were detected.30 Formation of this bis adduct (Figure 5.4) involved an unusual 
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transformation of the Pt-bound N(H)6,6!-Me2dpa ligand from the tridentate to the bidentate 
coordination mode. Pt(Lbi)G2 adducts can have as many as two head-to-head (HHu and HHd) 
and two head-to-tail (ΛHT and ΔHT) conformers, depending on the bulk and symmetry of the 








Figure 5.3: The two possible rotamers (syn, top; anti, bottom) for Pt(Ltri)G complexes with 
tridentate ligands unsymmetrical with respect to the coordination plane but symmetrical about a 
plane perpendicular to the coordination plane are illustrated for Ltri = N(H)6,6!-Me2dpa and G = 
5!-GMP. Protons in the chelate ligand N–CH2 groups are called endo if they project down and 
away from the chelate ligand NH proton and exo if they project up toward this NH proton. The 
NH proton and the H8 proton of 5!-GMP are highlighted with a magenta circle. 
 
 In this study, we examined Pt(N(R)6,6!-Me2dpa)G mono adducts (R = methyl, propionoic 
acid, and 6-methyl-2-picolyl) formed from [Pt(N(R)6,6!-Me2dpa)Cl]Cl (N(R)6,6!-Me2dpa) = N-
(Me)-di-(6-methyl-2-picolyl)amine,  N-(propionoic acid)-di-(6-methyl-2-picolyl)amine, and tris-
(6-methyl-2-picolyl)amine, Figure 5.2). We have employed NMR techniques to assess the 
influence of bulky R groups on the central nitrogen on the properties of Pt(N(R)6,6!-Me2dpa)G 
mono adducts, as compared to the properties of Pt(N(H)6,6!-Me2dpa)G mono adducts. In the 
presence of an excess of G, the Pt(N(Me)6,6!-Me2dpa)G mono adducts were always present, 
unlike Pt(N(H)6,6!-Me2dpa)G mono adducts which converted readily to the Pt(N(H)6,6!-
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Me2dpa)G2 bis adduct. As the bulk is increased on the central nitrogen (as for Pt(N(prop)6,6!-
Me2dpa)G and Pt(6,6!,6!!-Me3tpa)G), the abundance of bis adducts became small to 
undetectable. A previous study,29 revealed that the anti rotamer was more abundant for 
Pt(N(H)dpa)(5!-GTP) because of a weak hydrogen bond between the 5!-GTP γ-phosphate group 
and the N(H)dpa central N-H. In this study, the Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6-
Me2dpa)(5!-GTP) adducts show similar results and the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and 
Pt(6,6!,6!!-Me2dpa)(5!-GTP) adducts show no change in the syn H8:anti H8 ratio at various pH 
values. Thus, providing further evidence of the role of a trans NH ligand group influencing 
rotamer abundance. 
 
Figure 5.4: Possible transformation of Pt(N(R)6,6!-Me2dpa)G mono adducts to Pt(N(R)6,6!-
Me2dpa)G2 bis adducts in the presence of excess G. 
 
5.2 EXPERIMENTAL SECTION 
5.2.1 Starting Materials  
K2[PtCl4], 5!-guanosine monophosphate disodium salt (5!-GMP), 3!-guanosine 
monophosphate disodium salt (3!-GMP), and 5!-guanosine triphosphate disodium salt (5!-GTP) 
were obtained from Aldrich. cis-Pt(DMSO)2Cl2,39 di-(6-methyl-2-picolyl)amine (N(H)6,6!-
Me2dpa),40 N-(Me)-di-(6-methyl-2-picolyl)amine (N(Me)6,6!-Me2dpa),41 N-(propionic acid)-di-
(6-methyl-2-picolyl)amine (N(prop)6,6!-Me2dpa),42 N-(propionic acid)-di-(2-picolyl)amine 
(N(prop)dpa),43 tris-(6-methyl-2-picolyl)amine (6,6!,6!!-Me3tpa),44 tris-(2-picolyl)amine (tpa),44 
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N-(Me)-di-(2-picolyl)amine (N(Me)dpa),41 [Pt(N(H)6-Medpa)Cl]Cl,30 and Pt(N(H)6,6!-
Me2dpa)Cl]Cl31 were synthesized as described in the literature, and the 1H NMR chemical shifts 
observed matched the reported values. The known complexes, [Pt(N(Me)dpa)Cl]Cl45 and 
[Pt(tpa)Cl]Cl,46 were synthesized using Method A in this study, and the 1H NMR chemical shifts 
observed matched the reported values (Appendix D).  
5.2.2 NMR Measurements  
NMR spectra were recorded on an Avance-III Prodigy 500 MHz Bruker spectrometer, 
typically with 10 mM samples in DMSO-d6 or in a D2O/DMSO-d6 (64:36) mixture (pH adjusted 
with 0.5 M solutions of DNO3 or NaOD in D2O). For 1H and 13C NMR spectra in D2O/DMSO-d6, 
peak positions are referenced relative to TMS by using the signals of DMSO-d6 at 2.50 ppm 
(residual) and 39.5 ppm, respectively.47 A presaturation pulse to suppress the water peak was 
used when necessary. ROESY experiments were performed at 15 °C by using a 200 ms mixing 
time. 1H–13C HSQC NMR spectra were recorded in order to assign the signals of the adducts. 
NMR data were processed with TopSpin and MestreNova software.  
5.2.3 X-ray Data Collection and Structure Determination  
Single crystals were placed in a cooled nitrogen gas stream at 90, 95, or 100 K (see Table 
1) on a Bruker Kappa Apex-II DUO diffractometer equipped with Mo Κα radiation (λ = 0.71073 
Å). Refinement was performed by full-matrix least squares methods using SHELXL,48 with H 
atoms in idealized positions.  
5.2.4 Synthesis of New [Pt(Ltri)Cl]+ Complexes 
Methanol solutions (15 ml) of the ligand (0.12 mmol) and cis-Pt(Me2SO)2Cl2  (0.12 
mmol) were heated at reflux and stirred overnight. The solvent was removed by rotary 
evaporation and the residue was washed with H2O and diethyl ether and required no further 
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purification (Method A). X-ray quality crystals were obtained by mixing equal volumes (1 mL) 
of cis-Pt(Me2SO)2Cl2 (12.5 mM) and the ligand (12.5 mM) in acetonitrile and allowing mixture 
to stand at room temperature. Yellow to orange, block-like crystals were obtained within 5 days 
(Method B). 
5.2.4.1 [Pt(N(Me)6,6!-Me2dpa)Cl]Cl. With N(Me)6,6!-Me2dpa (29 mg, 0.12 mmol) and 
cis-Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(Me)6,6!-Me2dpa)Cl]Cl as a 
yellow precipitate (50 mg, 83% yield). Method B afforded yellow block-shaped crystals that 
were characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) in DMSO-d6: 
8.07 (t, J = 7.8 Hz, 2H, H4/4!), 7.55 (d, J = 7.7 Hz, 2H, H5/5!), 7.51 (d, J = 7.8 Hz, 2H, H3/3!), 
5.54 (d, J = 15.7 Hz, 2H, endo-H7/7!), 4.59 (d, J = 15.7 Hz, 2H, exo-H7/7!), 2.94 (s, 6H, 6/6!-
CH3), 2.80 (s, 3H, N-CH3). NMR shifts were identical for both methods. 
 5.2.4.2 [Pt(N(prop)6,6!-Me2dpa)Cl]Cl. With N(prop)6,6!-Me2dpa (36 mg, 0.12 mmol) 
and cis-Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(prop)6,6!-Me2dpa)Cl]Cl as 
a yellow precipitate (60 mg, 89% yield). Method B afforded yellow block-shaped crystals that 
were characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) upon 
dissolution of the crystals in DMSO-d6: 8.08 (t, J = 7.8 Hz, 2H, H4/4!), 7.51 (d, J = 7.8 Hz, 4H, 
H3/3! and H5/5!), 5.61 (d, J = 16.0 Hz, 2H, endo-H7/7!), 4.78 (d, J = 16.2 Hz, 2H, exo-H7/7!), 
3.02 (t, J = 6.5 Hz , 2H, N-CH2), 2.93 (s, 6H, 6/6!-CH3), 2.16 (t, J = 6.4 Hz, 2H, OC-CH2). NMR 
shifts were identical for both methods. 
5.2.4.3 [Pt(6,6!,6!!-Me3tpa)Cl]Cl. With 6,6!,6!!-Me3tpa (40 mg, 0.12 mmol) and cis-
Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(6,6!,6!!-Me3dpa)Cl]Cl as an orange 
precipitate (58 mg, 81% yield). Method B afforded orange block-shaped crystals that were 
characterized by single-crystal X-ray crystallography. 1H NMR signals (ppm) in DMSO-d6: 7.98 
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(t, J = 7.8 Hz, 2H, H4/4!), 7.71 (d, 1H, H3!!), 7.59 (t, 1H, H4!!) 7.48 (d, J = 7.7 Hz, 2H, H3/3!), 
7.32 (d, J = 7.9 Hz, 2H, H5/5!), 5.62 (d, J = 16.0 Hz, 2H, endo-H7/7!), 4.97 (d, J = 16.0 Hz, 2H, 
exo-H7/7!), 4.09 (s, 2H, H7!!), 2.77 (s, 6H, 6/6!-CH3), 2.24 (s, 3H, 6!!-CH3). NMR shifts were 
identical for both methods. 
5.2.4.4 [Pt(N(prop)dpa)Cl]Cl. With N(prop)dpa (33 mg, 0.12 mmol) and cis-
Pt(Me2SO)2Cl2 (51 mg, 0.12 mmol), Method A afforded [Pt(N(prop)dpa)Cl]Cl as a yellow 
precipitate (59 mg, 92% yield). 1H NMR signals (ppm) in DMSO-d6: 8.78 (d, J = 4.9 Hz, 2H, 
H6/6!), 8.28 (t, J = 7.8 Hz, 2H, H4/4!), 7.76 (d, J = 7.9 Hz, 2H, H3/3!), 7.67 (t, J = 6.2 Hz, 2H, 
H5/5!), 5.32 (d, J = 15.7 Hz, 2H, endo-H7/7!), 4.85 (d, J = 15.7 Hz, 2H, exo-H7/7!), 3.25 (t, J = 
7.4 Hz, 2H, N-CH2), 2.53 (t, J = 7.3 Hz, 2H, OC-CH2). NMR shifts were identical for both 
methods. ESI-MS m/z : [M+] calcd. for C13H15ClN3Pt, 501.846; found, 501.066.  
5.2.5 Adduct Formation of [Pt(N(R)6,6!-Me2dpa)Cl]Cl with 5!-GMP, 3!-GMP, and 5!-GTP  
(R = Me, propionic acid, and 6-methyl-2-picolyl) 
  
A 10 mM solution of [Pt(N(R)6,6!-Me2dpa)Cl]Cl in 600 µL of a 64:36 D2O/DMSO-d6 
(385 µL/215 µL) mixture] was treated with 3.5 equiv of G to give a 1:3.5 ratio (10 mM:35 mM) 
of Pt:GMP, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was 
employed to improve the solubility of the reactants.) An excess of G was used to ensure that the 
reaction went to completion. The reaction, which was repeated several times, was monitored by 
1H NMR spectroscopy until there was no change in the bound vs free G H8 signal intensity. In 
general the [Pt(N(R)6,6!-Me2dpa)Cl]+ signals usually did not completely disappear and no futher 
reaction was noted after 8 d. Because of limited solubility of the nucleotides, ~ 5 % of 
unchanged starting material, [Pt(Ltri)Cl]+, was usually present. 
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5.2.6 Adduct Formation of [Pt(N(R)dpa)Cl]Cl with 5!-GMP,  3!-GMP and 5!-GTP (R = 
Me, prop, and 2-picolyl) 
  
A 10 mM solution of [Pt(N(R)dpa)Cl]Cl in 600 µL of a 64:36 D2O/DMSO-d6 (385 
µL/215 µL) mixture] was treated with 2.5 equiv of G to give a 1:2.5 ratio (10 mM:25 mM) of 
Pt:5!-GMP, and the solution (pH ~4) was kept at 25 °C. (The D2O/DMSO-d6 mixture was 
employed to improve the solubility of the reactants.) An excess of G was used to ensure that the 
reaction went to completion. The reaction, which was repeated several times, was monitored by 
1H NMR spectroscopy until there was no change in the bound vs free G H8 signal intensity, or 
until the [Pt(N(R)dpa)Cl]+ signals completely disappeared. No further reaction occurred after 2 d. 
5.3 RESULTS AND DISCUSSION 
5.3.1 Structural Results for [Pt(N(R)6,6!-Me2dpa)Cl]+ Complexes. Overall Aspects 
Summarized in Table 5.1 are the crystal data and details of the structural refinement of 
[Pt(N(Me)6,6!-Me2dpa)Cl]Pt(DMSO)Cl3 (1), [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (2), and [Pt(6,6!,6!!-
Me3tpa)Cl] Pt(DMSO)Cl3 (3). Selected bond lengths and angles are reported in Table 5.2. The 
ORTEP plots of the cations of these three complexes and the numbering scheme used to describe 
the solid-state data are shown in Figure 5.5. All other references (e.g., NMR discussion) to these 
ligands and complexes will employ the atom-numbering scheme shown in Figure 5.2. 
5.3.2 Coordination Parameters  
The [Pt(N(Me)6,6!-Me2dpa)Cl]+ (1), [Pt(N(prop)6,6!-Me2dpa)Cl]+ (2), and [Pt(6,6!,6!!-
Me3tpa)Cl]+ (3) cations exhibit pseudo square planar geometry, with a tridentate ligand bound to 
the Pt with its three N atoms; a Cl atom trans to the N(2) atom completes the coordination around 
Pt (Figure 5.2). All three complexes have comparable N(1)–Pt–N(3) bite angles (Table 5.2), 
which are similar to the 166° bite angle reported for [Pt(N(H)dpa)Cl]Cl•H2O,49 [Pt(N(H)6-
Medpa)Cl]PF6•H2O,30 and [Pt(N(H)6,6!-Me2dpa)Cl]Cl.31 The Pt–N(1) and Pt–N(3) bond 
! 119 
distances for all complexes in this study (Table 2) compare well with other Pt–N(sp2) bond 
distances ranging from 1.99–2.08 Å.50,51 
Table 5.1: Crystal Data and Structure Refinement for [Pt(N(Me)6,6!-Me2dpa)Cl]Pt(DMSO)Cl3 
(1), [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (2), and [Pt(6,6!,6!!-Me3tpa)Cl]Pt(DMSO)Cl3 (3). 
!
empirical  formula C15H19ClN3Pt•C2H6Cl3OPtS C17H21ClN3O2Pt•Cl C21H24ClN4Pt• 
C2H6Cl3OPtS 
fw 851.44 565.36 942.55 
crystal system monoclinic monoclinic triclinic 
space group P21/n P21/n Pī 
a (Å) 8.6313(4) 8.644(2) 6.8378(3) 
b (Å) 17.6564(9) 13.405(3) 13.2929(5) 
c (Å) 14.7003(7) 15.603(3) 15.5886(6) 
α 90 90 82.065(2) 
β (deg) 96.666(3) 90.049(10) 82.090(2) 
γ 90 90 87.019(2) 
V (Å3) 2222.15(19) 1808.0(7) 1389.21(10) 
T (K) 100 95 90 
Z 4 4 2 
ρcalc (Mg/m3) 2.542 2.077 2.253 
abs coeff (mm-1) 13.15 8.07 10.54 
2θmax (°) 66.2 80.2 72.6 
R [I> 2σ(I)]a 0.032 0.029 0.027 
wR2b 0.081 0.062 0.067 
data/param 8452/258 11195/229 13465/321 
Res. dens (eÅ-3) 3.31, -4.83 4.47, -4.03 2.97, -4.49 
a R = (∑||Fo| - |Fc||)/∑|Fo|. b wR2 = [∑[w(Fo2 - Fc2)2]/∑[w(Fo2)2]]1/2,  in which w = 1/[σ2(Fo2) + (dP)2 
+ (eP)] and P = (Fo2 + 2Fc2)/3. 
!
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For [Pt(N(Me)6,6!-Me2dpa)Cl]+, [Pt(N(prop)6,6!-Me2dpa)Cl]+, and [Pt(6,6!,6!!-
Me3tpa)Cl]+, the Pt–Cl bond lengths (Table 5.2) are comparable to the Pt–Cl bond length 
(2.301(2) Å) of [Pt(N(H)dpa)Cl]Cl•H2O,49 whereas for [Pt(N(H)6,6!-Me2dpa)Cl]Cl steric 
interaction between the Cl and the Me groups is reflected in a slightly longer [2.421(3) Å] Pt–Cl 
bond. All three complexes have comparable trans N(2)–Pt–Cl bond angles similar to that 
reported for [Pt(N(H)dpa)Cl]Cl•H2O [168.7(6)°],49 but larger than that in [Pt(N(H)6,6!-
Me2dpa)Cl]+ [159.1(3)°].31  
Table 5.2: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(Me)6,6!-
Me2dpa)Cl]Pt(DMSO)Cl3 (1), [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (2), and [Pt(6,6!,6!!-
Me3tpa)Cl]Pt(DMSO)Cl3 (3). 
!
 1 2 3 
bond distances 
Pt–N(1) 2.047(3) 2.0507(18) 2.0256(11) 
Pt–N(2) 2.026(4) 2.0188(17) 2.0341(11) 
Pt–N(3) 2.063(3) 2.046(2) 2.0232(11) 
Pt–Cl 2.3060(10) 2.3121(7) 2.3111(3) 
bond angles 
N(1)–Pt–N(3) 164.16(14) 165.04(9) 165.29(5) 
N(1)–Pt–Cl 95.56(11) 97.21(5) 97.58(3) 
N(2)–Pt–Cl 166.41(10) 169.22(5) 163.53(3) 
N(3)–Pt–Cl 100.28(10) 97.65(7) 97.13(3) 
N(1)–Pt–N(2) 82.01(14) 82.24 (7) 82.87(4) 
N(2)–Pt–N(3) 82.67(14) 82.83(9) 83.15(4) 
When an aliphatic substituent is present on N(2), the geometry of N(2) changes, becoming more 
tetrahedral. The Pt–N–C6 and Pt–N–C7 bond angles for 1, 2, and 3 are ~105°, compared to the 
Pt–N–C6 and Pt–N–C7 bond angles (~110°) of [Pt(N(H)6,6!-Me2dpa)Cl]Cl31 and of ~ 110° of 
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(1) !(2)  
(3) 
[Pt(N(H)dpa)Cl]Cl•H2O.49 This change in geometry of the central nitrogen causes the pyridyl 
rings to tilt up above the coordination plane (Figure D.1), reducing the steric strain between the 
coordinated Cl and the bulky methyl groups; consequently, the Pt–Cl bond distances and N(2)–
Pt–Cl bond angles are comparable to those found for [Pt(N(H)dpa)Cl]Cl•H2O.49  
 The trans N(2)–Pt–Cl bond angles for 1 and 3 are smaller than the corresponding bond 
angles of [Pt(N(Me)dpa)Cl]Cl•H2O (179.53(9)°)45 and [Pt(tpa)Cl]Cl•2H2O (176.8(2)°)46 (Table 
D.1). The Pt–N(2) bond distance for all of the complexes  is comparable to most Pt–N(tertiary 
sp3) bond distances, ranging from 2.01–2.14 Å.45,46,52,53 The slightly longer Pt–N(2) bond 
distances found for 1, 2, and 3 (Table 5.2) vs the 1.973(8) Å distance for [Pt(N(H)6,6!-











        
 
Figure 5.5: Ortep plots of the cations [Pt(N(Me)6,6!-Me2dpa)Cl]+ (1), [Pt(N(prop)6,6!-
Me2dpa)Cl]+ (2), and [Pt(6,6!,6!!-Me3tpa)Cl]+ (3). Thermal ellipsoids are drawn with 50% 
probability. 
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5.3.3 [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!-Me2dpa)Cl]Cl, [Pt(6,6! ,6! !-
Me3tpa)Cl]Cl, and  [Pt(N(prop)dpa)Cl]Cl NMR Signal Assignments 
  
The 1H NMR signals for [Pt(N(Me)6,6!-Me2dpa)Cl]+ in a 64:36 D2O/DMSO-d6 mixture 
are presented in Table 5.3, and the aromatic region is shown in Figure 5.6. The equivalent 
[Pt(N(Me)6,6!-Me2dpa)Cl]+ methylene groups have equivalent carbon atoms (C7 and C7!), but 
each carbon bears inequivalent methylene protons (designated as endo-H7/7! and exo-H7/7!, 
Figure 3). Because the exo-H7/7! protons are closer to the N-Me group than are the endo-H7/7! 
protons, a ROESY experiment was used to assign these signals. A strong NOE cross-peak from 
the N-Me signal (2.70 ppm) to the signal at 4.40 ppm assigns the exo-H7/7! signals. A weak N-
Me-endo-H7/7! NOE cross-peak (2.70-5.23 ppm) assigns the endo-H7/7! signal. 
Table 5.3: Selected 1H NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!-








H4/4! 7.84 7.86 7.77 
H3/3! 7.32 7.31 7.26 
H5/5! 7.32 7.33 7.16 
endo-H7/7! 5.23 5.34 5.34 
exo-H7/7! 4.40 4.59 4.49 
6/6!-CH3 2.81 2.78 2.64 
a N-Me signal: 2.70 ppm. b propionic signals (ppm): 3.01 N-CH2, and 2.04 OC-CH2. c Dangling 
signals (ppm): 7.52 H4!!, 7.64 H3!!, 6.91 H5!!, 3.96 H7!!, and 2.15 6!!-CH3. 
 
In the 1H NMR spectrum of [Pt(N(Me)6,6!-Me2dpa)Cl]+ in D2O/DMSO-d6 (64:36 
mixture), the triplet at 7.84 ppm (Figure 5.6) is assigned to H4/4!, the only type of aromatic 
proton that can give a triplet. The H3/3! and H5/5! signals are overlapped into a single doublet at 
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7.32 ppm. In a ROESY spectrum (not shown), an NOE cross-peak from the H3/3! signal to the 
singlet at 2.70 ppm confirms the N-Me signal. The NOE cross-peak from the H5/5! signal to the 
signal at 2.81 ppm assigns the 6/6!-Me signal (Table 5.3).  
 
 
Figure 5.6: Aromatic region of the 1H NMR spectra of [Pt(N(Me)6,6!-Me2dpa)Cl]+ (a) and of the 
reaction mixture 3 d after adding 3.5 equiv of G to form the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) (b), 
Pt(N(Me)6,6!-Me2dpa)(3!-GMP) (c), and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) (d) adducts (25 °C, 
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). Peaks labeled with an * are from the bis adduct. 
 
Assignments of the 13C NMR signals for [Pt(N(Me)6,6!-Me2dpa)Cl]+ were made through 
an HSQC experiment (Table 5.4 and Figure D.2, Appendix D). Cross-peaks (ppm) involving 
H3/3! (7.32-122.0), H4/4! (7.84-142.2), H5/5! (7.32-128.8), 6/6!-Me (2.81-2.74), and N-Me 
(2.70-49.9) signals assign the C3/3!, C4/4!, C5/5!, C(6/6!-Me), N-C(Me) 13C NMR signals, 
respectively. Cross-peaks from the endo-H7/7! and exo-H7/7! signals assign the 13C NMR signal 
at 72.8 ppm to C7/7! (Table 5.4). 
The two very downfield signals in the 13C NMR spectrum of [Pt(N(Me)6,6!-
Me2dpa)Cl]Cl (Figure D.2) do not have HSQC cross-peaks; these features are expected for C2/2! 
and C6/6!. The shifts for these carbons attached to the pyridyl nitrogen are expected to be 
downfield, and they are not directly attached to a proton, accounting for the absence of an HSQC 
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cross-peak. The C2/2! and C6/6! signals were assigned with HMBC cross-peaks to H7/7! and 
6/6!-Me signals (Figure D.3, Table 5.4). The 1H and 13C NMR signals for [Pt(N(prop)6,6!-
Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl were assigned in a similar manner as above and are 
listed in Tables 5.3, 5.4, and D.2 and D.3 and shown in Figure D.4, D.5, and D.6.  
Table 5.4: Selected 13C NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, [Pt(N(prop)6,6!-








C4/4! 142.2 142.4 141.8 
C3/3! 122.0 121.4 121.4 
C5/5! 128.8 128.7 128.3 
C7/7! 72.8 72.9 73.3 
6/6!-CH3 27.4 27.1 27.0 
C2/2! 165.3 165.3 165.3 
C6/6! 164.8 165.1 164.4 
a N-Me signal: 49.9 ppm. b Propionic signals (ppm): 60.0 N-CH2, 34.0 OC-CH2, 174.7 CO. c 
Dangling signals (ppm): 139.3 C4!!, 126.3 C3!!, 125.9 C5!!, 67.8 C7!!, 24.2 6!!-CH3, 152.0 C2!!, 
and 159.7 C6!!. 
 
5.3.4 Pt(N(Me)6,6!-Me2dpa)(5!-GMP) and Pt(N(Me)6,6!-Me2dpa)(3!-GMP) Adducts  
The reaction of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GMP or 3!-GMP 
in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 2.5 h, and 3 d. 
The 1H NMR spectrum taken after 10 min exhibited two new sharp, downfield, undoubtedly 
mono G H8 singlets and a group of H8 signals attributable to the bis adduct (Figure 5.6). H8 is 
the only type of aromatic proton in the reaction mixture that can give a singlet, and the downfield 
shift changes relative to the free 5!-GMP H8 singlet (7.98) and free 3!-GMP H8 singlet (7.87) are 
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consistent with coordination of 5!-GMP or 3!-GMP to Pt(II) via N7. No change in the free vs 
bound H8 signal intensity was seen after 3 d (Figure 5.6). 
Table 5.5: Selected 1H NMR Shifts (ppm) for the Pt(N(Me)6,6!-Me2dpa)G, Pt(N(prop)6,6!-
Me2dpa)G, and Pt(6,6!,6!!-Me3tpa)G adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in 














Pt(N(Me)6,6!-Me2dpa)(5!-GMP) 7.99 9.09 9.06 5.73 5.87 5.85 
Pt(N(Me)6,6!-Me2dpa)(3!-GMP) 7.87 9.00 8.86 5.72 5.87 5.81 
Pt(N(Me)6,6!-Me2dpa)(5!-GTP) 8.07 9.10 9.12 5.72 5.86 5.83 
       
Pt(N(prop)6,6!-Me2dpa)(5!-GMP)a 7.97 9.03 9.03 5.71 5.89 5.83 
Pt(N(prop)6,6!-Me2dpa)(3!-GMP) 7.89 8.98 8.82 5.72 5.87 5.80 
Pt(N(prop)6,6!-Me2dpa)(5!-GTP) 8.06 9.00 9.11 5.72 5.86 5.83 
       
Pt(6,6!,6!!-Me3tpa)(5!-GMP) 7.98 9.03 8.98 5.71 5.82 5.79 
Pt(6,6!,6!!-Me3tpa)(3!-GMP) 7.89 9.00 8.78 5.71 5.84 5.76 
Pt(6,6!,6!!-Me3tpa)(5!-GTP) 8.06 9.09 9.05 5.73 5.81 5.79 
a H8 signals at pH 7.3: 9.13 (anti) and 8.98 (syn) ppm. 
Using reasoning discussed above and in previous work,29-31 we assign the two downfield 
H8 singlets (Figure 6) to the syn (9.06 ppm) and anti (9.09 ppm) rotamers of the Pt(N(Me)6,6!-
Me2dpa)(5!-GMP) adduct (Table 5.5). The syn H8:anti H8 intensity ratio is 1:2.02, similar to the 
syn:anti H8 ratio of 1:2.04 of  Pt(N(H)6,6!-Me2dpa)(5!-GMP). The Δδ between the two H8 
signals (0.03 ppm) is much smaller than the Δδ ~ 0.22 ppm found for Pt(N(H)6,6!-Me2dpa)(5!-
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GMP) (Table 5.6). The N(Me)6,6!-Me2dpa carrier-ligand signals of Pt(N(Me)6,6!-Me2dpa)(5!-
GMP) are reported in Table 5.7 and Figures 5.6 and D.7.  
Table 5.6: Syn H8:Anti H8 Intensity Ratios for Pt(N(Me)6,6!-Me2dpa)G, Pt(N(prop)6,6!-
Me2dpa)G, and Pt(6,6!,6!!-Me3tpa)G Adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in 
D2O/DMSO-d6 (64:36, 25 °C). 
 
 pH syn H8:anti H8 ratio Δδ 
Pt(N(Me)6,6!-Me2dpa)(5!-GMP) 4.0  1:2.02
 0.03 

































Pt(6,6!,6!!-Me3tpa)(5!-GMP)f 4.0  1:1.42 0.05 











     
a H8: 9.07 (syn and anti signal overlapped). b H8: 9.11 (anti), and 9.12 (syn) ppm. c H8: 9.13 
(anti), and 8.98 (syn) ppm. d H8: 9.07 (anti), and 8.79 (syn) ppm. e H8: 8.98 (syn), and 9.08 (anti) 
ppm. f H8: 9.12 (anti), and 9.05 (syn) ppm. g H8: 9.10 (anti), and 9.03 ppm (syn). h H8: 9.08 
(anti), and 9.05 ppm (syn). 
 
For the Pt(N(H)6-Medpa)G30 and Pt(N(H)6,6!-Me2dpa)G31 adducts, the syn 6/6!-Me 
signals were more upfield than the anti 6/6!-Me signals because these 6/6!-Me groups are on the 
same side of the coordination plane as the more shielding guanine six-membered ring. From this 
information, we assign the upfield signals (1.96 and 1.93 ppm) and the downfield signals (2.24 
and 2.21 ppm) of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct to the 6/6!-Me signals of the syn 
and anti rotamers, respectively (Figure D.7). A ROESY experiment was performed to confirm 
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H8 signals at 9.06 (syn) and 9.09 (anti) ppm, confirm the assignments of the syn and anti H8 
signals of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct. Correlating the abundance of the H8 
signals with that of the H1! signals, we establish that the anti H1! signal is downfield from that of 
the syn H1! signal.  
For the Pt(N(Me)6,6!-Me2dpa)(3!-GMP) adduct, we assign the H8 singlets to the syn 
(8.85 ppm) and anti (9.01 ppm) rotamers (Table 5.5) in a similar manner as above. The syn 
H8:anti H8 intensity ratio is 1:2.28 (Figure 5.6), similar to the syn:anti ratio of 1:2.03 for 
Pt(N(H)6,6!-Me2dpa)(3!-GMP).31 The Δδ between the two H8 signals (0.16 ppm) is smaller than 
the Δδ ~ 0.27 ppm found for Pt(N(H)6,6!-Me2dpa)(3!-GMP) (Table 5.6). The N(Me)6,6!-Me2dpa 
carrier-ligand signals in the Pt(N(Me)6,6!-Me2dpa)(3!-GMP) adduct have shifts similar to those 
of the  Pt(N(Me)6,6!-Me2dpa)(5!-GMP) adduct (Table 5.7 and Figures 5.6 and D.7).  
 5.3.5 Pt(N(Me)6,6!-Me2dpa)(5!-GTP)  
The reaction of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GTP in 
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 2.5 h, and 3 d. No 
change in the free vs bound H8 signal intensity was seen after 3 d (Figure 5.6). We assign the H8 
singlets to the syn (9.12 ppm) and anti (9.10 ppm) rotamers; the syn H8:anti H8 intensity ratio is 
1:2.13 (Figure 5.6 and Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.02 ppm) is 
smaller than the Δδ ~ 0.17 ppm found for Pt(N(H)6,6!-Me2dpa)(5!-GTP). The N(Me)6,6!-Me2dpa 
carrier ligand signals in the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct have shifts similar to those of 
the adducts above (Table 5.7 and Figures 5.6 and D.7). 
For Pt(N(Me)6,6!-Me2dpa)(5!-GTP), the syn H8 signal is more downfield from than the 
anti H8 signal but the syn H1! signal is more upfield than the anti H1! signal. The anti H8 signal 
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(9.10 ppm) of Pt(N(Me)6,6!-Me2dpa)(5!-GTP) is similar to the anti H8 signal (9.09 ppm) of 
Pt(N(Me)6,6!-Me2dpa)(5!-GMP); therefore, the syn H8 signal is shifted downfield. A ROESY 
experiment (not shown) confirms these syn and anti H8 assignments. 
5.3.6 Pt(N(prop)6,6!-Me2dpa)(5!-GMP)  
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GMP in 
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 8 d. The 1H 
NMR spectrum taken after 10 min exhibited overlapped, downfield, undoubtedly G H8 singlets 
and no bis adduct signals were detectable. No change in the free vs bound H8 signal intensity 
was seen after 8 d (Figure 5.7 and D.8). We assign the singlet at 9.03 ppm to the overlapped syn 




















Figure 5.7: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and 
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(5!-
GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm). 
Peaks labeled with an * are from the bis adduct. 
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The resolved syn and anti H1! signals were used to determine the syn:anti rotamer ratio 
because the two H8 signals were not resolved.  The syn H1!:anti H1! ratio was 1:8.53, highly 
favoring the anti rotamer, as discussed later (Table 5.6). The N(prop)6,6!-Me2dpa carrier-ligand 
signals in the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct have shifts similar to those observed for 
other adducts (Table 5.7 and Figures 5.7 and D.8). 
In order to resolve the two H8 signals, the pH of the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) 
solution was raised to ~7.3 to deprotonate the carboxylic acid group. The 1H NMR spectrum of 
the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) solution at pH 7.3 exhibited two sharp H8 signals at 9.13 
(anti) and 8.98 (syn) ppm  and the syn H8:anti H8 ratio increased to 1:5.77 (Figure 5.7 and 
Tables 5.5 and 5.6). A ROESY experiment (not shown) confirms these syn and anti H8 
assignments. 
5.3.7 Pt(N(prop)6,6!-Me2dpa)(3!-GMP)  
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 3!-GMP in 
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d. No 
change in the free vs bound H8 signal intensity was seen after 7 d (Figures 5.8 and D.9). The two 
closely spaced H8 singlets are assigned to the syn (8.82 ppm) and anti (8.98 ppm) rotamers 
(Table 5.5). The syn H8:anti H8 intensity ratio is 1:7.96, highly favoring the anti rotamer, as seen 
for the 5!-GMP adduct (Figure 5.8 and Table 5.6). The Δδ between the two H8 signals (0.16 
ppm) is larger than the Δδ found for Pt(N(prop)6,6!-Me2dpa)(5!-GMP) (Table 5.6). The 
N(prop)6,6!-Me2dpa carrier-ligand signals in the Pt(N(prop)6,6!-Me2dpa)(3!-GMP) adduct have 
shifts similar to that observed for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct (Table 5.7 and 


























Figure 5.8: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and 
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(3!-
GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm). 
Peaks labeled with an * are from the bis adduct. 
 
5.3.8 Pt(N(prop)6,6!-Me2dpa)(5!-GTP)  
The reaction of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl with 3.5 molar equiv of 5!-GTP in 
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d. No 
change in the free vs bound H8 signal intensity was seen after 7 d (Figures 5.9 and D.10). We 
assign the H8 singlets to the syn (9.11 ppm) and anti (9.00 ppm) rotamers; the syn H8:anti H8 






















Figure 5.9: Aromatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) and 
of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-Me2dpa)(5!-
GTP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm). 
Peaks labeled with an * are from the bis adduct. 
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The Δδ between the two H8 signals (0.11 ppm) is comparable to the Δδ ~ 0.17 ppm 
found for Pt(N(H)6,6!-Me2dpa)(5!-GTP). The N(prop)6,6!-Me2dpa carrier-ligand signals in the 
Pt(N(prop)6,6!-Me2dpa)(5!-GTP) adduct have shifts similar to those observed for the 
Pt(N(prop)6,6!-Me2dpa)(5!-GMP) and Pt(N(prop)6,6!-Me2dpa)(3!-GMP) adducts (Table 5.7 and 
Figures 5.9 and D.10), and as for the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct, the syn H8 signal is 
downfield from the anti H8 signal, and the syn H1! signal is upfield from the anti H1! signal. 
However, in spectra taken of the solution of the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adduct at pH 
~7.3, the anti H8 signal is shifted downfield of the syn H8 signal, most likely because of the 
overhanging deshielding phosphate chain of 5!-GTP (Figure 5.9 and Table 5.6). 
5.3.9 Pt(6,6!,6!!-Me3tpa)(5!-GMP), Pt(6,6!,6!!-Me3tpa)(3!-GMP), and Pt(6,6!,6!!-Me3tpa)(5!-
GTP) Adducts  
 
The reaction of [Pt(6,6!,6!!-Me3tpa)Cl]Cl with 3.5 molar equiv of 5!-GMP, 3!-GMP, or 5!-
GTP in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 7 d. 
No change in the free vs bound H8 signal intensity was seen after 7 d  (Figures 5.10 and D.11).  
 
 
Figure 5.10: Aromatic region of the 1H NMR spectra of [Pt(6,6!,6!!-Me3tpa)Cl]+ (a) and of the 
reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (b), 
Pt(6,6!,6!!-Me3tpa)(3!-GMP) (c), and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (d) adducts (25 °C, 
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). 
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For the Pt(6,6!,6!!-Me3tpa)(5!-GMP) adduct, we assign the H8 singlets to the syn (8.98 
ppm) and anti (9.03 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.42 (Figure 5.10 and 
Tables 5.5 and 5.6). The Δδ between the two H8 signals is ~ 0.05 ppm. The 6,6!,6!!-Me3tpa 
carrier-ligand signals in the Pt(6,6!,6!!-Me3tpa)(5!-GMP) adduct have shifts similar to those 
observed for the Pt(N(R)6,6!-Me2dpa)G adducts above (Table 5.7 and Figures 5.10 and D.11). 
For the Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct, we assign the H8 singlets to the syn (8.78 
ppm) and anti (9.00 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:2.43 (Figure 5.10 and 
Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.23 ppm) is larger than the Δδ ~ 0.05 
ppm found for Pt(6,6!,6!!-Me3tpa)(5!-GMP). The 6,6!,6!!-Me3tpa carrier ligand signals in the 
Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct have shifts similar to those observed for the other adducts 
(Table 5.7 and Figures 5.10 and D.11). 
For the Pt(6,6!,6!!-Me3tpa)(5!-GTP) adduct, we assign the H8 singlets to the syn (9.05 
ppm) and anti (9.09 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.53 (Figure 5.10 and 
Tables 5.5 and 5.6). The Δδ between the two H8 signals (0.05 ppm) is comparable to the Δδ ~ 
0.05 ppm found for Pt(6,6!,6!!-Me3tpa)(5!-GMP). The 6,6!,6!!-Me3tpa carrier ligand signals in the 
Pt(6,6!,6!!-Me3tpa)(5!-GTP) adduct have shifts similar to those observed for the other adducts 
(Table 5.7 and Figure 5.10 and D.11). 
5.3.10 Pt(N(Me)dpa)(5!-GMP) and Pt(N(Me)dpa)(3!-GMP) Adducts  
The reaction of [Pt(N(Me)dpa)Cl]Cl with 2.5 molar equiv of 5!-GMP or 3!-GMP in 
D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The 
reaction reached completion after ~2 d, as evidenced by the complete disappearance of the 
[Pt(N(Me)dpa)Cl]Cl signals by 2 d  (Figures D.12 and D.13).  
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For Pt(N(Me)dpa)(5!-GMP), we assign the H8 singlets to the syn (8.69 ppm) and anti 
(9.03 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.55:1 (Figure D.12 and Table D.4). 
The Δδ between the two H8 signals (0.34 ppm) is larger than the Δδ ~ 0.03 ppm found for 
Pt(N(Me)6,6!-Me2dpa)(5!-GMP) but comparable to the Δδ ~ 0.36 ppm found for Pt(N(H)dpa)(5!-
GMP) (Table D.4).29 The N(Me)dpa carrier ligand signals in the Pt(N(Me)dpa)(5!-GMP) adduct 
have shifts similar to those observed for the Pt(N(H)dpa)(5!-GMP) adduct (Table D.5 and Figure 
D.12). 
The Pt(N(Me)dpa)(3!-GMP) adduct has properties (Tables D.4, D.5 and Figure D.13) that 
are very similar to those of the Pt(N(Me)dpa)(5!-GMP) adduct. We assign the H8 singlets to the 
syn (8.60 ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.65:1 (Figure 
D.13 and Table D.4). The Δδ between the two H8 signals (0.37 ppm) is comparable to the Δδ ~ 
0.34 ppm found for Pt(N(Me)dpa)(5!-GMP).  
5.3.11 Pt(tpa)(5!-GMP) and Pt(tpa)(3!-GMP) Adducts  
The reaction of [Pt(tpa)Cl]Cl with 2.5 molar equiv of 5!-GMP in D2O/DMSO-d6 (64:36) 
was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The reaction reached 
completion after ~2 d, as evidenced by the complete disappearance of the [Pt(tpa)Cl]Cl signals 
by 2 d  (Figure D.14 and D.15).  
For Pt(tpa)(5!-GMP), we assign the H8 singlets to the syn (8.64 ppm) and anti (9.11 ppm) 
rotamers; the syn H8:anti H8 intensity ratio is 1.28:1 (Figure D.14 and Table D.4). The Δδ 
between the two H8 signals (0.47 ppm) is larger than the Δδ ~ 0.05 ppm found for Pt(6,6!,6!!-
Me3tpa)(5!-GMP). The tpa carrier ligand signals in the Pt(tpa)(5!-GMP) adduct are reported in 
Table D.5 and shown in Figure D.14. 
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The Pt(tpa)(3!-GMP) adduct has properties (Tables D.4 and D.5, and Figure D.15) that 
are very similar to those of the Pt(tpa)(5!-GMP) adduct. We assign the H8 singlets to the syn 
(8.60 ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.32:1 (Figure 
D.15 and Table D.4). The Δδ between the two H8 signals (0.37 ppm) is comparable to the Δδ ~ 
0.47 ppm found for Pt(tpa)(5!-GMP).  
5.3.12 Pt(N(prop)dpa)(5!-GMP), Pt(N(prop)dpa)(3!-GMP), and Pt(N(prop)dpa)(5!-GTP) 
Adducts  
 
The reaction of [Pt(N(prop)dpa)Cl with 2.5 molar equiv of 5!-GMP, 3!-GMP, or 5!-GTP 
in D2O/DMSO-d6 (64:36) was monitored by 1H NMR spectroscopy at 10 min, 1 d, and 2 d. The 
reaction reached completion after ~2 d, as evidenced by the complete disappearance of the 
[Pt(N(prop)Cl]Cl signals by 2 d (Figures D.16, D.17, D.18).  
For Pt(N(prop)dpa)(5!-GMP), we assign the H8 singlets to the syn (8.66 ppm) and anti 
(8.89 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1:1.32 favoring the anti rotamer 
(Figure D.16 and Table D.4). The Δδ between the two H8 signals (0.33 ppm) is much larger than 
that found for Pt(N(prop)6,6!-Me2dpa)(5!-GMP). The N(prop)dpa carrier-ligand signals in the 
Pt(N(prop)dpa)(5!-GMP) adduct are reported in Table D.5 and shown in Figure D.16. 
The Pt(N(prop)dpa)(3!-GMP) and Pt(N(prop)dpa)(5!-GTP) adducts have properties 
(Tables D.4 and D.5, and Figures D.17 and D.18) that are very similar to those of the 
Pt(N(prop)dpa)(5!-GMP) adduct. For Pt(N(prop)dpa)(3!-GMP), we assign the H8 singlets to the 
syn (8.58 ppm) and anti (8.92 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.48:1 (Figure 
D.17 and Table D.4). For Pt(N(prop)dpa)(5!-GTP), we assign the H8 singlets to the syn (8.74 
ppm) and anti (8.97 ppm) rotamers; the syn H8:anti H8 intensity ratio is 1.23:1 (Figure D.18 and 
Table D.4). 
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5.3.13 Pt(N(H)6-Medpa)(5!-GTP), Pt(N(H)6,6!-Me2dpa)(5!-GTP), Pt(N(Me)dpa)(5!-GTP), 
and Pt(N(R)6,6!-Me2dpa)(5!-GTP) Adducts 
  
In past work, rotamer distribution was found to be influenced by H-bonding interactions 
between phosphate and N–H groups. In addition, either the N-H group was cis to G in an amine 
ligand of Pt(Ltri)G and Pt(Lbi)(G)2 adducts, or else the G N1-H group was on an adjacent cis G 
residue in Pt(Lbi)(G)2 adducts.24,33,36,37,54-56!For the Pt(N(H)dpa)(5!-GTP) adduct, the presence of a 
trans N–H group was found to influence the rotamer abundance. The long triphosphate chain of 
the 5!-GTP in this adduct could extend far enough for the γ-phosphate group to form a weak 
hydrogen bond with the trans N–H of the carrier ligand when the 5!-GTP nucleotide has the anti 
conformation.29 The Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6!-Me2dpa)(5!-GTP) adducts were 
studied in order to assess the role of the trans N–H group in influencing rotamer abundance. The 
Pt(N(Me)dpa)(5!-GTP) adduct was used as a control because the trans N–H group is replaced by 
a methyl group; therefore, no change in rotamer abundance should be observed. 
The reactions of [Pt(N(H)6-Medpa)Cl]+ and [Pt(N(Me)dpa)Cl]+ with 2.5 molar equiv of 
5!-GTP were essentially complete at 1.5 h and 2 d. The formation reaction of the Pt(N(H)6,6!-
Me2dpa)(5!-GTP) adduct was carried out with a 1:1 ratio of [Pt(N(H)6,6!-Me2dpa)Cl]:5!-GTP 
because the Pt(N(H)6,6!-Me2dpa)(5!-GTP)2 adduct forms when more G is present in the mixture. 
Formation of the Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct was complete at 10 min. For all three 5!-
GTP adducts, sharp product H8 singlets were observed for the anti rotamer (the downfield H8 
and H1! signals) and the syn rotamer (the upfield H8 and H1! signals) (Figures 5.11 and D.19, 
and Tables D.4 and D.6). For the solution of the Pt(N(H)6-Medpa)(5!-GTP) adduct at pH 4.3, the 
syn:anti H8 ratio was 1.96:1 (Table D.6) with a δΔ of ~ 0.41 ppm. The slightly larger δΔ for the 
5!-GTP rotamers than for the 5!-GMP rotamers (δΔ = ~ 0.36) is explained by the deshielding of 
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the H8 by the overhanging phosphate groups of 5!-GTP.29 Similar results were seen for the 
Pt(N(H)dpa(5-GTP) adduct with a δΔ of ~ 0.41.29 For the Pt(N(H)6,6!-Me2dpa)(5!-GTP) solution 
at pH 4.1, the syn:anti H8 ratio was 1:2.01 (Table D.6) with δΔ of ~ 0.17 ppm, similar results 
seen for the Pt(N(H)6,6!-Me2dpa)(5!-GMP) adduct. The smaller δΔ may arise from the reduced 
canting of the syn rotamer, which shifts the syn H8 downfield. For the Pt(N(Me)dpa)(5!-GTP) 
solution the syn:anti H8 ratio was 1.55:1 (Table D.4) with a δΔ of ~ 0.33 ppm. 
To obtain further evidence that for Pt(N(H)6-Medpa)(5!-GTP) and Pt(N(H)6,6!-
Me2dpa)(5!-GTP) the anti rotamer could form a hydrogen bond from the γ-phosphate group to 
the central N-H, the pH of the solution was raised from 4.3 to 7.3 to deprotonate more fully the 




Figure 5.11: H8 and H1! regions of the 1H NMR spectra of the Pt(N(H)6-Medpa)(5!-GTP) and 
Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct (25 °C, D2O/DMSO-d6 (64:36), shifts in ppm) at pH 2.7 
(bottom), 4.3 (middle) and 7.3 (top). The small peaks in the spectra are from 5!-GDP that forms 
over time. 
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For Pt(N(H)6-Medpa)(5!-GTP), the syn:anti H8 ratio (1.96:1) was essentially the same at 
both pH values. On the other hand, when the pH was lowered to 2.7, the ratio increased to 
2.66:1, and the some signals shifted noticeably (Table D.7 and Figure 5.11). When the pH was 
raised from 4.3 to 7.3 for Pt(N(H)6,6!-Me2dpa)(5!-GTP), the syn:anti H8 ratio (1:1.98) was 
essentially unchanged. Upon lowering the pH to 2.8, the ratio decreased to 1:1.38, and some 
signals shifted noticeably (Table D.7 and Figure 5.11). The Pt(N(Me)dpa)(5!-GTP) adduct was 
used as a “control” because there is no trans N–H, and thus no H-bonding should occur. When 
the pH was varied from 2.7 to 4.3 and to 7.4, the syn:anti H8 ratio remained unchanged (Table 
D.7). In order to confirm that the syn rotamer is more favored at low pH owing to the lack of H-
bonding from a protonated γ-phosphate group, the solution of Pt(N(H)6-Medpa)(5!-GMP) was 
lowered to pH 2.7 because no H-bonding should occur and the syn H8:anti H8 ratio should 
remain the same. Upon lowering the pH from 4.3 to 2.7 for Pt(N(H)6-Medpa)(5!-GMP), the syn 
H8:anti H8 remained the same, confirming the formation of a weak hydrogen bond from the γ-
phosphate group to the central N–H (Table D.7). For the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and 
Pt(6,6!,6!!-Me3tpa)(5!-GTP) adducts, the syn:anti H8 ratio remained unchanged upon varying the 
pH, as expected because no trans N–H is present (Table 5.6). 
5.3.14 Factors Influencing the syn:anti Ratio of the Pt(N(Me)6,6!-Me2dpa)G, 
Pt(N(prop)6,6!-Me2dpa)G, and Pt(6,6! ,6! !-Me3tpa)G Adducts 
  
In this section, we assess how changes in the features of the carrier ligand could explain 
the trend of the syn:anti ratio of rotamers for the following Pt(Ltri)G mono adducts: Pt(6,6!,6!!-
Me3tpa)G > Pt(N(Me)6,6!-Me2dpa)G >>> Pt(N(prop)6,6!-Me2dpa)G. 
In previous work, we pointed out that the anti rotamer of the Pt(N(H)dpa)G and 
Pt(N(H)6-Medpa)G adducts has the nucleobase H8 proton on the same side of the coordination 
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plane as the H6/6! protons (Figure 5.3). The resulting proximity of H8 to the H6/6! and H6! 
protons leads to unfavorable electrostatic repulsion between the partial positive charges of these 
protons and to a lower abundance of the anti rotamer (Figure 5.12). In contrast, the H8 of the syn 
rotamer is on the side of the coordination plane opposite to the H6/6! and H6! protons. Thus, the 
greater separation between these protons in the syn rotamer decreases H8-H6/6! and H8-H6! 
electronic repulsions. Also, the partially negative O6 of guanine is on the same side of the 
coordination plane as the partially positive H6/6! and H6! protons of the carrier ligand, a 
juxtaposition possibly leading to favorable electrostatic interactions in the syn rotamer of 
Pt(N(H)dpa)G and Pt(N(H)6-Medpa)G adducts (Figure 12). For the Pt(N(H)6,6!-Me2dpa)G 
adducts, in which there are no H6! protons, the rotamer abundance is influenced by repulsive 
steric interactions between the G 6-membered ring and the 6/6!-Me groups (Figure 5.12). 
Consequently, in this study we assess the influences of the N-substituents of the carrier ligands 
on the syn H8:anti H8 intensity ratio.  
For all of the Pt(N(Me)6,6!-Me2dpa)G adducts studied, the syn H8:anti H8 intensity 
ratios (Table 5.6) were very similar to the syn H8:anti H8 ratios of the Pt(N(H)6,6!-Me2dpa)G 
adducts (Table D.6), as expected because of the non bulky methyl group. The syn H8:anti H8 
ratios for the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (1:1:42) and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (1:1.53) 
adducts were increased because the phosphate group is on the 5!-position and prefers the anti 
conformation, in which the phosphate group points toward the overhanging 6-methyl-2-picolyl 
chain (Table 5.6). This proximity creates a destabilizing interaction, therefore increasing the 
abundance of the syn rotamers of these adducts. For the Pt(6,6!,6!!-Me3tpa)(3!-GMP) adduct, the 
phosphate group is on the 3!-position, which points away from the coordination site, therefore 
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relieving the steric interaction between the 6-methyl-2-picolyl chain of the carrier ligand and the 
sugar phosphate group of 3!-GMP. This result explains the more favored anti rotamer with a syn 




















Figure 5.12: Models of the syn (A) and anti (B) rotamers of the Pt(N(H)dpa)G adducts, syn (C) 
and anti (D) rotamers of the Pt(N(H)6-Medpa)G adducts, and of the syn (E) and anti (F) rotamers 
of the Pt(N(H)6,6!-Me2dpa)G adducts. The R group of G is omitted for clarity. The van der 
Waals radii of all atoms were taken into account in constructing these models. The green arrows 
indicate steric repulsions and red arrows indicate electrostatic repulsions, with thicker arrows 
indicating stronger steric or electrostatic repulsions. Note that the 6-membered guanine ring in 
the syn conformers is toward the top of the figure, putting the ring on the same side of the 
coordination plane, allowing favorable electrostatic attraction (blue arrows) between the G 6-
membered ring δ- O6 and the δ+ H6/6! and H6! protons in A and C. However, steric repulsion 
between the G 6-membered ring and the 6-Me and 6!-Me groups in E and with the 6-Me group 
in C. The latter interaction is alleviated by canting. Note that the 6-membered guanine ring in the 
anti conformers is toward the bottom of the figure, alleviating the crowding in F but increasing 
electrostatic repulsion between the G 5-membered ring δ+ H8 and the δ+ H6/6! and H6! protons 
in B and D, respectively. Because for Pt(N(H)6,6!-Me2dpa)G adducts, there are no H6/6! protons, 
electrostatic repulsion is not an issue for the anti rotamer (F), possibly accounting for the high 
abundance of the anti rotamer of these adducts.31 By having an N-R group, steric repulsions 
between the N-R group and 6-membered ring of G are introduced for the syn rotamers. 
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For all of the Pt(N(prop)6,6!-Me2dpa)G adducts, the anti rotamer is highly favored. The syn 
H8:anti H8 ratios for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) (1:8.53) and Pt(N(prop)6,6!-
Me2dpa)(3!-GMP) (1:7.97) adducts were similar, whereas the Pt(N(prop)6,6!-Me2dpa)(5!-GTP) 
adduct had a syn H8:anti H8 ratio of 1:6.32 (Table 5.6). For the Pt(N(prop)6,6!-Me2dpa)(5!-GTP) 
adduct, the slightly increased abundance of the syn rotamer is the result of the steric interactions 
between the carboxylate group of the carrier ligand and the triphosphate group of 5!-GTP in the 
anti rotamer. Upon raising the pH of all Pt(N(prop)6,6!-Me2dpa)G solutions to ~7.3, the 
abundance of the syn rotamer increased for all adducts. At pH ~ 7.3 the carboxylate group of the 
carrier ligand and the γ-phosphate of 5!-GTP are deprotonated, therefore creating an electrostatic 
repulsion between both negatively charged groups in the anti rotamer of Pt(N(prop)6,6!-
Me2dpa)(5!-GTP) and hence a higher abundance of the syn rotamer. 
For the Pt(N(prop)dpa)(5!-GTP) and Pt(N(prop)dpa)(3!-GMP) adducts, the syn rotamer is 
favored, but for the Pt(N(prop)dpa)(5!-GMP) adduct, the anti rotamer is favored. Upon raising 
the pH of the Pt(N(prop)dpa)(5!-GMP) solution from pH 4.1 to 7.3, the syn:anti H8 ratio changed 
from 1:1.32 to 1:1.09, showing an increased abundance of the syn rotamer (Table D.4), as found 
for the Pt(N(prop)6,6!-Me2dpa)(5!-GMP) adduct discussed above. The syn H8:anti H8 ratio for 
the Pt(N(prop)dpa)(3!-GMP) adduct was essentially unchanged when the pH was changed from 
4.1 to 7.3 (Table D.4). Upon raising the pH of the Pt(N(prop)dpa)(5!-GTP) solution from 4.1 to 
7.3, the syn H8:anti H8 increased dramatically from 1.23:1 to 2.91:1 (Table D.4). As seen also 
for Pt(N(prop)6,6!-Me2dpa)(5!-GTP), the electrostatic repulsion between the negatively charged 
carboxylate and the γ-phosphate destabilizes the anti rotamer, therefore highly favoring the syn 
rotamer for the Pt(N(prop)dpa)(5!-GTP) adduct. 
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5.3.15 Pt(N(Me)6,6!-Me2dpa)G2, Pt(N(prop)6,6!-Me2dpa)G2, and Pt(6,6! ,6! !-Me3tpa)G2 
Adducts 
  
In addition to the signals of the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) mono adduct, the 
spectrum of the 5!-GMP reaction mixture also contained signals attributable to the bis adduct, 
Pt(N(Me)6,6!-Me2dpa)(5!-GMP)2 (Figure 5.6). At 3 d the 1H NMR spectrum showed ~60% of 
the total product to be in the form of the mono adduct, Pt(N(Me)6,6!-Me2dpa)(5!-GMP). 
However, unlike Pt(N(H)6,6!-Me2dpa)(5!-GMP),31 which forms at 100%, only ~40% of the total 
product was the Pt(N(Me)6,6!-Me2dpa)(5!-GMP)2 bis adduct, and the mono adduct dominated at 
~60%. The Pt(N(Me)6,6!-Me2dpa)(3!-GMP) and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) adducts also 
converted to the Pt(N(Me)6,6!-Me2dpa)(3!-GMP)2 (Figure 5.6) and Pt(N(Me)6,6!-Me2dpa)(5!-
GTP)2 (Figure 5.6) adducts with total product intensity percentages of 44 and 49, respectively. 
The Pt(N(prop)6,6!-Me2dpa)G2 adducts were essentially non-existent with a total product 
intensity of less than 15% (Figures 5.7, 5.8, and 5.9). The Pt(6,6!,6!!-Me3tpa)G2 adducts were 
never detected for all adducts formed (Figure 5.10). This result indicates that the amount of bis 
adduct formed depends on the bulk of the N-substituent, with higher bulk resulting in low 
amounts of bis adduct formed. 
5.4 CONCLUSIONS 
The bulk of the 6/6!-Me group is sufficient to impede rotation of the guanine base about 
the Pt–N7 bond of the Pt(N(R)6,6!-Me2dpa)G adducts; as was found for the Pt(N(H)6,6!-
Me2dpa)G adducts.31 The syn:anti ratio of rotamers for the Pt(Ltri)G mono adducts studied 
follows the trend: Pt(6,6!,6!!-Me3tpa)G ~ Pt(N(Me)6,6!-Me2dpa)G <<< Pt(N(prop)6,6!-
Me2dpa)G, all favoring the anti rotamer for adducts formed.!The lack of change, upon changing 
the pH, in the syn H8:anti H8 intensity ratio for the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and 
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Pt(6,6!,6!!-Me3tpa)(5!-GTP) adducts further supports the proposal that a weak hydrogen bond 
between the γ-phosphate group of 5!-GTP and the central N–H of the carrier ligand in the 
Pt(N(H)dpa)(5!-GTP) adduct.29 The increase in the syn H8:anti H8 ratio of Pt(N(prop)6,6!-
Me2dpa)(5!-GTP), upon raising the pH, arises from the electrostatic repulsion between the 
carboxylate group of the carrier ligand and the γ-phosphate group of 5!-GTP, therefore 
increasing the abundance of the syn rotamer. The trend in increasing bulk of the N-substituent of 
the carrier ligand is reflected in the order of abundance of bis adducts: Pt(6,6!,6!!-Me3tpa)G2 <<< 
Pt(N(prop)6,6!-Me2dpa)G2 < Pt(N(Me)6,6!-Me2dpa)G2.  
This study was motivated by the desire to understand the effect of more steric bulk of the 
N-substituent of the carrier ligand on the bound guanine derivative. The dramatically different 
stability of the Pt(N(R)6,6!-Me2dpa)G mono adducts compared to that of the Pt(N(H)6,6!-
Me2dpa)G31 mono adducts can be explained by the increased bulk of the N-substituent, making 
the bidentate coordination mode of the carrier ligand unfavorble. Furthermore, our work 
identifies a monofunctional Pt(II) complex with a bulky carrier ligand that has Pt–N bonds of 
normal lengths and strong enough to prevent bifunctional binding to DNA. 
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CHAPTER 6. SUMMARY AND CONCLUSIONS 
 
Pt(N(H)dpa)(G) adducts were used to assess whether a tridentate carrier ligand having 
bulk concentrated in the coordination plane can impede guanine nucleobase rotation. The 
observation of two sharp, comparably intense guanine H8 NMR signals provided evidence that 
these Pt(N(H)dpa)(G) adducts exist as mixtures of syn and anti rotamers, that rotational 
interchange is impeded by N(H)dpa, and that the key interactions involved steric repulsions 
between the pyridyl and guanine rings. The relative proximity of the guanine H8 to the 
anisotropic pyridyl rings allowed us to conclude that the syn rotamer was usually more abundant. 
However, the anti rotamer was more abundant for the Pt(N(H)dpa)(5!-GTP) adduct, in which a 
hydrogen bond between the 5!-GTP γ-phosphate group and the N(H)dpa central N–H is 
geometrically possible. In all previous examples of the influence of hydrogen bond formation on 
rotamer abundance in Pt(II) guanine adducts, these hydrogen bonding interactions occurred 
between ligand groups in cis positions. Thus, the role of a trans ligand group in influencing 
rotamer abundance, as found here, is unusual. 
When 9-EtG was added to [Pt(N(H)6,6!-Me2dpa)Cl]Cl. not only the expected 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ mono adduct having syn and anti conformers formed, but also a 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ bis adduct consisting of ΛHT and ΔHT conformers (HT = 
head-to-tail). For both adducts, the two conformers exist as a dynamic equilibrium mixture. 
Concomitant with formation of the bis adduct, the binding mode of the N(H)6,6!-Me2dpa ligand 
converts from tridentate to bidentate. The secondary nitrogen is an asymmetric center, and each 
conformer exists as a racemic mixture of two enantiomers. For a given configuration at the 
secondary amine of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ adduct, the more abundant HT 
conformer can form a hydrogen bond between the NH of the bidentate ligand and the cis 9-EtG 
!
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O6. [Pt(N(H)6,6!-Me2dpa)Cl]Cl forms the mono adduct in ~1/20 the time for its parent, 
[Pt(N(H)dpa)Cl]Cl, which exhibited typical behavior in forming only a mono adduct. We 
attribute the unusual new findings for [Pt(N(H)6,6!-Me2dpa)Cl]Cl to Pt–N bond weakening 
induced by the steric bulk of 6/6!-Me groups.  
The steric effects of the tridentate carrier ligand, N(H)6-Medpa, bearing a 6-methyl group 
and a 6!-proton projecting toward the nucleobase, in Pt(N(H)6-Medpa)G adducts formed syn and 
anti rotamers with the guanine O6 and the central N–H of N(H)6-Medpa on the same or opposite 
side of the coordination plane, respectively. Pt(N(H)6-Medpa)G adducts have some properties 
(ease of rotamer interchange and extent of conversion to bis adducts, Pt(N(H)6-Medpa)G2) 
intermediate to properties reported for analogues having a tridentate ligand with zero or two 
methyl groups. However, in comparison, the syn rotamer of Pt(N(H)6-Medpa)G adducts have an 
unexpectedly high abundance. This high abundance of the syn rotamer is attributable to guanine 
base canting, such that the 6-membered guanine ring is positioned away from the bulky 6-Me 
group. This canting both relieves electrostatic repulsion between the partially positive H6! and 
the guanine H8 protons and creates a favorable electrostatic attraction between the H6! proton 
and the partially negative guanine O6.  
The steric effects of the coordinated tridentate carrier ligands [N-(Me)-di-(6-methyl-2-
picolyl)amine (N(Me)6,6!-Me2dpa), N-(propionic acid)-di-(6-methyl-2-picolyl)amine 
(N(prop)6,6!-Me2dpa), and tris(6-methyl-2-picolyl)amine (6,6!,6!!-Me2dpa), all ligands with two 
6-methyl groups in the coordination plane and bearing a bulky the substituents on the central N], 
in Pt(N(R)6,6!-Me2dpa)G mono adducts (G = 5!-GMP, 5!-GTP, 3!-GMP formed syn and anti 
rotamers that have the guanine O6 and the central N–R of N(R)6,6!-Me2dpa on the same or 
opposite side of the coordination plane, respectively. The Pt(N(prop)6,6!-Me2dpa)G adducts 
!
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highly favor the anti rotamer. A high abundance of the anti rotamer at high pH for the 
Pt(N(H)6,6!-Me2dpa)(5!-GTP) adduct compared to the Pt(N(H)6,6!-Me2dpa)(5!-GMP) adduct and 
the absence of change in the syn H8:anti H8 ratio of the Pt(N(Me)6,6!-Me2dpa)(5!-GTP) and 
Pt(6,6!,6!!-Me2dpa)(5!-GTP) further supports the proposal that a trans NH ligand group 
influences rotamer abundance. The increased bulk of the N-substituents of Pt(N(R)6,6!-
Me2dpa)G adducts dramatically changes the stability of these adducts, highly favoring the mono 
adducts. The Pt(N(prop)6,6!-Me2dpa)G and Pt(6,6!,6!!-Me2dpa)G adducts highly favor mono 
adduct stability, with the formation of the bis adduct being essentially undetectable. This high 
















Figure A.2: The aromatic and H1! region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GMP) after 10 min, 













Figure A.4: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GDP) after 10 min, 












Figure A.5: Aromatic and H1! region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-GTP) after 10 min, 













Figure A.6: 1H-1H ROESY spectrum of the aromatic region of the Pt(N(H)dpa)(5!-GTP) adduct 












Figure A.7: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming Pt(N(H)dpa)(5!-IMP) after 10 min, 












Figure A.8: Aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and the reaction mixture forming [Pt(N(H)dpa)(Guo)]2+ after 10 min, 











Figure A.9: 1H NMR spectra (25 °C, D2O/DMSO-d6) of [Pt(N(H)dpa)Cl]+ (bottom) and the 







Figure A.10: Part of the aromatic region of the 1H NMR spectra (25 °C, D2O/DMSO-d6) of 
[Pt(N(H)dpa)Cl]+ (bottom) and of the reaction mixture forming Pt(N(H)dpa)(5!-GMP) after 10 
min, 7 h, and 49 h (shifts in ppm). 
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APPENDIX B. SUPPLEMENTARY MATERIAL FOR CHAPTER 3 
 
Synthesis of [Pt(N(H)dpa)Cl][H2PO4]•H3PO4•H2O. [Pt(N(H)dpa)Cl]Cl (9.23 mg in 2 mL of H2O) 
was treated with an aqueous solution of NaPF6 (3.40 mg in 2 mL of H2O) until the solution 
became slightly cloudy. The solution was left at room temperature and a small yellow crystal 
was obtained after 3 weeks. The hydrolysis of NaPF6 over time yielded a salt with the unusual 
H2PO4- anion. 1H NMR signals (ppm) DMSO-d6: 8.81 (d, 2H, H6/6!), 8.67 (bs, 1H, NH), 8.24 (t, 
2H, H4/4!), 7.76 (d, 2H, H3/3!), 7.61 (t, 2H, H5/5!), 4.93, 4.90 (dd, 2H, CH2), 4.62, 4.58 (dd, 2H, 
CH2). The 1H NMR signals agree with the previously reported values for [Pt(N(H)dpa)Cl]Cl,1 
except for the NH signal. As explained in other reports, in solvents such as DMSO-d6 the counter 
ion can form a weak hydrogen bond to coordinated proton-bearing amine donors; the effect of 
the hydrogen bonding interaction is to cause an anion-dependent downfield shift of the NH 
signal.2,3 
Supporting NMR Assignments and Experiments. All experiments utilized 64:36 D2O/DMSO-d6 
solutions (385 μL/215 μL). For all NMR spectra, the complex concentration was 10 mM and the 
solution pH was generally 4.0 or 4.1 unless noted otherwise. 
Carrier-Ligand Signal Assignments for [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+. For the bis adduct, the 
atoms in the chelate half of the N(H)6,6!-Me2dpa ligand are numbered with no prime, whereas 
those in the dangling half are designated with a prime (Figure 3.4). As stated in the main text, the 
ΛHT:ΔHT conformer ratio was 63:37. Therefore, we can assign the 1H and 13C NMR signals of 
the dangling pyridyl protons by using the fact that the intensities of the ΛHT signals are higher 
than those of the ΔHT signals. The bound pyridyl H4 signal should be the most downfield triplet 
(as seen for [Pt(N(H)6,6!-Me2dpa)Cl]+), thus assigning the triplets at 7.86 and 7.85 ppm (Figure 
3.7) to the H4 signals of the ΛHT and ΔHT conformers, respectively (Table 3.5). In an expanded 
! 161 
region of the HSQC spectrum (Figure B.9), the overlapped triplets have a cross-peak to the 13C 
NMR peak at 142.0 ppm, assigning this C4 13C NMR signal to both HT conformers. The triplet 
at 7.65 ppm (overlapped with an H8 singlet) has a cross-peak to the 13C NMR peak at 139.8 
ppm. This same 13C NMR peak has a cross-peak to the peak at 7.56 ppm (overlapped with a 
doublet). Thus the 13C NMR peak is assigned to overlapped C4! signals of both HT conformers 
and the triplets at 7.65 and 7.56 ppm to ΛHT and ΔHT conformers, respectively (Table 3.5). 
With the H4 and H4! signals thus assigned, a COSY experiment (not shown) allowed us to assign 
signals to bound and dangling pyridyl groups.  
Because the H3, H3!, H5, and H5! signals are all doublets within the same chemical shift range 
and have COSY cross-peaks to either H4 or H4!, the 6-Me-to-H5 and 6!-Me-to-H5! NOE cross-
peaks in a ROESY spectrum (not shown) were used to assign and to distinguish H5 and H5! 
doublets from the H3 and H3! doublets. The NOE cross-peaks from the 6-Me signals at 1.75 
(ΛHT) and 1.88 (ΔHT) ppm (Table 5) assigns the doublet at 7.12 ppm to the H5 signal for both 
HT conformers. The NOE cross-peaks from the ΛHT and ΔHT 6!-Me signals (Table 3.5) to 
doublets at 7.07 and 7.03 ppm assign these doublets to H5! of the ΛHT and ΔHT conformers, 
respectively.  
From the HSQC spectrum (Figure B.9), the H5 signal at 7.12 ppm has a cross-peak to the 13C 
NMR signal at 127.7 ppm, thus assigning this C5 signal to both HT conformers. The H5! signals 
at 7.07 and 7.03 ppm have an elongated cross-peak to the 13C NMR signals at 125.0 and 124.8 
ppm, thus assigning the C5! signals of the ΛHT and ΔHT conformers, respectively. The 
remaining doublets are H3 or H3!. The H3 signals are overlapped at 7.48 ppm. These overlapped 
signals have a cross-peak to the 13C signals at 121.7 and 121.8 ppm, thus assigning the two 
signals as the C3 signals; on the basis of intensity, these were assigned to the ΛHT and ΔHT 
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conformers, respectively. The ΛHT H3! signal at 7.55 ppm (overlapped with the H4! signal) and 
the ΔHT H3! signal at 7.28 ppm have HSQC cross-peaks, allowing the 13C NMR signals at 124.0 
and 123.2 ppm to be assigned to the ΛHT and ΔHT C3! signals, respectively.  
In Figure B.13, the chelate ring methylene protons are designated as endo-H7 and exo-H7 for 
protons projecting toward and away from platinum, respectively. Because the methylene group 
in the dangling 6-methyl-2-picolyl chain is not in a fixed position, we do not use these 
designations. The C7 signal at a characteristic shift (63.2 ppm) has HSQC cross-peaks (Figure 
S10) to the signals at 5.12, 5.00, and 4.57 ppm (masked by the HOD signal), thus allowing 
assignment of the peaks at 5.12 and 5.00 ppm to the ΔHT and ΛHT endo-H7 signals, 
respectively, on the basis of shift and intensity. The peak at 4.57 ppm is assigned to the exo-H7 
signals for both HT rotamers, again according to signal shift and intensity. The C7! signals at 
59.5 and 59.6 ppm have cross-peaks to 1H NMR signals at 3.72 and 3.68 ppm and to the signals 
masked by the CH2 signals of 9-EtG at 3.86 and 3.82 ppm. H3!-H7! NOE cross-peaks in a 
ROESY spectrum (not shown) allow us to assign the ΛHT and ΔHT H7! signals. The ΔHT H3! 
signal at 7.28 ppm has cross-peaks to the signals at 3.82 (masked by the CH2 signal of 9-EtG) 
and 3.68 ppm, thus assigning these as the two ΔHT H7! signals. The ΛHT H3! signal at 7.55 ppm 
has cross-peaks to the signals at 3.86 (masked by the CH2 signal of 9-EtG) and 3.72 ppm, thus 
assigning these as the two ΛHT H7! signals. An HMBC cross-peak from the H5 signal at 7.12 
ppm to the 13C signals at 162.4 and 162.5 ppm assign the ΛHT C6 and ΔHT C6 signals, 
respectively (Figure B.11). HMBC cross-peaks from the ΛHT H5! (7.07 ppm) and ΔHT H5! 
(7.03 ppm) signals to the 13C signals at 159.6 and 159.5 ppm assigns the latter to the ΛHT  and 
ΔHT C6! signals. An HMBC cross-peak from the overlapped ΛHT and ΔHT H3 signals at 7.48 
ppm to the 13C signals at 162.8 and 162.6 ppm assign these to C2, and the relative intensity 
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allows assignment of the signals to the ΛHT and ΔHT conformers, respectively. HMBC cross-
peaks from the ΛHT H3! (7.55 ppm) and ΔHT H3! (7.28 ppm) signals assign the 153.4 and 153.3 
ppm 13C signals to C2! of the ΛHT and ΔHT conformers, respectively (Figure B.11). This 
completes the assignment of the 1H and 13C NMR signals for the two [Pt(N(H)6,6!-Me2dpa)(9-




















Table B.1: Selected 1H NMR and 13C NMR Shifts (ppm) for N(H)6,6!-Me2dpa in D2O/DMSO-d6 
(64:36) at pH 4.1 and 11.2 at 25 °C 
 carbons 
 C4/4! C3/3! C5/5! C7/7!  C2/2! C6/6! 6/6!-(C)Me 
pH 4.1 140.8 122.9 125.9 52.0 151.1 159.8 24.3 
pH 11.2 139.7 121.6 124.1 54.6 158.9 159.2 24.4 
!
 protons 
 H4/4!   H3/3!    H5/5!   H7/7!   6/6!-Me 
pH 4.1 7.67 7.21 7.23 4.21 2.40 















Figure B.1: Overlay of [Pt(N(H)6,6!-Me2dpa)Cl]+ (yellow) and [Pt(N(H)dpa)Cl]+ 4 (purple) 













Figure B.2: HSQC spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6, pH 4.0, shifts 
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Figure B.3: HMBC spectrum of [Pt(N(H)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6, pH 4.0, 
shifts in ppm). Peaks labeled X are a mixture of solvated species and impurities. Peaks labeled S 




























Figure B.4: Models of the syn (A) and anti (B) rotamers of the [Pt(N(H)dpa)(9-EtG)]2+adduct and of the 
syn (C) and anti (D) rotamers of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ adduct. The van der Waals radii of 
all atoms were taken into account in constructing these models. Note that the 6-membered guanine ring 
in syn conformers (A and C) is close to H6,6! or 6,6!-Me, which leads to crowding in C, possibly 


























Figure B.5: 1H-1H ROESY spectrum of the H8-6/6!-Me region of [Pt(N(H)6,6!-Me2dpa)(9-





















Figure B.6: 1H-1H ROESY spectrum of the H8-H8 region of [Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+ (15 

























































Figure B.7: Aliphatic region of the 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!-
Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6 at pH 4.0) before (bottom), 15 min after (middle), and 4.5 h 
after (top) mixing with 2.5 molar equiv of 9-EtG. Signals for the mono-adduct intermediate, 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+, are labeled in the middle trace, and those for the final bis-
adduct product, [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+, are labeled in the top trace. Detailed 
assignments of signals to the ΛHT and ΔHT conformers appear in Table 5. In figure, G = 9-EtG, 





















Figure B.8: Possible orientations of the guanine bases in the HHu (top) and HHd (bottom) 




































Figure B.9: Aromatic region of the HSQC spectrum of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ 

































Figure B.10: Aliphatic region of the HSQC spectrum of the [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ 
adduct (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). Peaks labeled X are a mixture of solvent 








































































































Figure B.11: HMBC spectrum of the aromatic region (A) of [Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ 
and the 1D 13C NMR spectrum (B) of the C2, C2!, C6, and C6! regions of [Pt(N(H)6,6!-





























Figure B.12: HMBC spectrum of the aromatic (13C) and aliphatic (1H) cross-peak region of 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)2]2+ (25 °C, D2O/DMSO-d6, pH 4.0, shifts in ppm). Peaks labeled X 
are a mixture of solvent and solvent impurities. The cross-peaks circled in the spectrum shows 








Figure B.13: Designation of the methylene endo-H7 and exo-H7 protons and the methylene H7! 
protons of the chelating and dangling 6-methyl-2-picolyl chains of the [Pt(N(H)6,6!-




















8 7 5 4 3


















Figure B.14: 1H NMR spectra (shifts in ppm) of a solution of [Pt(N(H)6,6!-Me2dpa)Cl]+ (25 °C, 
D2O/DMSO-d6), 10 min (bottom), 1 h (middle), and 24 h (top) after mixing with 10 µL of 
concentrated HCl. In the bottom trace, the assignments for the [Pt(N(H)6,6!-Me2dpa)Cl]+ original 
signals are labeled. The bidentate intermediate signals are labeled with red and blue asterisks for 
the dangling and the chelated 6-methyl-2-picolyl chains, respectively. The top trace shows the 







H6/6' H4/4' H3/3' H5/5'
 
Figure B.15: 1H NMR spectra (shifts in ppm) of the aromatic region of a solution of 
[Pt(N(H)dpa)Cl]+ (25 °C, D2O/DMSO-d6 ), 10 min (bottom) and 24 h (top) after mixing with 10 










Figure B.16: Aromatic region of the 1H NMR spectra (shifts in ppm) of a solution of 
[Pt(N(H)6,6!-Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6) 10 min after (bottom) and 6 h after (top) 
mixing with 3.5 molar equivalents of 3!-GMP (pH 4.1). H8 signals for the mono-adduct 
intermediate, Pt(N(H)6,6!-Me2dpa)(3!-GMP), are labeled in the bottom trace, and those for the 
final bis-adduct product, Pt(N(H)6,6!-Me2dpa)(3!-GMP)2, are labeled in the top trace. Peaks 
labeled with an asterisk (*) are from the carrier-ligand signals of Pt(N(H)6,6!-Me2dpa)(3!-
GMP)2. 
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Figure B.17: 1H NMR spectrum of the H1! and 6/6!-Me regions of a solution of [Pt(N(H)6,6!-
Me2dpa)Cl]+ (25 °C, D2O/DMSO-d6, pH 4.1) 15 min after (bottom), and 3 d after (top) mixing 
with 3.5 molar equiv of 5!-GMP. Signals for the mono-adduct intermediate, Pt(N(H)6,6!-
Me2dpa)(5!-GMP), are labeled in the bottom trace, and those for the final bis-adduct product, 
Pt(N(H)6,6!-Me2dpa)(5!-GMP)2, are labeled in the top trace. Peaks labeled x are from solvent 
impurity. For the Pt(N(H)6,6!-Me2dpa)(5'-GMP) adduct, the syn (5.83 ppm) and anti (5.88 ppm) 
H1' signals are shifted downfield of the free 5'-GMP H1' signal at 5.71 ppm. The overlapped H1' 
signals of the Pt(N(H)6,6!-Me2dpa)(5'-GMP)2 adduct are found between 5.70-5.60 ppm, upfield 
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APPENDIX C. SUPPLEMENTARY MATERIAL FOR CHAPTER 4 
 
Supporting NMR assignments and experiments. For all NMR spectra, the complex concentration 
was 10 mM, and data in all tables and figures were obtained at pH ~ 4 in 64:36 D2O/DMSO-d6 
solutions (385 μL/215 μL). 
Carrier-Ligand Signal Assignments for [Pt(N(H)6-Medpa)(9-EtG)]2+. As discussed in the main 
text, the syn:anti ratio was found to be 2.10:1, with the syn rotamer being the major rotamer. 
Therefore, we can assign the 1H and 13C NMR signals of the syn and anti rotamer signals by 
using the relative signal intensities of the these signals, as the signal intensities are larger for the 
syn rotamer signals than for the anti rotamer. In Figure 4.6, the bottom trace for [Pt(N(H)6-
Medpa)Cl]+ shows an H6! signal at 8.75 ppm (the H6! signal should be the most downfield 
pyridyl signal because of the proximity of the endocyclic nitrogen), but the spectrum of the 
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct (top) has no doublets in this region. As seen in similar 
studies,1 the anisotropy of the N7-coordinated guanine nucleobase shifts the H6! doublet into the 
same narrow shift region as the H3, H3!, H5, and H5! signals. The 13C NMR signals of C6!, C3, 
C3!, C5, and C5! are widely dispersed in distinctive regions for the [Pt(N(H)6-Medpa)(9-EtG)]2+ 
adduct. We relied on [Pt(N(H)6-Medpa)Cl]Cl assignments (Figures 4.7, C.1, and C.2, Tables 4.3, 
C.2, and C.3) to make the 1H and 13C NMR assignments for the [Pt(N(H)6-Medpa)(9-EtG)]2+ 
adduct (Figures 4.10 and C.3, Tables 4.3, C.4, and C.5).  
In contrast to the close H6! proton, the H3 and H3! protons are the pyridyl protons of the 
[Pt(N(H)6-Medpa)(9-EtG)]2+ adduct farthest from the coordinated guanine nucleobase. The H3 
and H3! doublets of the adduct are not influenced by the anisotropic guanine nucleobase and thus 
have shifts (7.30–7.44 ppm) similar to the H3 and H3! signals of the starting [Pt(N(H)6-
Medpa)Cl]Cl complex. As a result, the H3, H3! and H6! doublets of the [Pt(N(H)6-Medpa)(9-
!
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EtG)]2+ adduct have similar shifts (Table 4.3). The 1D 13C NMR spectrum shows two resolved 
C6! peaks at 149.0 and 148.2 ppm. In the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+ 
adduct, the H6!-C6! cross-peaks can be identified by the characteristic C6! 13C NMR shift of 
~149 ppm. One cross-peak involves the overlapped signal at ~7.48 ppm and the C6! signal at 
148.2 ppm; both signals are attributable to the anti rotamer, on the basis of intensity. The other 
cross-peak involves the overlapped signal at ~7.23 ppm and the C6! signal at 149.0 ppm; these 
signals are attributable to the syn rotamer. The C3 pyridyl signals at characteristic shifts (121.5 
and 121.6 ppm) of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct have an HSQC cross-peak to the 
overlapping signals at 7.36 and 7.38 ppm, thus assigning these signals to the syn and anti H3 and 
C3 signals, respectively. The C3! pyridyl signals at characteristic shifts (124.0 and 124.1 ppm) 
have a cross-peak with the overlapping signals at 7.49 and 7.51 ppm, thus assigning the syn and 
anti H3! and C3! signals, respectively.  
The C5 pyridyl signals at characteristic shifts (128.2 and 128.4 ppm) have an elongated cross-
peak to the overlapped signals at 7.18 and 7.28 ppm, thus assigning the two signals to the H5 
signals; on the basis of intensity these were assigned to the syn and anti rotamers, respectively. 
The C5! pyridyl signals at characteristic shifts (126.5 and 128.8 ppm) have cross-peaks to the 
overlapped signals at 7.21 and 7.28 ppm, thus assigning these signals to the syn and anti H5 and 
C5 signals, respectively. This multiplet peak at ~7.22 ppm also had a cross-peak to the syn C6! 
signal, indicating that the H5, H5!, and syn H6! signals are all overlapped. The C4 and C4! 
pyridyl signals at a characteristic shift (142.7 and 142.8, respectively) show cross-peaks to the 




The C7 signal of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct at a characteristic shift (62.2 ppm) 
has HSQC cross-peaks (Figure C.2) to the overlapped signals at 4.93, 4.88, and to the signal at 
4.56 ppm (masked by the HOD signal), thus allowing assignment of the peaks at 4.93 and 4.88 
ppm to the syn and anti endo-H7 signals, respectively, on the basis of shift and intensity. The 
peak at 4.56 ppm is assigned to the exo-H7 signals for both rotamers. The overlapped C7! signal 
at 60.5 ppm has cross-peaks to the overlapped 1H NMR signals at 4.78 and 4.74 ppm and to the 
signal masked by the HOD signal at 4.58 ppm, thus allowing the assignment of the peaks at 4.78 
and 4.74 ppm to the syn and anti endo-H7! signal signals, respectively, on the basis of shift and 
intensity. The peak at 4.58 ppm is assigned to the exo-H7 signals for both rotamers. HMBC 
cross-peaks from the H5 signals at 7.18 (syn) and 7.22 (anti) ppm to the 13C signals at 162.8 and 
163.2 ppm assign the syn and anti C6, respectively. HMBC cross-peaks from the overlapped H3 
signals at 7.36 (syn) and 7.38 (anti) ppm to the 13C signals at 166.7 and 166.5 ppm assign these 
to C2, and the relative intensity allows assignment of the signals to syn and anti rotamers, 
respectively. HMBC cross-peaks from the overlapped H3! signals at 7.49 (syn) and 7.51 (anti) 
ppm to the 13C signals at 168.1 and 168.4 ppm assign the syn and anti C2! signals, respectively. 
The discussion here and in the main text complete the assignment of the 1H and 13C NMR signals 






Table C.1: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(H)6,6!-Me2dpa)Cl]Cl, 












Pt–N(1) 2.048(7) 2.069(16) 2.008(6) 2.010(5) 
Pt–N(2) 1.973(8) 1.96(2) 2.009(12) 1.952(7) 
Pt–N(3) 2.047(7) 2.019(16) 2.011(5) 2.014(6) 
Pt–Cl(1) 2.421(3) 2.316(3) 2.301(2) - 
Pt–O(1) - 2.069(16) 2.008(6) 2.048(7) 
bond angles 
N(1)–Pt–N(3) 166.3(3) 164.3(6) 166.0(2) 166.7(2) 
N(1)–Pt–Cl(1) 95.96(18) 103.7(7) 97.2(2) - 
N(2)A–Pt–Cl(1) 159.1(3) 169.4(5) 168.7(6) - 
N(3)–Pt–Cl(1) 95.34(18) 92.0(6) 97.8(2) - 
N(2)A–Pt–N(1) 83.2(3) 83.4(6) 83.3(3) 83.6(2) 
N(2)A–Pt–N(3) 83.4(3) 81.4(4) 83.3(3) 83.2(2) 
N(2)A–Pt–O(1) - - - 176.4(3) 
N(1)–Pt–O(1) - - - 93.4(3) 
N(3)–Pt–O(1) - - - 99.8(3) 
a Ref 2. b Ref 3.
!
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Table C.2: 1H NMR Shifts (ppm) for [PtN(H)dpa)Cl]Cl, [Pt(N(H)6-Medpa)Cl]Cl, and 








H4(s) or H4!(u) 7.98(u) 8.02(u), 7.82(s) 7.80(s) 
H3(s) or H3!(u) 7.48(u) 7.43(u), 7.30(s) 7.23(s) 
H5(s) or H5!(u) 7.34(u) 7.42(u), 7.28(s) 7.27(s) 
endo-H7(s) or H7!(u) 4.73(u) 4.69(u), 4.86(s) 4.87(s) 
exo-H7(s) or H7!(u) 4.49(u) 4.46(u), 4.50(s) 4.47(s) 
6/6!-CH3 or 6-CH3 - 2.74 2.80  
H6/6! or H6! 8.61 8.75 - 




Table C.3: 13C NMR Shifts (ppm) for [PtN(H)dpa)Cl]Cl, [Pt(N(H)6-Medpa)Cl]Cl, and 
[Pt(N(H)6,6!-Me2dpa)Cl]Cl  in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C).  
 
carbona [PtN(H)dpa)Cl]Clb [Pt(N(H)6-Medpa)Cl]Cl [Pt(N(H)6,6!-Me2dpa)Cl]Clc 
C4(s) or C4!(u) 142.5(u) 142.6(u), 142.2(s) 142.0(s) 
C3(s) or C3!(u) 124.1(u) 123.7(u), 121.1(s) 120.6(s) 
C5(s) or C5!(u) 126.6(u) 126.3(u), 128.4(s) 128.5(s) 
C7(s) or C7!(u) 60.8(u) 60.7(u), 62.8 (s) 63.3(s) 
6/6!-CH3 or 6-CH3 - 27.9 27.5 
C6(s) or C6!(u) 150.4(u) 149.7(u), 165.3(s) 164.8(s) 
C2(s) or C2!(u) 167.5(u) 168.3(u), 166.5(s) 166.7(s) 
 




Table C.4: 1H NMR Shifts (ppm) for [PtN(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and 
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+  in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
protona [Pt(N(H)dpa)(9-EtG)]2+b,c [Pt(N(H)6-Medpa)(9-EtG)]2+c [Pt(N(H)6,6!-
Me2dpa)(9-EtG)]2+b,d 
G H8 8.73e, 8.40f 8.80e, 8.43f 8.84e, 8.54f 
H4(s) or H4!(u) 8.02g(u) 8.01e(u), 7.99f(u), 7.86g(s) 7.80g(s) 
H3(s) or H3!(u) 7.56g(u) 7.51e(u), 7.49f(u), 7.38e(s), 7.36f(s) 7.31g(s) 
H5(s) or H5!(u) 7.25g(u) 7.28e(u), 7.21f(u), 7.18e(s), 7.22f(s) 7.12g(s) 
endo-H7(s) or H7!(u)  4.84e(u), 4.78f(u) 4.78d(u), 4.74f(u), 4.93e(s), 4.88f(s) 4.88e(s), 4.81f(s) 
exo-H7(s) or H7!(u) 4.58g(u) 4.58g(u), 4.56g(s) 4.50g(s) 
6/6!-CH3 or 6-CH3 - 1.80
e, 1.73f 2.05e, 1.75f 
H6/6! or H6! 7.56e, 7.48f 7.48e, 7.23f - 
9-EtG CH2 4.16e, 4.05f 4.15e, 4.03f 4.10e, 4.01f 
9-EtG CH3 1.44e, 1.34f 1.39e, 1.30f 1.26e, 1.30f 
 
a (s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 9-EtG signals 
(ppm): H8 7.72; CH2 3.91; CH3 1.25. d Ref 2. e Signals from the anti rotamer. fSignals from the 














Table C.5: 13C NMR Shifts (ppm) for [PtN(H)dpa)(9-EtG)]2+, [Pt(N(H)6-Medpa)(9-EtG)]2+, and 





G C8 142.91e, 142.86f 142.9e, 143.1f 142.6e, 142.7f 
C4(s) or C4!(u) 142.3g(u) 142.8 g(u), 142.7g(s) 142.0g(s) 
C3(s) or C3!(u) 124.4e(u), 124.3f(u) 124.1e(u), 124.0f(u), 
121.6e(s), 121.5f(s) 
121.2e(s), 121.1f(s) 
C5(s) or C5!(u) 126.8e(u), 126.9f(u) 126.5e(u), 126.8f(u), 
128.4e(s), 128.2f(s) 
128.6g(s) 
C7(s) or C7!(u) 60.6e(u), 60.8f(u) 60.5g(u), 62.2g(s) 62.6e(s), 62.2f(s) 
6/6!-CH3 or 6-CH3 - 24.7e, 25.2f 26.1e, 24.8f 
C6(s) or C6!(u) 149.7e(u), 150.3f(u) 148.2e(u), 149.0f(u), 
163.2e(s), 162.8f(s) 
163.9e(s), 163.8f(s) 
C2(s) or C2!(u) 167.4e(u), 167.2f(u) 168.4e(u), 168.1f(u), 
166.5e(s), 166.7f(s) 
167.3e(s), 167.7f(s) 
9-EtG CH2 41.9e, 41.7f 41.8e, 41.6f 41.63e, 41.59f 
9-EtG CH3 15.6g 16.1e, 15.8f 16.4e, 16.0f 
 
a (s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring.b Ref 1. c Free 9-EtG signals 
(ppm): C8 140.8; CH2 40.2; CH3 16.2. d Ref 2. e Signals from the anti rotamer. fSignals from the 
syn rotamer. g syn and anti signals are overlapped. 
!
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Table C.6: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(5!-GMP), Pt(N(H)6-Medpa)(5!-GMP), and  
Pt(N(H)6,6!-Me2dpa)(5!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
protona Pt(N(H)dpa)(5!-GMP)b,c Pt(N(H)6-Medpa)(5!-GMP)c Pt(N(H)6,6!-Me2dpa)(5!-GMP)c,d 
G H8 9.08e, 8.72f 9.13e, 8.77f, 8.76f 9.14e, 8.95 f 
H4(s) or H4!(u) 7.97g(u) 7.98g(u), 7.83g(s) 7.76g(s) 
H3(s) or H3!(u) 7.51g(u) 7.47g(u), 7.35g(s) 7.26g(s) 
H5(s) or H5!(u) 7.21g(u) 7.28e(u), 7.18f(u), 7.14e(s), 
7.19f(s) 
7.10g(s) 
6/6!-CH3 or 6-CH3 - 1.84
e, 1.81e, 1.76f, 1.73f 2.05e, 2.06e, 1.84f, 1.81f 
H6/6! or H6! 7.57e, 7.51f, 7.44 f 7.47e, 7.30e, 7.24f - 
a (s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 5!-GMP signals 
(ppm): H8 7.97; H1! 5.71. d Ref 2. e Signals from the anti rotamer. f Signals from the syn rotamer. 
















Table C.7: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(5!-GTP), Pt(N(H)6-Medpa)(5!-GTP), and  
Pt(N(H)6,6!-Me2dpa)(5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
protona Pt(N(H)dpa)(5!-GTP)b,c Pt(N(H)6-Medpa)(5!-GTP)c Pt(N(H)6,6!-Me2dpa)(5!-GTP)c,d 
G H8 9.21e, 8.79f 9.22e, 9.21e, 8.84f, 8.81f 9.22e, 9.05f 
H4(s) or H4!(u) 7.97g(u) 7.94g(u), 7.81g(s) 7.79g(s) 
H3(s) or H5!(u) 7.49g(u) 7.45g(u), 7.32g(s) 7.29g(s) 
H5(s) or H5!(u) 7.23g(u) 7.27e(u), 7.18f(u), 7.13e(s), 
7.17f(s) 
7.11g(s) 
6/6!-Me or 6-Me - 1.81e, 1.83f, 1.72e, 1.75f 2.05e, 2.07e, 1.84f, 1.81f 
H6/6! or H6! 7.57e, 7.49f, 7.43f 7.44e, 7.28f, 7.22f - 
a (s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b Ref 1. c Free 5!-GTP signals 
(ppm): H8 7.97; H1! 5.71. d Ref 2. e Signals from the anti rotamer. f Signals from the syn rotamer. 




Table C.8: 1H NMR Shifts (ppm) for Pt(N(H)dpa)(3!-GMP), Pt(N(H)6-Medpa)(3!-GMP), and  
Pt(N(H)6,6!-Me2dpa)(3!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
protona Pt(N(H)dpa)(3!-GMP)b,c Pt(N(H)6-Medpa)(3!-GMP)c Pt(N(H)6,6!-Me2dpa)(3!-GMP)c,d 
G H8 8.98e, 8.64f 9.05c, 9.04c, 8.76d 9.05c, 8.78d 
H4(s) or H4!(u) 8.01g(u) 7.99g(u), 7.86g(s) 7.79g(s) 
H3(s) or H3!(u) 7.54g(u) 7.49g(u), 7.37e(s), 7.36f(s) 7.31g(s) 
H5(s) or H5!(u) 7.25g(u) 7.28e(u), 7.20f(u),  
7.18e(s), 7.23f(s) 
7.12g(s) 
6/6!-CH3 or 6-CH3 - 1.84
e, 1.82e, 1.75f 2.05c, 2.06c, 1.80d, 1.79d 
H6/6! or H6! 7.62e, 7.60e, 7.50f 7.50e, 7.28f - 
a (s) = substituted pyridyl ring, (u) = unsubstituted pyridyl ring. b This work; adduct was prepared 
in a similar manner as reported in Ref 1. c Free 3!-GMP signals (ppm): H8 7.97; H1! 5.71. d Ref 2. 
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Figure C.1: 1H-1H ROESY spectrum showing H3-endo-H7, H3!-endo-H7!, H3-exo-H7, and H3!-

























































Figure C.2: HMBC spectrum (top) of [Pt(N(H)6-Medpa)Cl]Cl and 1D 13C NMR spectrum 
(bottom) of the C2, C2!, C6, C6!, C4, and C4! regions of [Pt(N(H)6-Medpa)Cl]Cl (D2O/DMSO-






































Figure C.3: Aliphatic region of the HSQC spectrum of the [Pt(N(H)6-Medpa)(9-EtG)]2+ adduct 
(D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peak labeled free G H8 is from an excess 






































Figure C.4: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GMP) adduct (top) recorded at 1.5 h after 






Figure C.5: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(5!-GTP) adduct  at 10 min (middle) and 1.5 h 
(top) after mixing (D2O/DMSO-d6 (64:36), pH 4.0, 25 °C, shifts in ppm). Peaks labeled X are 
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Figure C.6: 1H-1H ROESY spectrum showing H8-H6! NOE cross-peaks and absence of H8-H8 
EXSY cross-peaks of Pt(N(H)6-Medpa)(5!-GMP) (D2O/DMSO-d6 (64:36), pH 4.0, 15 °C, shifts 
in ppm). X = solvent impurity. The spectrum was recorded 2 h after initiation of the adduct 

































Figure C.7: Aliphatic region of the 1H NMR spectra of [Pt(N(H)6-Medpa)Cl]+ (bottom) and of 
the reaction mixture forming the Pt(N(H)6-Medpa)(3!-GMP) adduct at 10 min (middle) and 3 h 






Figure C.8: 1H NMR spectrum of the Pt(N(H)6-Medpa)(5!-GMP) adduct (D2O/DMSO-d6 
(64:36), pH 4.0, 15 °C, shifts in ppm) at 1 d  after mixing. Labeled peaks show the formation of 














Figure C.9: 1H NMR spectrum of the Pt(N(H)6-Medpa)(3!-GMP) adduct (D2O/DMSO-d6 
(64:36), pH 4.0, 15 °C,  shifts in ppm) at 1 d (top) after mixing. Labeled peaks show the 





References   
 
1. Andrepont, C.; Marzilli, P. A.; Marzilii, L. G. Inorg. Chem. 2012, 51, 11961-11970. 
2. Andrepont, C.; Pakhomova, S.; Marzilli, P. A.; Marzilii, L. G. Inorg. Chem. 2015, in press. 





APPENDIX D. SUPPLEMENTARY MATERIAL FOR CHAPTER 5 
 
Table D.1: Selected Bond Distances (Å) and Angles (deg) for [Pt(N(Me)6,6!-













Pt–N(1) 2.047(3) 2.006(3) 2.0256(11) 2.004(6) 
Pt–N(2) 2.026(4) 2.017(3) 2.0341(11) 2.022(5) 
Pt–N(3) 2.063(3) 2.007(3) 2.0232(11) 2.007(6) 
Pt–Cl(1) 2.3060(10) 2.3048(10) 2.3111(3) 2.293(2) 
bond angles 
N(1)–Pt–N(3) 164.16(14) - 165.29(5) 166.7(2) 
N(1)–Pt–Cl(1) 95.56(11) 96.62(9) 97.58(3) - 
N(2)A–Pt–Cl(1) 166.41(10) 179.52(9) 163.53(3) 176.8(2) 
N(3)–Pt–Cl(1) 100.28(10) 96.82(9) 97.13(3) - 
N(2)A–Pt–N(1) 82.01(14) 83.35(12) 82.87(4) 83.5(2) 
N(2)A–Pt–N(3) 82.67(14) - 83.15(4) 83.2(2) 









Table D.2: Selected 1H NMR Shifts (ppm) for the [Pt(N(Me)dpa)Cl]Cl, [Pt(N(prop)dpa)Cl]Cl, and 
[Pt(tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
 [Pt(N(Me)dpa)Cl]Cla [Pt(N(prop)dpa)Cl]Clb [Pt(tpa)Cl]Clc 
H4/4! 8.06 8.07 7.93 
H3/3! 7.57 7.55 7.42 
H5/5! 7.45 7.46 7.29 
endo-H7/7! 5.02 5.08 5.14 
exo-H7/7! 4.49 4.63 4.81 
H6/6! 8.67 8.63 8.46 
a N-Me signal: 2.91 ppm. b Propionic signals (ppm): 3.23 N-CH2, and 2.40 OC-CH2. c Dangling 














Table D.3: Selected 13C NMR Shifts (ppm) for the [Pt(N(Me)6,6!-Me2dpa)Cl]Cl, 
[Pt(N(prop)6,6!-Me2dpa)Cl]Cl, and [Pt(6,6!,6!!-Me3tpa)Cl]Cl adducts in D2O/DMSO-d6 (64:36, 
pH 4.0, 25 °C). 
 
 [Pt(N(Me)dpa)Cl]Cla [Pt(N(prop)dpa)Cl]Clb [Pt(tpa)Cl]Clc 
C4/4! 142.9 143.0 142.5 
C3/3! 125.5 124.9 124.8 
C5/5! 127.0 127.0 126.5 
C7/7! 70.8 70.5 70.6 
C2/2! 165.7 166.0 166.1 
C6/6! 151.0 150.9 150.6 
a N-Me signal: 52.0 ppm. b Propionic signals (ppm): 61.4 N-CH2, and 33.7 OC-CH2, and 174.6 















Table D.4: Selected 1H NMR Shifts (ppm) for the Pt(N(Me)dpa)G, Pt(N(prop)dpa)G, and 
Pt(tpa)G adducts (G = 5!-GMP, 3!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
 H8 free anti H8 syn H8 free H1! anti H1! syn H1! syn:anti ratio 
Pt(N(Me)dpa)(5!-GMP) 7.96 9.03 8.69 5.71 5.98 5.85 1.55:1 
Pt(N(Me)dpa)(3!-GMP) 7.87 8.97 8.60 5.72 5.87 5.81 1.65:1 
Pt(N(Me)dpa)(5!-GTP) 8.07 9.08 8.75 5.72 5.97 5.91 1.55:1 
        
Pt(N(prop)dpa)(5!-GMP)a 7.99 8.89 8.66 5.72 6.00 5.90 1:1.32 
Pt(N(prop)dpa)(3!-GMP)b 7.88 8.92 8.58 5.72 5.98 5.89 1.48:1 
Pt(N(prop)dpa)(5!-GTP)c 8.17 8.97 8.74 5.74 5.98 5.91 1.23:1 
        
Pt(tpa)(5!-GMP) 7.97 9.12 8.65 5.72 5.98 5.88 1.28:1 
Pt(tpa)(3!-GMP) 7.88 9.01 8.55 5.71 6.00 5.86 1.32:1 
a pH 7.3 syn H8:anti H8 ratio: 1:1.09. b pH 7.3 syn H8:anti H8 ratio: 1.38:1. c pH 7.3 syn H8:anti 












Table D.5: 1H NMR Shifts (ppm) for Pt(N(Me)dpa)G, Pt(N(prop)dpa)G and Pt(tpa)G adducts (G 
= 5!-GMP, 3!-GMP, and 5!-GTP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
  H5/5! H4/4! H3/3! H6/6! 
Pt(N(Me)dpa)(5!-GMP)a  7.31b, 7.27c 8.03d 7.59d 7.65b, 7.53c, 7.49c 
Pt(N(Me)dpa)(3!-GMP)e  7.33b, 7.29c 8.05d 7.61d 7.67b, 7.65b, 7.54c, 7.51c 
Pt(N(Me)dpa)(5!-GTP)f  7.33b, 7.26c 8.01d 7.57 d 7.65b, 7.51c, 7.45c 
      
Pt(N(prop)dpa)(5!-GMP)g  7.33b, 7.27c 8.07b, 8.04c  7.57d 7.63b, 7.61b, 7.51c, 7.47c 
Pt(N(prop)dpa)(3!-GMP)h  7.34b, 7.30c 8.08b, 8.06c 7.62b, 7.59c 7.65b, 7.63b, 7.54c, 7.51c 
Pt(N(prop)dpa)(5!-GTP)i  7.36b, 7.26c 8.06b, 8.02c 7.60b, 7.56c 7.66b, 7.65b, 7.51c, 7.44c 
      
Pt(tpa)(5!-GMP)j  7.20b, 7.13c 7.93b, 7.88c 7.46b, 7.39c 7.55b, 7.48b, 7.41c, 7.35c 
Pt(tpa)(3!-GMP)k  7.18b, 7.16c 7.93b, 7.90c 7.48b, 7.41c 7.51b, 7.47b, 7.43c, 7.40c 
a N-Me signal: 2.95 (syn) and  2.97 (anti) ppm. b Signals from the anti rotamer. c Signals from the 
syn rotamer. d Syn and anti signals are overlapped Signals from the anti rotamer. e N-Me signal: 
2.97 (syn) and 2.96 (anti) ppm. f N-Me signal: 2.94 (syn) and 2.98 (anti) ppm. g Propionic signals 
(ppm): 3.24 (anti) and 3.32 (syn) N-CH2, 2.32 (anti) and 2.86 (syn) OC-CH2. h Propionic signals 
(ppm): 3.25 (syn) and 3.31 (anti) N-CH2, 2.89 (syn) and 2.42 (anti) OC-CH2. i Propionic signals 
(ppm): 3.23 (syn) and 3.32 (anti) N-CH2, 2.43 (syn) and 2.90 (anti) OC-CH2. j Dangling signals 
(ppm): 8.51 (syn and anti signals overlapped) H3!!, 7.43 (syn) and 7.60 (anti) H4!!, 7.00 (syn) 
and 7.03 (anti) H5!!, 8.12 (syn) and 8.19 (anti) H6!!. k Dangling signals (ppm):  8.53 (syn and anti 
signals overlapped) H3!!, 7.46 (syn) and 7.56 (anti) H4!!, 7.00 (syn) and 7.04 (anti) H5!!, 8.13 









Table D.6: Selected 1H NMR Shifts (ppm), Syn H8:Anti H8 Intensity Ratios, and Δδ for the 
Pt(N(H)dpa)(G), Pt(N(H)6-Medpa)(G), and [Pt(N(H)6,6!-Me2dpa)(G) adducts (G = 9-EtG, 5!-
GMP, and 3!-GMP) in D2O/DMSO-d6 (64:36, pH 4.0, 25 °C). 
 
adducts free H8 syn H8 anti H8 syn H8:anti H8 Δδ 
[Pt(N(H)dpa)(9-EtG)]2+a 7.72 8.40 8.73 1.28:1 0.33 
Pt(N(H)dpa)(3!-GMP)b 7.87 8.64 8.98 1.35:1 0.34 
Pt(N(H)dpa)(5!-GMP)a 7.96 8.72 9.08 1.14:1 0.36 
Pt(N(H)dpa)(5!-GTP)a 7.97 8.79 9.21 1:1.22 0.42 
      
[Pt(N(H)6-Medpa)(9-EtG)]2+b 7.73 8.43 8.80 2.10:1 0.37 
Pt(N(H)6-Medpa)(3!-GMP)b 7.87 8.67 9.05, 9.04 2.27:1 0.38 
Pt(N(H)6-Medpa)(5!-GMP)b 7.97 8.77, 8.76 9.13 2.19:1 0.36 
Pt(N(H)6-Medpa)(5!-GTP)b 7.98 8.84, 8.81 9.22, 9.21 1.96:1 0.41 
      
[Pt(N(H)6,6!-Me2dpa)(9-EtG)]2+c 7.72 8.54 8.84 1:1.42 0.30 
Pt(N(H)6,6!-Me2dpa)(3!-GMP)c 7.87 8.78 9.05 1:2.03 0.27 
Pt(N(H)6,6!-Me2dpa)(5!-GMP)c 7.97 8.92 9.14 1:2.04 0.22 
Pt(N(H)6,6!-Me2dpa)(5!-GTP) 7.98 9.05 9.22 1:2.01 0.17 










Table D.7: Syn H8:Anti H8 Intensity Ratios for Pt(N(H)dpa)G, Pt(N(Me)dpa)G, Pt(N(H)6-
Medpa)G, and Pt(N(H)6,6!-Me2dpa)G Adducts (G = 5!-GMP and 5!-GTP) in D2O/DMSO-d6 
(64:36, 25 °C). 
 
 pH syn:anti ratio 














Pt(N(H)6-Medpa)(5!-GMP)f 2.7 2.21:1 
















a Ref 3.    b H8: 9.16 (anti), and 8.75 ppm (syn). c H8: 9.22 (anti), and 8.79 ppm (syn). d H8: 9.06 
(anti), and 8.71 ppm (syn). e H8: 9.07 (anti), and 8.73 ppm (syn). f Ref 4. g H8: 9.19, 9.18 (anti), 
and 8.81, 8.78 ppm (anti). h H8: 9.22, 9.21 (anti), and 8.84, 8.81 ppm (syn). i Ref 5. j H8: 9.18 
















Figure D.1: Overlap of [Pt(N(H)6,6!-Me2dpa)Cl]+ (red) and [Pt(N(Me)6,6!-Me2dpa)Cl]+ (blue) 






























Figure D.2: HSQC spectrum of [Pt(N(Me)6,6-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6  (64:36), pH 

























Figure D.3: HMBC spectrum of [Pt(N(Me)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH 





























Figure D.4: HSQC spectrum of [Pt(N(prop)6,6!-Me2dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), 





















Figure D.5: HSQC spectrum of [Pt(6,6!,6!!-Medpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH 4.0, 














































Figure D.6: HSQC spectrum of [Pt(N(prop)dpa)Cl]Cl (25 °C, D2O/DMSO-d6 (64:36), pH 4.0, 

















Figure D.7: Aliphatic region of the 1H NMR spectra of [Pt(N(Me)6,6!-Me2dpa)Cl]+ (a) and of the 
reaction mixture 3 d after adding 3.5 equiv of G to form the Pt(N(Me)6,6!-Me2dpa)(5!-GMP) (b), 
Pt(N(Me)6,6!-Me2dpa)(3!-GMP) (c), and Pt(N(Me)6,6!-Me2dpa)(5!-GTP) (d) adduct (25 °C, 
D2O/DMSO-d6 (64:36), pH 4.0, shifts in ppm). Peaks labeled with an * are from the bis adduct. 













































Figure D.8: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) 
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-
Me2dpa)(5!-GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts 























































Figure D.9: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) 
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-
Me2dpa)(3!-GMP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts 














































Figure D.10: Aliphatic region of the 1H NMR spectra of [Pt(N(prop)6,6!-Me2dpa)Cl]+ (bottom) 
and of the reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(N(prop)6,6!-
Me2dpa)(5!-GTP) adduct at pH 4.1 (middle) and 7.3 (top) (25 °C, D2O/DMSO-d6 (64:36), shifts 





















Figure D.11: Aliphatic region of the 1H NMR spectra of [Pt(6,6!,6!!-Me3tpa)Cl]+ (a) and of the 
reaction mixture 7 d after adding 3.5 equiv of G to form the Pt(6,6!,6!!-Me3tpa)(5!-GMP) (b), 
Pt(6,6!,6!!-Me3tpa)(3!-GMP) (c), and Pt(6,6!,6!!-Me3tpa)(5!-GTP) (d) adduct (25 °C, 




























Figure D.12: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(5!-GMP) adduct (top) 































Figure D.13: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(3!-GMP) adduct (top) 







































Figure D.14: Aromatic region of the 1H NMR spectra of [Pt(tpa)Cl]+ (bottom) and of the reaction 
mixture 2 d after adding 2.5 equiv of G to form the Pt(tpa)(5!-GMP) adduct (top) (25 °C, 





































Figure D.15: Aromatic region of the 1H NMR spectra of [Pt(tpa)Cl]+ (bottom) and of the reaction 
mixture 2 d after adding 2.5 equiv of G to form the Pt(tpa)(3!-GMP) adduct (top) (25 °C, 
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Figure D.16: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(5!-GMP) adduct at 


































Figure D.17: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(3!-GMP) adduct at 






































Figure D.18: Aromatic region of the 1H NMR spectra of [Pt(N(prop)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(prop)dpa)(5!-GTP) adduct at 

























Figure D:19: Aromatic region of the 1H NMR spectra of [Pt(N(Me)dpa)Cl]+ (bottom) and of the 
reaction mixture 2 d after adding 2.5 equiv of G to form the Pt(N(Me)dpa)(5!-GTP) adduct (top) 
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